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The extreme amino (N)-terminus of a protein is highly informative of protein stability, 
localisation, function, as well as regulation. Protein N-termini often undergo post-
translational modifications (PTMs), some of which generate new proteoforms with neo-N-
termini due to proteolytic processing. N-terminal PTMs and the resulting proteoforms 
greatly contribute to the complexity of the proteome. Additionally, authentic N-termini may 
differ from those predicted by genome analysis.  
This thesis describes studies to further develop and to optimise techniques that modify, 
enrich and identify the N-termini of proteins. The previously reported “NHS-Sepharose 
technique” removes unwanted peptides after acetylation of amino groups and protease 
digestion, thereby enriching for N-terminal peptides. Using this negative selection strategy, 
the desired N-terminal peptides were shown to be contaminated with specific neo-peptides. 
Various parameters were therefore systematically modified in conjunction with model 
proteins to achieve complete removal of neo-peptides. Investigation of alternative amine-
reactive chemistries using N-succinimidyl S-acetylthioacetate or citraconic anhydride 
indicated that they were not superior to the original amine acetylation approach. 
The studies also explored a positive selection strategy that directly enriches for protein N-
termini. Selective Transamination Of N-Ends (STONE) is a promising reaction for this purpose. 
Use of STONE with subsequent biotinylation of the introduced carbonyl groups allowed N-
terminal affinity tagging of synthetic peptides and model proteins. It was confirmed that the 
latter were amenable to avidin-biotin affinity enrichment. Treatment of extracts from Jurkat 
T-lymphocytes by STONE allowed the experimental verification of N-termini from a range of 
proteins. Previously unreported N-terminal methionine excision was also uncovered in 
cytoplasmic serine-tRNA ligase (SYSC_HUMAN) and peptidyl-prolyl cis-trans isomerase 
FKBP5 (FKBP5_HUMAN). 
STONE-mediated removal of the α-amino groups of peptides and proteins alters their net 
charge. This suggested that it could be used to achieve orthogonal peptide separations in LC-
MS/MS, and hence discover additional peptides in shotgun proteomic experiments. Using 
protein extracts from Jurkat T-cells, STONE was shown to increase the number of identified 
peptides by 25%, thereby significantly also increasing protein sequence coverage and the 
number of assigned proteins. The unexpectedly large increase in the number of detected 
peptides, coupled with the versatility and simplicity of STONE, suggests that it may find 




I would like to thank my supervisor, Prof. David O’Connor for leading me into the fascinating 
world of science. I have been dreaming of working in proteomics since the third year of my 
undergraduate study, so this is indeed a dream come true. I am sincerely grateful to his 
supervision and guidance during the past five years. Most importantly, I thank him for the 
support when I met so many unexpected encounters in my life. All in all, it has been a 
fulfilling experience to work in his lab. 
I would also like to thank my second supervisor, Prof. Rob Beynon, and two PhD assessors, 
Prof. Claire Eyers and Dr David Ruiz-Carrillo, for the inspirational discussions about my 
research. I also need to acknowledge both Xi’an Jiaotong-Liverpool University and the 
University of Liverpool for providing this opportunity to do my research and the financial 
support. 
I would like to express my sincere gratitude to the past and present members in the DO’C lab: 
Jing Li, Yanni Xue, Zimeng Zhang, Li Shen, Yu Gan, and Manting Xue. In particular, I truly 
thank Jing Li for sharing the lab knowledge and helping me analyse all the data. I would like 
to acknowledge Zimeng Zhang and Yu Gan for the participation in systematic refinement of 
the NHS-Sepharose method and investigation of alternative amine-reactive chemistries, 
respectively. All the data were jointly analysed. I am also grateful to Li Shen for our mutual 
understanding and the crazy talks about science. 
In addition, I am truly grateful to other research groups in the Department of Biological 
Sciences at XJTLU. In particular, I thank Prof. Tatsuhiko Kadowaki and Dr Magdalini Matziari 
for providing reagents and valuable suggestions on my research. I appreciate Dr Hebin Liu 
and Dr Rong Rong for providing Jurkat cell line. 
I am sincerely grateful to the PhD community in the Department, including Dr Xiaochen (Will) 
Liu, Dr Xiaofeng Dong, Dr Fan Bu, Dr Adharsh Rajasekar, Dr Kiran Kumar, and Dr Dongqing 
Ma. In particular, I am grateful to Zhen Wei and Jingting Zhu for the training on statistical 
analysis with R and cell culture skills, respectively.  
I cannot give enough credits to my friends, Guangcai Xu, Cheng Jiang, Bingjie Jiang, Liji Huang, 
who were always turning my complaints into positive thinking. Finally, my eternal gratitude 
goes to my parents and my wife for their unconditional love. My biggest regret during the 
past five years is not being with my mother when she suffered so much for me. 
IV 
 
Table of Contents 
Abstract ..................................................................................................................................... II 
Acknowledgements .................................................................................................................. III 
Table of Contents ..................................................................................................................... IV 
List of Abbreviations ................................................................................................................ VII 
Chapter 1. Introduction ............................................................................................................. 1 
1.1 Proteome and proteomics ......................................................................................... 1 
1.1.1 Mass spectrometry-based proteomics ............................................................... 2 
1.1.2 Major focus areas of MS-based proteomics ..................................................... 11 
1.2 Protein PTMs and N-terminal PTMs ......................................................................... 15 
1.2.1 Protein PTMs .................................................................................................... 15 
1.2.2 Examples of covalent PTMs .............................................................................. 16 
1.2.3 Proteolysis as a PTM ......................................................................................... 18 
1.2.4 N-terminal PTMs ............................................................................................... 19 
1.3 High-throughput techniques in N-terminalomics .................................................... 21 
1.3.1 Negative selection strategies............................................................................ 22 
1.3.2 Positive selection strategies ............................................................................. 27 
1.4 Transamination of protein N-termini ....................................................................... 29 
1.4.1 Selective transamination of protein N-termini and other transamination routes 
  .......................................................................................................................... 29 
1.4.2 Applications of Nt-transamination ................................................................... 32 
1.4.3 Alternative amine-reactive chemistry .............................................................. 34 
1.5 Jurkat T-lymphocytes as a model system ................................................................. 36 
1.5.1 T-cell biology and the Jurkat model system ..................................................... 36 
1.5.2 Jurkat proteomics ............................................................................................. 39 
1.6 Aims of the present work ......................................................................................... 40 
Chapter 2. Materials and Methods ......................................................................................... 41 
V 
 
2.1 Materials .................................................................................................................. 41 
2.2 Cell culture ............................................................................................................... 42 
2.3 Protein extraction .................................................................................................... 42 
2.4 Protein quantitation ................................................................................................. 42 
2.5 Negative selection of protein N-termini by NHS-Sepharose method ...................... 43 
2.6 Systematic refinement of NHS-Sepharose approach ............................................... 43 
2.7 Blocking of primary amines with SATA or CA ........................................................... 44 
2.8 Transamination ........................................................................................................ 45 
2.9 Chemical tagging of the transaminated proteins or peptides ................................. 46 
2.10 Enrichment of the biotinylated proteins .................................................................. 46 
2.11 Gel electrophoresis and immunoblotting ................................................................ 47 
2.12 Sample preparation .................................................................................................. 48 
2.13 LC-MS/MS ................................................................................................................. 48 
2.14 Data analysis............................................................................................................. 49 
2.15 Data mining .............................................................................................................. 49 
Chapter 3. Critical assessment of the NHS-Sepharose approach for recovery of N-terminal 
peptides ................................................................................................................................... 51 
3.1 Introduction ............................................................................................................. 51 
3.2.1 Implementation of the NHS-Sepharose approach ........................................... 54 
3.2.2 Method improvement by refining experimental conditions ............................ 66 
3.2.3 Use of SATA and CA as an alternative approach to select protein N-termini .. 81 
3.3 Discussion ................................................................................................................. 91 
Chapter 4. Feasibility of selective transamination for tagging the N-termini of proteins ...... 99 
4.1 Introduction ............................................................................................................. 99 
4.2 Results .................................................................................................................... 102 
4.2.1 Design of a transamination-based positive selection strategy ...................... 102 
4.2.2 Experiments with model peptides .................................................................. 105 
4.2.3 Experiments with model proteins .................................................................. 119 
VI 
 
4.3 Discussion ............................................................................................................... 136 
Chapter 5. Use of the transamination approach in shotgun proteomics ............................. 146 
5.1 Introduction ........................................................................................................... 146 
5.2 Results .................................................................................................................... 148 
5.2.1 Experiments with complex protein mixtures from Jurkat T-cells ................... 148 
5.2.2 Proteomic identification of the N-termini of Jurkat proteins using selective 
transamination .............................................................................................................. 153 
5.2.3 Proteomic analysis of Jurkat T-cells using selective transamination .............. 164 
5.3 Discussion ............................................................................................................... 177 
Chapter 6. Conclusions .......................................................................................................... 188 




List of Abbreviations 
2D  Two-dimensional 
3D  Three-dimensional 
2PCA  2-Pyridinecarboxaldehyde 
ACTH  Adrenocorticotropic hormone 
AD  Alzheimer’s disease 
AI  Artificial intelligence 
ANOVA  Analysis of variance 
AP  Affinity purification 
APC  Antigen-presenting cell 
APEX  Absolute protein expression 
AP-MS  Affinity purification–mass spectrometry 
AQUA  Absolute quantification 
BCA  Bicinchoninic acid 
Bis-Tris  Bis(2-hydroxyethyl)amino-tris(hydroxymethyl)methane 
BnONH2 O-Benzylhydroxylamine 
bp  Base-pair 
BSA  Bovine serum albumin 
CA  Citraconic anhydride 
CD  Cluster of differentiation 
ChaFRADIC Charge-based fractional diagonal chromatography 
CID  Collision-induced Dissociation 
COFRADIC Combined fractional diagonal chromatography 
DAVID  Database for Annotation, Visualization and Integrated Discovery 
DC  Direct current 
DDA  Data-dependent acquisition 
DIA  Data-independent acquisition 
DNPH  2,4-Dinitrophenylhydrazine 
DTT  DL-Dithiothreitol 
E-value  Peptide expectation value 
EDTA  Ethylenediaminetetraacetic acid 
emPAI  Exponentially modified protein abundance index 
ESI  Electrospray ionisation 
ETD  Electron Transfer Dissociation 
VIII 
 
FBS  Foetal bovine serum 
FDR  False discovery rate 
GO  Gene Ontology 
h  Hour 
HCD  Higher-energy Collisional Dissociation 
HD  Huntington’s disease 
HPG-ALD Hyperbranched polyglycerol-aldehydes 
iBAQ  Intensity-based absolute quantification 
ID  Identifier (Swiss-Prot or ProteomeXchange) 
IEF  Isoelectric focusing 
IgG  Immunoglobulin G 
IL-2  Interleukin-2   
iTRAQ  Isobaric peptide tags for relative and absolute quantification 
Kd  Dissociation constant 
LC  Liquid chromatography 
LC-MS/MS Liquid chromatography–tandem mass spectrometry  
m  Mass 
MALDI  Matrix-assisted laser desorption/ionisation 
MES  2-(N-Morpholino)ethanesulfonic acid 
MetAP  Methionine aminopeptidase 
MGF  Mascot generic format 
MHC  Major histocompatibility complex 
min  Minute 
MMP  Matrix metalloproteinases 
MOPS  3-(N-Morpholino)propanesulfonic acid 
MS  Mass spectrometry 
MS1  Full mass spectrum 
MS2  Tandem mass spectrum 
MW  Molecular weight 
MWCO  Molecular weight cut-off 
m/z  Mass-to-charge ratio 
N  Total number of replicates 
NAT  N-terminal acetyltransferase 
N-CLAP  N-terminalomics by chemical labeling of the α-amine of proteins 
IX 
 
NHS  N-hydroxysuccinimide 
NL  Normalised intensity level 
NME  N-terminal methionine excision 
Nrich  N-terminal peptides enrichment on the filter 
N-TAILS  N-terminal amine isotopic labeling of substrates 
P-value  Probability value 
PBS  Phosphate-buffered saline 
PEG  Polyethylene glycol 
pH  Potential for hydrogen 
pI  Isoelectric point 
PITC  Phenyl isothiocyanate 
pKa  Acid dissociation constant 
PLCγ1  Phospholipase C-gamma1 
PLP  Pyridoxal-5’-phosphate 
PMSF  Phenylmethanesulfonyl fluoride 
PPI  Protein-protein interaction 
ppm  Parts per million 
PQD  Pulsed Q Collision-induced Dissociation 
PRINT  PRotect, INcise, Tag 
PSM  Peptide-spectrum match 
PTM  Post-translational modification 
PTAG  Phospho-tagging 
Q  Quadrupole 
QqQ  Triple quadrupole 
R  Resolution (mass analyser)  
RP-HPLC Reversed-phase high-performance liquid chromatography 
RF  Radiofrequency 
RT  Room temperature 
RT  Retention time 
RS  N‑Methylpyridinium-4-carboxaldehyde 
s  Second 
SATA  N-succinimidyl S-acetylthioacetate 
SCX  Strong cation exchange 
SDS  Sodium dodecyl sulfate 
X 
 
SDS-PAGE Sodium dodecyl sulfate–polyacrylamide gel electrophoresis 
SILAC  Stable isotope labeling with amino acids in cell culture 
SRM  Selected reaction monitoring 
STONE  Selective Transamination Of N-Ends 
SUMO  Small ubiquitin-like modifier 
SWATH  Sequential window acquisition of all theoretical fragment-ion spectra 
TAP  Tandem affinity purification 
TCA Trichloroacetic acid 
TCR T-cell receptor 
TEV Tobacco etch virus 
TFT-α Tumor necrosis factor-α 
TIC Total ion current chromatogram 
TMPP N-succinimidyloxycarbonylmethyl tris(2,4,6-trimethoxyphenyl)phosphonium 
bromide 
TMT  Tandem mass tag 
TNBS  2,4,6-trinitrobenzenesulfonic acid 
TOF  Time-of-flight 
Tris  Tris(hydroxymethyl)aminomethane 
Ub  Ubiquitin 
UPS  Ubiquitin-proteasome system 
UV  Ultraviolet 
UVPD  Ultraviolet Photodissociation  
v  Volume 
w  Weight 
XIC  Extracted ion chromatogram 
Y2H  Yeast two-hybrid   
z  Electric charge  
1 
 
Chapter 1. Introduction 
1.1 Proteome and proteomics 
After the completion of the Human Genome Project in 2003, we are now living in a post-
genomic era with more than 5,000 reference genomes available to the public (source: Kyoto 
Encyclopedia of Genes and Genomes, 12 Jan. 2018). However, the number of protein-coding 
genes does not faithfully reflect the complexity of organisms. For instance, human only 
possesses approximately 19,600 protein-coding genes (The UniProt Consortium, 2013), 
which are even fewer than those in a small worm like Caenorhabditis elegans (20,447; Bass 
et al., 2016). The discrepancy between gene number and species complexity drives further 
research on the function of the “Junk DNA”, non-coding RNA, as well as proteins. As 
described in the central dogma of molecular biology, proteins are the receiving terminal of 
genetic information that flows from nucleic acids (Crick, 1970). The central dogma is often 
illustrated as DNA ↔ RNA → Protein. Proteins are essential biomolecules that are 
synthesised through the assembly of amino acids into polypeptide chains. These 
biomolecules participate in virtually all cellular processes and contribute in a major way to 
the phenotype of individual organisms. 
Given the importance of protein functions and the availability of genome sequences, there 
have been tremendous efforts to study the entire complement of proteins expressed in an 
organism. The original idea of the “total protein set” is analogous to the genome in concept, 
and the term “proteome” was first introduced by Marc Wilkins at a meeting in Siena, 1994 
to properly describe this idea (Wilkins et al., 1996). Similarly, the study of the proteome is 
termed “proteomics” by analogy with the genomics. Even though the traditional view of the 
“static genome” has drastically changed in the last decade, the proteome is still considered 
much more dynamic than the genome, by several orders of magnitude (Brower, 2001). 
Within an individual organism, the proteome varies considerably between different 
tissue/cell types and different times. Furthermore, the proteome exhibits characteristic 
perturbations in response to environmental stimuli and in disease states. As a result, the 
proteome is currently defined as the total set of expressed proteins in a specific biological 
context (cell, tissue, or organism) at a particular time and under defined conditions 
(Chandramouli and Qian, 2009). 
Proteomics is a multifaceted research field, encompassing a wide variety of technical 
disciplines that range from the yeast two-hybrid (Y2H) system to microarray-based 
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techniques (Aebersold and Mann, 2003). Such techniques can be employed to determine 
protein-protein interactions (PPIs), protein structures and locations, as well as to detect and 
measure changes in gene expression under different conditions. However, it is well 
acknowledged that the global analysis of proteins poses great technical challenges. The 
difficulty partly owes to the spatio-temporal variability and dynamic nature of the proteome 
(as described above). This difficulty is further compounded by alternative splicing at mRNA 
level, post-translational modifications (PTMs) of proteins, and PPIs. Another tier in the 
complexity originates from the physico-chemical diversity of proteins and the wide dynamic 
range of protein expression (Altelaar et al., 2013). 
1.1.1 Mass spectrometry-based proteomics  
Over the past twenty years, there have been many technological breakthroughs in protein 
separation, analytical science, and bioinformatics to resolve the said complexity. In this 
regard, proteomics is a research field driven by technology (Wilkins and Appel, 2007). 
Among all the breakthroughs, the maturation of mass spectrometry (MS) has fundamentally 
transformed the proteomic research. MS-based proteomics provides reliable identification 
and quantitation of proteins in a high-throughput manner. There are a large variety of MS 
instruments, but each basically consists of an ion source, one or more mass analysers, and a 
detector (Figure 1.1). Such systems measure the mass-to-charge ratio (m/z) of charged 
particles from which the mass can usually be deduced. 
 
Figure 1.1 Basic setup of mass spectrometry (MS) instrumentation, which invariably consists of an ion 
source, one or more mass analysers, and a detector (adapted from Gross, 2017). In MS-based 
proteomics, protein samples are typically converted to peptides and then introduced to a liquid 
chromatography (LC) system. This sample inlet is coupled online to an MS instrument. 
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Although MS is an essential tool in proteomics, it is not a novel technology specifically 
developed for this purpose. The first mass spectrometer was invented by J. J. Thomson in 
the early 20th century to measure the m/z of atoms and indeed the electron (reviewed in 
Griffiths, 2008). The use of MS largely remained in the realm of physics and chemistry until 
the late 1980s, when the ionisation of proteins and peptides was made possible. Two “soft” 
ionisation techniques, matrix-assisted laser desorption/ionisation (MALDI) and electrospray 
ionisation (ESI), were developed to ionise such biological macromolecules for MS analysis 
without significant fragmentation (Karas and Hillenkamp, 1988, Fenn et al., 1989). The 
MALDI technique involves pulsed laser irradiation of protein/peptide analytes that have 
been mixed with light-absorbing compounds (i.e. the “matrix”). Upon irradiation, the matrix 
absorbs ultraviolet (UV) light and sublimes, transferring energy to the embedded analytes 
for ionisation. In MALDI-MS, protein/peptide analytes are converted into gas-phase ions 
mostly with a single charge (Karas et al., 2000). Ionised analytes are then accelerated by 
electric potentials into most often a time-of-flight (TOF) mass analyser.  
A TOF analyser deduces the m/z values of ionised analytes by simply measuring the time 
taken by ions to fly through a tube of set length under vacuum to reach the mass detector. 
Such deduction is based on the direct relationship between the flight time and the m/z of 
ions, which are accelerated by application of a constant voltage. This relationship can be 
expressed as: m/z = K × t2, where t is flight time and K is a coefficient determined by the 
voltage and tube length (El-Aneed et al., 2009). A reflector that turns around the ion path is 
employed by modern TOF analysers to correct for small differences in initial kinetic energies 
of the accelerated ions, as well as to increase the flight distance. As a result, TOF analysers 
provide outstanding resolving power (~ 25,000) and mass accuracy (5 – 10 parts per million, 
ppm), the fastest data acquisition, as well as a very high m/z range (Calvete, 2014).  
MALDI-MS is often used to characterise protein/peptide samples of low complexity 
(Aebersold and Mann, 2003). Recently, there has been a tremendous advance in imaging 
techniques that rely on MALDI-MS (referred to as “MALDI-MS imaging”). Their applications 
include the resolution of protein spatial distribution in tissue specimens (Aichler and Walch, 
2015).  
Meanwhile, the ESI technique employs a strong electric field (≥ 2 kV) to charge liquid 
droplets, which emerge from the tip of an electrospray capillary and typically contain 
proteins or peptides previously separated by liquid chromatography (LC). The charged 
droplets are emitted from the capillary to the counter electrode at atmospheric pressure. 
Due to solvent evaporation, the charged droplets gradually shrink and then produce smaller 
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droplets by Coulomb explosions (Dole et al., 1968). Ultimately, each charged droplet 
contains a single protein/peptide and yield gas-phase ions (Thomson and Iribarne, 1979). In 
contrast to MALDI, ESI can be conveniently coupled to LC systems as well as a large variety 
of mass analysers (see below). Equally importantly, it yields multiply-charged peptide and 
protein ions, which brings large molecules into the analysable range. ESI-MS is therefore 
currently preferred for analysing complex proteomes (Aebersold and Mann, 2003).  
A quadrupole (Q) mass analyser is composed of four parallel magnetic rods to which a direct 
current (DC) and a superimposed radiofrequency (RF) potential are applied. An alternating 
electromagnetic field is thus created, serving as a mass filter for ions of the specified m/z to 
pass through and reach the mass detector. Ions other than those of the desired m/z value 
have unstable trajectories and will collide with the metal rods and hence are not detected. A 
range of m/z values can be systematically scanned by continuously varying the amplitudes of 
the applied DC/RF potentials at a fixed ratio (Dawson, 2013).  
A Q analyser is of limited resolution (4,000) and mass accuracy (100 ppm), and lacks the 
ability to perform tandem mass spectrometry (MS/MS) on its own (Calvete, 2014). The 
MS/MS technique is pivotal to contemporary proteomics since not only does it determines 
the m/z value of an ionised peptide but also provides sequence information of the peptide 
through a fragmentation process (Steen and Mann, 2004). The lack of MS/MS capability can 
be compensated for, however, by coupling a Q analyser to other mass analysers. This is 
exemplified by triple quadrupole (QqQ) and other hybrid configurations (e.g. Q-TOF). The 
high dynamic range (107) of Q analysers confers advantages in quantitative proteomics 
(Hart-Smith and Blanksby, 2012). 
Ion trap mass analysers, in either a linear or three-dimensional (3D) configuration, employ 
an RF electric field to confine ionised analytes. Trapped ions are then excited by increasing 
the RF amplitude and ejected to reach the mass detector outside the ion trap (Cooks et al., 
1991). As a result, the m/z of these ions can be scanned according to the correlation 
between RF amplitudes and m/z values (Wong and Cooks, 1997). The strengths of ion trap 
analysers primarily lie in their affordability, robustness, and simplicity. In addition, ion trap 
analysers possess high sensitivity and the capability to perform multistage mass 
spectrometry (MSn) analysis (Hart-Smith and Blanksby, 2012). But similar to Q analysers, ion 
traps have shortcomings in resolving power and mass accuracy. 
The Orbitrap is the most recent entry in this series of mass analysers. It is a modified ion trap 
consisting of a central spindle electrode and two endcap electrodes. Unlike conventional ion 
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traps, the Orbitrap confines ionised analytes by a ramping of electrostatic fields on the 
central electrode (a procedure known as "electrodynamic squeezing"; Hu et al., 2005). Once 
trapped inside the analyser, ions of different m/z values orbit the central electrode at 
different frequencies and are eventually separated into discrete rings. Such oscillations 
induce an image current on the endcap electrodes, which is then recorded by the mass 
detector. The m/z of these ions can be deduced through fast Fourier transformation of their 
orbiting frequencies (Lange et al., 2014a). Compared with other mass analysers described 
above, the Orbitrap exhibits the highest resolution (1,000,000) and accuracy (2 – 5 ppm), 
which underlie its widespread use in proteomics (Denisov et al., 2012, Calvete, 2014). 
As stated before, once a peptide is ionised and its m/z value (and thus the mass) determined, 
sequence information can be further provided by MS/MS, although this technique has not 
yet achieved the same extent of success when analysing intact proteins, i.e. “top-down 
proteomics” (Catherman et al., 2014). In MS/MS, an ionised peptide is selectively 
fragmented into its basic constituents and the resulting mass spectrum is interpreted to 
determine the peptide sequence. There are two operation modes for MS/MS: tandem-in-
space and tandem-in-time. The former refers to the physical coupling of two mass analysers 
for determination of mass and sequence information, respectively (de Hoffmann and 
Stroobant, 2007). The two analysers are separated by a device for peptide fragmentation, 
known as a collision cell, as exemplified by QqQ and Q-TOF configurations. On the other 
hand, both mass and sequence information of a peptide can be determined using a single 
mass analyser in the tandem-in-time mode. This is only possible with analysers that possess 
trapping capabilities (Johnson et al., 1990).  
The fragmentation step is critical to the success of MS/MS experiments, and there are a 
plethora of fragmentation techniques currently available to proteomics researchers. These 
include Collision-induced Dissociation (CID), Higher-energy Collisional Dissociation (HCD), 
Electron Transfer Dissociation (ETD), Pulsed Q Collision-induced Dissociation (PQD), and UV 
Photodissociation (UVPD). These fragmentation techniques ultimately define the resulting 
ion species, and each technique possesses unique characteristics that merit its specific 
application in MS/MS (Sleno and Volmer, 2004). 
As the most universal technique, CID has been employed for peptide fragmentation since 
the 1980s (Biemann, 1986, Hunt et al., 1986). During this process, ions that correspond to a 
peptide of interest (i.e. “precursor ions”) are first transmitted to a collision cell in the case of 
a QqQ configuration, or confined in an ion trap analyser whilst other ions are resonantly 
ejected from the trap. In either case, the selected precursor ions collide with inert gases (He, 
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Ar, or N2) and kinetic energies are imparted onto the precursor ions. Such events increase 
the internal energy of precursor ions, inducing fragmentation mainly through the lowest 
energy pathways (i.e. cleavage of peptide bonds; Roepstorff and Fohlman, 1984). The wide 
acceptance of CID in MS-based proteomics is primarily attributed to the ease of 
implementation and high fragmentation speed/efficiency (Wells and McLuckey, 2005). 
In peptide fragmentation along its backbone, breakage of Cα–C, C–N (the peptide bond), or 
N-Cα bond is possible between any two adjacent amino acid residues. Each bond breakage 
gives rise to a neutral fragment and a charged species (i.e. a “fragment ion”). Depending on 
which bond is cleaved, a charged species is designated as a-, b-, or c-ion if the charge is 
retained on the amino (N)-terminal fragment. On the other hand, an x-, y-, or z-ion is 
produced if the charge is retained on the carboxyl (C)-terminal fragment (Figure 1.2; 
Roepstorff and Fohlman, 1984, Johnson and Biemann, 1989). With respect to tryptic peptide 
fragmentation by CID, the charged fragments are predominantly b- and y-ion species 
(Wysocki et al., 2000). This knowledge of fragmentation patterns greatly facilitates 
interpretation of the resulting mass spectra. However, CID has intrinsic limitations in 
detecting fragment ions in the low m/z range as well as in preserving labile chemical groups 
on peptides subjected to post-translational modifications (PTMs; Sleno and Volmer, 2004, 
Creese and Cooper, 2007). These limitations largely hinder the use of CID for isobaric tag-
based quantitation or PTM identification (see sections 1.1.2 and 1.2). 
 
Figure 1.2 Roepstorff’s nomenclature of peptide fragmentation in tandem mass spectrometry 
(MS/MS; modified from Qi and Volmer, 2016). Cleavage of Cα–C bonds along the peptide backbone 
gives rise to a- and x-ions corresponding to N- and C-terminal fragments, respectively. Similarly, 
fragmentation of C–N bonds (i.e. the peptide bonds) produces b- and y-series fragment ions, whereas 
c- and z-ions result from fragmentation of N-Cα bonds along the peptide backbone. For a peptide of 
length n, a-, b-, and c-ions are labelled consecutively from the N-terminus as am, bm, and cm, where 
the subscript m denotes the number of amino acid residues in each fragment ion. The complementary 
x-, y-, and z-ions are designated as x(n-m), y(n-m), and z(n-m), where n-m equals the number of residues 




Alternative techniques have therefore been developed to complement CID for peptide 
fragmentation. Two such techniques of particular relevance, HCD and ETD, are introduced 
here. HCD is a variant of CID only available to mass spectrometers equipped with the 
Orbitrap analyser. In such instruments, external to the Orbitrap are a multipole collision 
chamber (i.e. the HCD cell) and an ion storage device (i.e. the C-trap) where beam-type CID 
fragmentation and trapping of fragment ions by a high RF voltage (2.5 kV) take place, 
respectively (Olsen et al., 2007). The trapped fragment ions are then injected into the 
Orbitrap analyser for spectral acquisition at high resolution. Compared with CID, HCD also 
produces b- and y-series fragment ions but the fragmentation pattern is slightly different (de 
Graaf et al., 2011). More importantly, HCD overcomes the intrinsic limitation of CID in low 
m/z regions and is thus compatible with isobaric tagging (Bantscheff et al., 2008). 
Developed by Syka et al. (2004), ETD is a fragmentation technique based on the chemistry of 
ion/ion reactions (McLuckey and Huang, 2009). In this process, electrons are transferred 
from reagent anions (e.g. fluoranthene) to precursor ions at higher charge states (e.g. +3). 
The electron transfer converts precursor ions into radical species, and a rearrangement of 
the radical species ultimately induces breakage of backbone N-Cα bonds in the case of 
peptide fragmentation. Consequently, ETD typically produces c- and z-series fragment ions 
from tryptic peptides, in contrast to b- and y-ions present in CID or HCD spectra (reviewed in 
Zhurov et al., 2013).  
Another distinction of ETD is the preservation of labile PTMs (e.g. phosphorylation and 
glycosylation) during peptide fragmentation (Mikesh et al., 2006). ETD is therefore well 
suited to the identification of exact PTM sites within a modified peptide. However, the 
fragmentation efficiency of ETD is lower than that of CID, leading to fewer total peptide 
identifications (Zubarev et al., 2008, Guthals and Bandeira, 2012). Consequently, ETD often 
serves as a complementary technique to improve peptide identification by CID or HCD. 
With the advent of all the techniques mentioned above, contemporary MS-based 
proteomics typically uses a “bottom-up” strategy and consists of three stages (Figure 1.3). 
The three stages are: I. sample preparation: proteins are extracted from cell/tissue samples 
and then digested into peptides with a site-specific protease (e.g. trypsin). II. LC-MS/MS 
analysis: peptides are separated by LC and then ionised through ESI; a mass spectrometer 
records the m/z of peptide ions (full mass spectra, MS1), which are then selected for 
fragmentation and acquisition of the fragment-ion spectra (tandem mass spectra, MS2). III. 
data analysis: the combination of MS1 and MS2 data facilitates protein identification and 




Figure 1.3 Overview of MS-based, bottom-up proteomics. Typical workflow consists of three stages: I. 
sample preparation; II. liquid chromatography–tandem mass spectrometry (LC-MS/MS); III. data 
analysis. Methods of label-based quantitation are denoted in red (adapted from Altelaar et al., 2013).  
In Stage I, protein extraction and digestion have often been intertwined with protein 
separation by sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) or 
two-dimensional (2D) gel electrophoresis, i.e. isoelectric focusing (IEF) + SDS-PAGE. 
Alternatively, sample fractionation (e.g. reversed-phase or ion-exchange chromatography) 
or affinity purification (AP) is carried out at protein or peptide level to reduce proteome 
complexity. In addition, protein or peptide samples are often labelled with stable isotopes 
via SILAC (stable isotope labeling with amino acids in cell culture) for protein quantitation 
(Ong et al., 2002). Alternatively, this can be achieved using isobaric tags, e.g. iTRAQ (isobaric 
peptide tags for relative and absolute quantification; Ross et al., 2004) or TMT (tandem mass 
tags; Thompson et al., 2003). 
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As reviewed by Aebersold and Mann (2016), three types of bottom-up methods can be 
adopted in Stage II: data-dependent acquisition (DDA), targeted proteomics (e.g. selected 
reaction monitoring, SRM), and data-independent acquisition (DIA) that comprises several 
cutting-edge techniques. The classical DDA method allows high-throughput protein 
identification (referred to as “shotgun proteomics”), hence it is primarily used for discovery 
purposes. In DDA, the most abundant few peptide precursor ions surveyed in MS1 scans are 
isolated for fragmentation according to their signal intensities (Domon and Aebersold, 2006). 
The m/z of the resulting fragment ions are then recorded in MS2 scans. The aforesaid 
software tools can perform a match between experimental MS2 spectra and the theoretical 
ones generated from sequence databases (e.g. Swiss-Prot; Bairoch and Apweiler, 2000). This 
process allows peptides to be identified and the corresponding proteins inferred.  
Compared with DDA, targeted proteomics requires a priori knowledge of the proteins of 
interest: specifically, one must know the m/z values of peptide precursors that are 
representative of the target proteins, and the m/z values of corresponding fragment ions 
that have high signal intensity (Lange et al., 2008). Several precursor/fragment ion pairs, or 
“transitions”, are selectively monitored over LC retention time by SRM-type techniques. This 
ensures the specificity, sensitivity, and high dynamic range required for accurate and 
reproducible quantitation of target proteins (Picotti and Aebersold, 2012). In targeted 
proteomics, data analysis can be performed with the Skyline software (MacLean et al., 2010). 
There is also a clear difference in the way that mass spectrometers are operated between 
DDA and the emerging DIA method. The history of DIA can be traced back to the 
development of MSE, a technique that utilises alternating low and high collision energy for 
simultaneous acquisition of MS spectra (Purvine et al., 2003, Plumb et al., 2006). MSE is 
similar to DDA in providing mass information on both precursor and fragment ions, but the 
acquisition of fragment-ion spectra is independent of the signal intensity of precursor ions.  
The concept of DIA is, however, best exemplified by the SWATH-MS (sequential acquisition 
of all theoretical mass spectra) technique. It cycles through a defined m/z range, which is 
divided into several precursor isolation windows (e.g. 25 m/z units each), over LC retention 
time (Gillet et al., 2012). The SWATH-MS technique simultaneously fragments all peptide 
precursor ions in each m/z window and records the fragment-ion spectra in a stepwise and 
iterative fashion. SWATH-MS (and similar DIA techniques) can generate time-resolved data 
of fragment ions for all detectable peptides in a sample, thus overcoming the stochasticity 
and sampling bias typically associated with DDA (Michalski et al., 2011).  
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In theory, DIA combines the advantages of both DDA and targeted proteomics for high-
throughput protein identification and reproducible quantitation. However, challenges in 
deciphering DIA data have been well established: in DIA data, each mass spectrum is highly 
convoluted due to the presence of numerous fragment ions that are derived from different 
peptide precursors within the same m/z window; the correspondence between precursor 
ions and their fragments is thus much more difficult to ascertain than in DDA data analysis 
(Doerr, 2014). At present, DIA data are analysed primarily through targeted extraction 
approaches, which rely on spectral libraries built from previous DDA/SRM experiments 
(Gillet et al., 2012). Similar to the analysis of SRM data, targeted extraction approaches 
involve construction of a peptide transition list from spectral libraries, generation of 
extracted ion chromatograms (XICs) for the selected fragment ions, scoring peptide groups 
by their chromatographic and signal-intensity profiles, as well as statistical validation based 
on decoy transitions (reviewed in Bilbao et al., 2015). OpenSWATH and Spectronaut 
represent software tools that can automate this process for high-throughput analysis (Rost 
et al., 2014, Bruderer et al., 2015).  
The dependence of targeted extraction approaches on spectral libraries is a limiting factor in 
DIA data analysis in spite of their popularity, and library-free approaches have thus been 
developed to alleviate this limitation (Tsou et al., 2015). Such approaches directly generate 
pseudo-MS2 spectra from DIA data without the need for prior knowledge. The pseudo-MS2 
spectra are then utilised for the sequence database search similar to that in the analysis of 
DDA data. Recently, DIA-Umpire has come into prominence in this category owing to its 
versatility and cross-platform applications (Tsou et al., 2016). However, questions are often 
raised regarding the reliability of library-free approaches since DIA data are highly complex 
(Rost et al., 2014). In conclusion, both targeted extraction and library-free approaches 
require further developments to realise the full potential of DIA. 
Typically, targeted proteomics and DIA require specific MS instruments. For instance, SRM-
type techniques are mainly compatible with QqQ instruments, whereas MSE and SWATH-MS 
are limited to Waters and AB SCIEX Q-TOF platforms, respectively. In contrast, most of the 
aforementioned mass analysers and their hybrids can be used for DDA. As the dominant 
method in shotgun proteomics, DDA is constantly improving and enabling scientific 
breakthroughs in many aspects (see section 1.1.2). At Xi’an Jiaotong-Liverpool University 
(XJTLU), an Orbitrap Elite™ hybrid ion trap-Orbitrap mass spectrometer (Thermo Fisher 




1.1.2 Major focus areas of MS-based proteomics 
With the numerous technological breakthroughs, MS-based proteomics has become an 
indispensable approach to study the correlation between the genotype and the phenotype 
(and its variations). Currently, the discovery of protein biomarkers is one of the most vibrant 
fields in proteomics. Proteins of which the abundance consistently correlates with a disease 
phenotype are considered potential biomarkers with paramount diagnostic or prognostic 
values (Altelaar et al., 2013). Searching with “protein biomarker” as key words now yields 
more than 600,000 publications in the PubMed database (Figure 1.4). 
 
Figure 1.4 Protein biomarker discovery is a dramatically expanding field in biological research, 
reflected by the more than 600,000 publications (source: PubMed, 12 Jan. 2018). PubMed was 
searched using the term: “protein biomarker”.  
Apart from such clinical applications, MS-based proteomics is heavily applied to study the 
following four aspects of the proteome: protein identification, protein quantitation, PPIs, 
and protein PTMs. Protein identification is mainly performed using the DDA approach, which 
allows for hypothesis-free profiling of the proteome of interest. With improvements in 
sample preparation and LC-MS/MS instrumentation, the yeast proteome can now be 
analysed in one hour (h) with > 90 % coverage (Hebert et al., 2014). Similarly, collective 
efforts to profile the entire human proteome (i.e. the Human Proteome Project) have led to 
the identification of more than 17,000 proteins, accounting for 87 % of the predicted human 
proteome (Wilhelm et al., 2014, Kim et al., 2014). 
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The last two decades have witnessed MS-based proteomics gradually turning quantitative. 
Many protein quantitation methods have been devised so far, allowing MS-based 
proteomics to measure the differential expression of proteins (e.g. as a function of cellular 
or disease states), or to determine the absolute quantity of distinct proteins within a sample 
(Ong and Mann, 2005). Quantitative proteomics is often divided into label-based and label-
free strategies. As mentioned above, SILAC and iTRAQ/TMT belong to the label-based 
strategies. They are widely employed for relative quantitation on the basis that native 
peptides and their labelled counterparts behave similarly in LC-MS/MS (Bantscheff et al., 
2007).  
Briefly, SILAC entails the in vivo metabolic labelling of proteins via cell culture in the 
presence of specific “heavy” (i.e. 13C and/or 15N-labelled) amino acids, e.g. lysine (K) and 
arginine (R). In such experiments, the control sample is typically heavy-labelled and then 1:1 
mixed with the test sample where cells have been grown with “light” (i.e. unlabelled) amino 
acids. Relative quantitation is achieved by determining the ratio of light/heavy peptide pairs, 
which exhibit a defined mass shift in MS1 spectra (Ong et al., 2002).  
On the other hand, iTRAQ/TMT involves the in vitro labelling of proteolytic peptides with 
isobaric mass tags. In other words, a chemical reaction is carried out after protein extraction 
and protease digestion, which results in the attachment of a mass tag at the N-terminus and 
K residues of each peptide. In an iTRAQ/TMT experiment, each sample is labelled with a 
variant of the mass tag; the differentially labelled samples are then pooled and analysed 
simultaneously by LC-MS/MS (Thompson et al., 2003, Ross et al., 2004). Due to the isobaric 
nature, the same peptides from differentially labelled samples will have identical m/z values 
and thus appear as a single composite peak in MS1 spectra. Fragmentation of such precursor 
ions then releases a reporter ion, with a characteristic m/z value, from each isobaric mass 
tag. The number of reporter ions released and detected is proportional to the relative 
abundance of the peptide in question, which in turn reflects the relative abundance of the 
protein from which it is derived. Therefore, the same peptides from different samples can be 
distinguished and relatively quantified according to the m/z and intensities of the reporter 
ions in MS2 spectra, respectively.  
As described above, SILAC and iTRAQ/TMT adopt different strategies for relative 
quantitation: the former relies on MS1 spectra whereas the latter is MS2-based. Compared 
with iTRAQ/TMT, the incorporation of stable isotopes and sample pooling are both 
performed at earlier stages in an SILAC experiment. This helps to diminish technical 
variations and thus ensures higher quantitation accuracy. Conversely, SILAC is more 
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expensive and less well-suited to multiplexing, which is the primary strength of the isobaric 
tagging methods (reviewed in Bantscheff et al., 2012). In addition to relative quantitation, 
label-based strategies have also been employed for absolute quantitation. For instance, 
isotope-labelled peptides that correspond to tryptic peptides derived from target proteins, 
known as AQUA peptides (AQUA stands for “absolute quantification”), are spiked into a 
sample in a known concentration (Gerber et al., 2003). These AQUA peptides serve as 
internal standards to determine the exact concentration of their unlabelled counterparts, 
which are derived from the target proteins in the sample. At present, AQUA peptides can be 
obtained commercially albeit at a relatively high cost. This method is thus better suited to 
targeted analysis in lieu of shotgun proteomics. 
The throughput of quantitative proteomics has increased dramatically since the advent of 
label-free strategies, which historically focused on relative quantitation of shotgun 
proteomic data  (Old et al., 2005). In general, label-free strategies can be subdivided into 
two categories: the first counts the number of peptide-spectrum matches (PSM) or the 
frequency of the observed peptides for each identified protein (i.e. “spectral counting”), 
whereas the second extracts peptide signal intensities from LC-MS/MS data in order to infer 
protein abundance (i.e. intensity-based methods). The spectral counting methods are based 
on the assumption that the abundance of a protein correlates with the number of PSMs 
detected per protein (Washburn et al., 2001). On the other hand, the linear correlation 
between the signal response and the abundance of a peptide over four orders of magnitude 
in LC-MS/MS lays the foundation for the intensity-based methods (Chelius and Bondarenko, 
2002). It should be stressed though that rigorous normalisation is essential to the accurate 
quantitation by label-free strategies, which are adversely affected by both biological and 
technical variations (Bantscheff et al., 2012). Additionally, both types of label-free 
quantitation strategy generally only work well with abundant proteins. 
Although label-based strategies (e.g. AQUA) are still regarded as superior for absolute 
quantitation, label-free strategies have gained popularity in recent years. The primary 
strength of such methods lies in the fact that they can be applied, even retrospectively, to 
large cohorts of shotgun proteomic data (Old et al., 2005). Two spectral counting methods, 
APEX (absolute protein expression; Lu et al., 2007) and emPAI (exponentially modified 
protein abundance index; Ishihama et al., 2005), are described here. APEX employs a 
sophisticated classification algorithm to estimate the detection probability of unique 
peptides for a given protein. For each protein, a correction factor Oi is then derived from the 
estimated detection probability and in turn facilitates absolute quantitation by normalising 
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the number of observed PSMs per protein. Meanwhile, the emPAI method assigns each 
protein with an abundance estimate (calculated as 10PAI – 1, where PAI is defined as the 
number of observed peptides per protein divided by the corresponding number of 
theoretically observable peptides). The emPAI value for each identified protein can be 
directly retrieved from the results of database searches using Mascot (Perkins et al., 1999).  
Similar to spectral counting, the intensity-based methods have also been adopted in efforts 
to achieve absolute quantitation. For instance, an iBAQ (intensity-based absolute 
quantification) value is calculated by dividing the sum of all observed peptide intensities for 
a protein by the corresponding number of theoretically observable peptides (Schwanhausser 
et al., 2011). Unlabelled spike-in standards often serve the purpose of sample-specific 
calibration, which facilitates accurate absolute quantitation. The iBAQ method has been 
integrated into the MaxQuant software (Cox and Mann, 2008). 
MaxQuant also employs the “proteomic ruler” method as an alternative for absolute 
quantitation (Wisniewski et al., 2014). In this method, histone proteins are set as a standard 
to estimate the copy number of individual proteins per eukaryotic cell without the need for 
spike-in standards or cell counting. The use of histone proteins is based on two assumptions: 
I. the abundance of total histones in an eukaryotic cell is approximately equal to the cell’s 
DNA content, which is a constant determined primarily by the species (van Holde, 1989); and 
II. the ratio of protein abundances between a specific protein and total histones is 
approximately equal to the ratio of the summed peptide intensities between the two 
(Wisniewski et al., 2012). The validity of proteomic ruler has been thoroughly evaluated on 
different species and cell types (reviewed in Wisniewski, 2017). Clearly, such an approach is 
limited to eukaryotic organisms as prokaryotes generally lack histones. 
APEX, emPAI, iBAQ, and the proteomic ruler approaches are only a small fraction of label-
free strategies developed thus far. Apart from these DDA-centric methods, targeted 
proteomics (e.g. multiplexed SRM) and DIA (e.g. SWATH-MS) are increasingly useful for 
label-free quantitation across multiple samples. This is exemplified by the quantitation of 
192 proteins from mouse liver samples in two metabolic states using SRM (Wu et al., 2014). 
In comparison, > 2,600 proteins were quantified by SWATH-MS across 386 mouse liver 
samples with the same experimental design (Williams et al., 2016). 
Over the years, proteomics has extended beyond the identification and quantitation of 
individual proteins, to determining protein interaction networks and the structures of 
macromolecular assemblies. The interconnectivity of proteins into complexes forms the 
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basis of many cellular functions and hence largely determines the phenotype of a cell 
(Altelaar et al., 2013). Affinity purification–mass spectrometry (AP-MS) has been extensively 
applied to identify PPIs, complementing the conventional Y2H assay. AP-MS employs 
antibodies to purify the endogenous “bait” protein and its binding partner (“prey”) for high-
throughput identification (Dunham et al., 2012). Alternatively, bait proteins are affinity 
tagged in a carefully controlled manner so that the tagged proteins are expressed at a 
physiological level. Tandem affinity purification (TAP) is an improvement in AP-MS that 
employs two sequential AP steps to significantly reduce background binding (Rigaut et al., 
1999). As TAP is less efficient in multicellular organisms, Rees et al. (2011) took advantage of 
transposable elements to achieve parallel tagging and AP-MS in fruit flies and other complex 
organisms. Quantitative methods (e.g. SILAC) allow AP-MS to further determine the 
stoichiometry of PPIs, distinguishing stable interactions from the weaker, transient ones 
(Rees et al., 2015).  
Multiple MS-based techniques have been applied to complement X-ray crystallography and 
nuclear magnetic resonance (NMR) for analysing the structure of large protein complexes. 
These include native MS, hydrogen-deuterium exchange (HDX) MS, and protein cross-linking 
(XL) coupled with MS. These methods are often combined with cryo-electron microscopy 
(cryo-EM) in an integrative approach to shed light on the topology, conformational changes, 
and stoichiometry of large protein assemblies (Holding, 2015). Finally, MS-based proteomics 
is widely used to study protein PTMs, as they result in defined shifts in protein or peptide 
mass. The following section will describe different types of protein PTMs and the proteomic 
strategies to study them. 
1.2 Protein PTMs and N-terminal PTMs 
1.2.1 Protein PTMs 
Protein PTMs involve either the covalent attachment of chemical groups to specific amino 
acid residues of a protein, or the proteolysis of the protein (Walsh et al., 2005). With regard 
to the former PTM, the chemical groups that are attached may be quite large and include 
oligosaccharides, lipids, and small proteins. Such attachments may be either reversible or 
irreversible. The latter PTM is tightly controlled and often referred to as proteolytic 
processing (Rogers and Overall, 2013). It is well acknowledged that cells utilise PTMs to 
regulate protein stability, subcellular localisation, functional state, and interaction with 
other molecules. As a result, cells can rapidly adapt to developmental and environmental 
changes. Currently, more than 400 types of PTMs have been identified, including 
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phosphorylation, methylation, acetylation, ubiquitination, glycosylation, as well as 
proteolytic processing (Giglione et al., 2015). 
The most notable example of PTMs is phosphorylation, which is crucial in cell signalling 
pathways (reviewed in Pawson and Scott, 2005). In such processes, a cascade of protein 
receptors and enzymes are activated or deactivated via the reversible addition or removal of 
phosphate groups, catalysed by opposing enzymes (protein kinases or phosphatases, 
respectively). These phosphorylation events mediate signal transduction within the cell, 
often leading to changes in gene expression that direct cellular responses to external stimuli. 
Conversely, dysregulated protein phosphorylation is frequently associated with different 
diseases including cancer (Olsen and Mann, 2013).  
Western blotting with specific antibodies is by convention the “gold standard” method to 
detect the presence of target proteins and protein PTMs (Aebersold et al., 2013). However, 
issues are often raised regarding the specificity of the antibodies targeting PTMs and the 
variability in the results (Campa and Kypta, 2011). In this regard, MS-based proteomics is 
ideal for studying PTMs. It allows the determination of such modifications and their exact 
locations on a system-wide scale. Tremendous challenges are associated with PTM analysis, 
owing in large part to the complexity, dynamic regulation, and varied stoichiometry of these 
modifications (Altelaar et al., 2013). But these challenges have been partially counteracted 
by the technological advances in sample preparation, MS instrumentation and quantitative 
analysis. Such improvements include the use of AP for a variety of PTMs (e.g. 
phosphorylation and ubiquitination), ETD fragmentation that facilitates identification of 
labile PTMs, and the increasing use of SRM and SWATH-MS. The following section is devoted 
to describe several representative PTMs. 
1.2.2 Examples of covalent PTMs 
 As stated above, protein phosphorylation is by far the most extensively analysed PTM due 
to its functional importance in regulating not only cell signalling, but also cell cycle 
progression, cell growth, and apoptosis (Ardito et al., 2017). Protein phosphorylation 
involves specific addition of a phosphate group primarily to the R group of serine (S), 
threonine (T), or tyrosine (Y) residues of a protein. In mammalian cells, the abundance 
distribution of pS/T/Y is 86.4 %, 11.8 %, and 1.8 %, respectively (Olsen et al., 2006). The 




Phosphoproteomics typically involves AP and fractionation of phosphopeptides that are 
produced by protease digestion of phosphoproteins, followed by MS-based identification 
and quantitation (Figure 1.5). The first major breakthrough in this field was reported by 
Olsen et al. (2006). It employed titanium dioxide (TiO2) and strong cation exchange (SCX) 
chromatography to enrich and fractionate peptides that bear pS/T, leading to the detection 
of 6,600 phosphorylation sites. This study also used SILAC to measure the dynamic change of 
phosphorylation upon growth factor stimulation. The enrichment of peptides bearing pS/T 
can also be achieved using immobilised metal-ion affinity chromatography (IMAC; Andersson 
and Porath, 1986). However, peptides that bear pY require an antibody-based approach for 
AP (Rush et al., 2005). Such techniques have been perfected over the years, and 
phosphoproteomics can now detect an astonishing number of phosphorylation sites (50,000) 
in just a single cell line (Sharma et al., 2014). Since then, the focus of phosphoproteomics 
has shifted towards understanding the functional aspect of this PTM, and clinical analyses of 
tissue samples (von Stechow et al., 2015). 
 
Figure 1.5 Overview of phosphoproteomics workflow (adapted from Macek et al., 2009). SILAC: stable 
isotope labeling by amino acids in cell culture; iTRAQ: isobaric tags for relative and absolute 
quantitation; SCX: strong cation exchange; TiO2: titanium dioxide. 
The importance of AP is also highlighted by proteomic studies on protein ubiquitination and 
another PTM involving small ubiquitin-like modifier (SUMO) proteins, i.e. SUMOylation. The 
former PTM starts with the formation of an isopeptide bond between the C-terminal glycine 
(G) of ubiquitin (Ub) and the ε-amino group of a K residue in the substrates, including other 
Ub proteins (Walsh et al., 2005). SUMO proteins resemble Ub in protein structure and the 
way they are attached to target proteins as well as themselves (Gill, 2004). Protein 
ubiquitination elicits distinct cellular outcomes through different signalling pathways, most 
notably the proteasomal degradation (i.e. ubiquitin-proteasome system, UPS). This system is 
responsible for 80 – 90 % of cellular proteolysis in eukaryotes (Rock et al., 1994). In contrast, 
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SUMOylation is largely confined to the nucleus, and one of its functions is to regulate DNA 
damage response (Hendriks and Vertegaal, 2016).  
Due to the low stoichiometry, rapid degradation, and the action by opposing enzymes (i.e. 
deubiquitinases or SUMO proteases), protein ubiquitination and SUMOylation present 
enormous challenges to proteomic studies (Peng and Gygi, 2001, Ordureau et al., 2015). 
Nonetheless, the development of K-ε-GG antibody has significantly transformed these 
research fields, since this antibody can recognise a GG signature in Ub/SUMO-modified 
proteins after protease digestion (Xu et al., 2010). In the latter case, SUMO mutants are 
expressed in transgenic cells to bear a GG motif (Impens et al., 2014). By enriching 
Ub/SUMO-modified proteins, K-ε-GG antibody has allowed AP-MS studies to identify 20,000 
ubiquitination sites and 5,000 SUMOylation sites, respectively (Udeshi et al., 2013, Hendriks 
and Vertegaal, 2016). 
1.2.3 Proteolysis as a PTM 
Proteolysis (or proteolytic processing) is not only a cellular process to degrade proteins that 
are marked by ubiquitination, but is also an important PTM in its own right. It involves the 
irreversible hydrolysis of peptide bonds, thereby dissociating proteins into smaller peptides 
or amino acids. This process is catalysed by a family of enzymes called proteases. With > 550 
members, proteases represent one of the largest enzyme families in humans (Vidmar et al., 
2017). These enzymes function to regulate a large variety of physiological processes, 
including the immune response, cell proliferation, and apoptosis (Sanman and Bogyo, 2014). 
For instance, a cascade of proteolytic processing events are involved in protein maturation. 
These include N-terminal methionine excision (NME), removal of signal or transit peptide, 
cleavage of polyproteins, and the removal of precursor domains. Proteolytic processing is a 
tightly regulated PTM due to its irreversible nature. Failure to do so can result in many 
pathological conditions such as inflammation, cancer and arthritis (Turk et al., 2012). To fully 
comprehend the cellular outcome of proteolytic processing, it is crucial to identify protease 
substrates, to determine cleavage specificities, and to measure protease activity and its 
dynamic changes under different conditions. 
Contemporary protease studies employ a wide range of techniques, including substrate 
phage display, synthetic peptide library, substrate- or activity-based probing, and gel-based 
methods. In substrate phage display, fusion proteins expressed by bacteriophages contain 
an affinity tag and a randomised peptide, which serves as a candidate of protease substrates. 
This method allows rapid survey of protease cleavage specificity (Matthews and Wells, 1993). 
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Similarly, libraries of synthetic peptides and peptide microarrays can be treated with a 
specific protease in order to determine cleavage sequence specificity (reviewed in Rogers 
and Overall, 2013). Meanwhile, substrate- and activity-based probes serve to measure 
protease activity in vitro. These probes replace the natural substrate for a target protease, 
and generate fluorescent signals upon cleavage or binding by the protease (reviewed in 
Sanman and Bogyo, 2014).  
2D gel electrophoresis represents the gel-based methods to identify protease substrates on 
a large scale. As reviewed by Agard and Wells (2009), proteins that are digested due to in 
vivo or in vitro protease activity can be resolved by either IEF + SDS-PAGE or two consecutive 
runs of SDS-PAGE to detect protease substrates. One example is the identification of 
proteolytic processing events, protease substrates, and cleavage specificity in Salmonella, 
due to the activation of PhoP-PhoQ virulence regulatory system (Adams et al., 1999). These 
early studies have spawned another gel-based method, namely PROTOMAP (protein 
topography and migration analysis platform). This method employs a single run of SDS-PAGE 
to compare proteins before and after protease digestion, and changes in protein band 
intensity or migration pattern are indicative of protease substrates (Dix et al., 2008). All 
these techniques require in-gel digestion and MS analysis to determine the identity of 
protease substrates and protease cleavage specificity. 
Similar to other PTMs, there has been a surge to study proteolytic processing (i.e. 
degradomics) by gel-free proteomics. However, enrichment of proteolytic products is a 
challenging task. The reason is as follows: proteolytic processing gives rise to newly formed 
N- and C-termini (i.e. neo-termini); these neo-termini on their own are chemically 
indistinguishable from the original N- and C-termini, thus preventing their AP (Agard and 
Wells, 2009). Positional proteomics (or more specifically, terminus proteomics), which labels 
the N- or C-terminus of a protein through chemical or enzymatic modifications, is critical to 
the success of studies on proteolytic processing. A subfield of positional proteomics that 
targets the N-terminus is named N-terminalomics, which will be described in depth in 
section 1.3. 
1.2.4 N-terminal PTMs 
As the name implies, N-terminalomics combines chemical or enzymatic labelling with MS 
analysis to enrich and globally analyse protein N-termini. It involves the identification of 
protein N-termini as well as their co- or post-translational modifications. N-terminal residue 
of a protein is linked to its in vivo stability, referred to as the “N-end rule” (Varshavsky, 2011). 
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In eukaryotes, the N-end rule pathway is part of UPS for protein degradation. Importantly, 
N-terminal PTMs are now recognised as major constituents of the N-end rule pathway, 
regulating the half-lives of N-terminally modified proteins. In fact, a majority of eukaryotic 
and prokaryotic proteins undergo N-terminal PTMs at some point (Giglione et al., 2015). 
These include co-translational NME, N-terminal (Nt)-acetylation, Nt-myristoylation, as well 
as post-translational Nt-methylation and Nt-ubiquitination (Varland et al., 2015; Figure 1.6). 
Rare PTMs at protein N-termini include Nt-propionylation and Nt-palmitoylation. These 
modifications are catalysed by a diverse array of enzymes, including peptidases (e.g. 
methionine aminopeptidases, MetAPs), transferases (e.g. N-terminal acetyltransferases, 
NATs), and ligases (e.g. E3 Ub ligase). Due to the ubiquity of N-terminal PTMs, proteins with 
unmodified α-amino groups (i.e. free N-termini) only constitute a small fraction of the total 
proteome in eukaryotes. In contrast, it is estimated that up to 70 % of the prokaryotic 
proteome have free N-termini (Ciechanover, 2005). 
 
Figure 1.6 Major co- and post-translational modifications (PTMs) at protein N-terminus (adapted from 
Varland et al., 2015). MetAPs: methionine aminopeptidases; NATs: N-terminal acetyltransferases; 
NMTs: N-terminal myristoyltransferses; NTMTs: N-terminal methyltransferases.  
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N-terminal modifications significantly contribute to protein stability and activity, and their 
involvement in cellular functions and pathological conditions are starting to be understood 
in recent years. NME and Nt-acetylation are two widespread PTMs. In eukaryotes, NME is 
estimated to occur on more than 50 % of all proteins, whereas Nt-acetylation affects 50 % 
and 80 % of proteins in yeast and humans, respectively (Giglione et al., 2015). In comparison, 
more than 50 % of prokaryotic proteins undergo NME (catalysed by peptide deformylases 
and MetAPs) but Nt-acetylation is rare. Recent studies reported that the principal function 
of these two modifications in eukaryotes is to create a specific protein degradation signal for 
the N-end rule pathway, forming a major branch called “Ac/N-end rule pathway” 
(Varshavsky, 2011, Lee et al., 2016). Other functions of Nt-acetylation include intracellular 
membrane targeting and protein complex formation (Varland et al., 2015). 
Nt-myristoylation is the addition with a myristoyl group to an N-terminal G residue, 
catalysed by N-terminal myristoyltransferases. This modification takes place on 0.5 – 4 % of 
cellular proteins and is important in cell signalling in cancer or immune responses (Martinez 
et al., 2008). Protein methylation is a pervasive and functionally versatile PTM. For instance, 
histone proteins are subject to a range of PTMs including mono-, di- or tri-methylation on a 
K residue, and mono- or di-methylation on an R residue. These modifications result in the 
alteration of chromatin structure and thus gene expression (Murn and Shi, 2017). In 
comparison, Nt-methylation is less well understood. Recent studies reported the 
involvement of this N-terminal PTM in protein-protein/DNA interactions (reviewed in 
Varland et al., 2015). Similar to Nt-methylation, Nt-ubiquitination is another emerging PTM, 
and it is functionally separated from the N-end rule pathway. Nt-ubiquitination has been 
suggested to perform protein quality control or to regulate protein homeostasis, but 
currently it is difficult to draw conclusions with limited information. Taken together, all these 
N-terminal PTMs contribute to a greater proteome complexity, thus presenting analytical 
challenges to MS-based proteomics.  
1.3 High-throughput techniques in N-terminalomics 
As briefly covered above, N-terminalomics focuses on the analysis of protein N-termini at 
the proteome level. A principal objective of N-terminalomics is to reduce the complexity of 
the proteome. As Beynon (2011) pointed out, standard shotgun proteomics often falls into 
“over-determinism”. Not only are more peptides analysed than strictly necessary to achieve 
the study aim, but also low-abundance proteins or their component peptides are often 
overshadowed by the abundant ones in the same sample. Specifically, protein N-termini are 
22 
 
often undetected in standard shotgun proteomics, largely owing to the sheer number and 
dynamic range of tryptic peptides in a sample (Hartmann and Armengaud, 2014). By 
selecting highly informative peptides such as protein N-termini, N-terminalomics may 
improve protein identification and achieve accurate annotation of their N-termini, which can 
be apparently different from those predicted at gene or transcript level (Rogers and Overall, 
2013). With respect to proteolytic processing, this PTM gives rise to new protein fragments 
with a neo-N-terminus (or a neo-C-terminus). As a result, N-terminalomics is suitable for 
analysing proteolytic products as well. Such approaches can be employed to identify in vivo 
proteolytic processing events, or the substrates of a specific protease.  
N-terminalomics generally takes advantage of the semi-unique chemistry of the α-amino 
group to chemically modify protein N-termini for enrichment. Compared to protein N-
termini, the C-termini are a lesser target for chemical modifications due to the lower 
reactivity of carboxyl groups. As a consequence, fewer C-terminalomic techniques have been 
developed so far (reviewed in Tanco et al., 2015). However, there is an intrinsic issue 
associated with N-terminalomics: “the lysine problem” (Rogers and Overall, 2013). It 
describes the similar chemical reactivity between protein N-termini which have α-amino 
groups and K residues which have ε-amino groups. For instance, the two amino groups only 
have a marginal difference in their basic strengths expressed as pKa values: the value of α-
amino groups is ~ 9.0, whereas that of ε-amino groups is approximately 10.5 (Dawson et al., 
2002). As a result, amine-reactive chemistry generally targets both protein N-termini and K 
residues simultaneously. 
In N-terminalomics, several strategies have been devised to try to circumvent the lysine 
problem by modifying both protein N-termini and K residues. Alternatively, there are 
emerging strategies that can discriminate between α- and ε-amino groups. All these 
strategies comprise the two branches in N-terminalomics: positive or negative selection of 
N-terminal peptides. The former directly enriches the N-terminal peptides, whereas the 
latter depletes all the other peptides to select protein N-termini (Figure 1.7A). 
1.3.1 Negative selection strategies 
One of the first negative selection strategies for N-terminalomics is N-terminal COFRADIC 
(combined fractional diagonal chromatography), developed by the Gevaert lab at VIB in 
Belgium (Gevaert et al., 2003). It is a negative selection strategy that combines 
indiscriminate amine-reactive chemistry with a series of LC steps to separate protein N-




Figure 1.7 Overview of major N-terminalomic techniques (adapted from Agard and Wells, 2009). (a) 
Typical workflow of N-terminalomics. (b) Some major negative selection strategies. (c) Some major 
positive selection strategies. PITC: phenyl isothiocyanate; HPG-ALD: hyperbranched polyglycerol-




1.7B). The latest protocol of N-terminal COFRADIC employs an N-hydroxysuccinimide (NHS) 
ester to acetylate both N-terminal α-amines and K ε-amines, often with isotopic labels for 
comparative or quantitative analysis. After tryptic digestion of the acetylated proteins, the 
resulting peptides are subjected to low-pH SCX, which removes the majority of internal 
peptides. The enriched peptides are then separated by the first run of RP-HPLC, followed by 
the reaction between neo-N-termini and 2,4,6-trinitrobenzenesulfonic acid (TNBS). This 
reaction confers additional hydrophobicity only to the remaining internal peptides and 
protein C-termini, and it is followed by the second run of RP-HPLC. Peptides that exhibit a 
dramatic shift in their RP-HPLC retention time (RT) correspond to the internal or C-terminal 
peptides, which are removed accordingly. Eventually, the original N-terminal peptides are 
enriched for LC-MS/MS analysis (Staes et al., 2017). 
Since its initial publication in 2003, N-terminal COFRADIC has been used for the global 
analysis of protein N-termini in yeast, fruit flies, mice, and humans. With the maturation of 
this technology, the number of identified protein N-termini has drastically expended from < 
400 to ~ 2,000 (Arnesen et al., 2009, Gawron et al., 2016). The main objectives of these 
studies are to determine the state of protein Nt-acetylation or alternative translation 
initiation. The majority of eukaryotic protein N-termini were reported to undergo Nt-
acetylation, ranging from 50 – 60 % in yeast to > 80 % in humans (Arnesen et al., 2009). On 
the other hand, these studies linked about 10 % of the identified protein N-termini in yeast 
and 20 % in humans to alternative sites for translation initiation (Helsens et al., 2011, Van 
Damme et al., 2014). 
To identify protease substrates or proteolytic processing events, N-terminal COFRADIC 
requires a sophisticated strategy of isotopic labelling and quantitation methods. Isotopic 
labelling may be achieved before protein extraction using SILAC or with trideutero(D3)-
labelled acetylation reagents after protein extraction, depending on the sample type and 
study aim. Nevertheless, this method identified 61 caspase substrates in humans using 
recombinant caspases (Wejda et al., 2012). Similarly, this technique was extensively 
employed to study the substrates and cleavage specificity of granzymes in mice and humans 
(Plasman et al., 2014). Several variants of N-terminal COFRADIC have been proposed to 
select N-terminal peptides, where TNBS is replaced by other amine-reactive compounds (e.g. 
Bland et al., 2014a). 
Two similar chromatographic approaches have been proposed in recent years, which 
separate internal peptides from protein N-termini via charge reduction or charge reversal. 
The charge reduction approach, namely ChaFRADIC (charge-based fractional diagonal 
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chromatography), involves protease digestion and the acetylation of primary amines on the 
resulting internal peptides (Venne et al., 2015). Acetylation results in a reduction of peptide 
charge, which is made use of by SCX chromatography to deplete internal peptides. Recently, 
the same research group provided a simpler format of this approach, where 
chromatographic separation was replaced by the use of pipette tips containing SCX beads 
(Shema et al., 2018). Meanwhile, the charge reversal approach can add up to four negative 
charges to the internal peptides via disulfo-modification (Lai et al., 2015). This charge 
reversal allows SCX to enrich for protein N-termini, since the negatively charged internal 
peptides do not bind to the SCX column. 
N-TAILS (N-terminal amine isotopic labeling of substrates) is one of the most widely adopted 
strategies in N-terminalomics. This is a negative selection strategy developed by the Overall 
lab at the University of British Columbia (Kleifeld et al., 2010). Similar to N-terminal 
COFRADIC, the N-TAILS approach also blocks both α- and ε-amino groups before protease 
digestion, and then depletes internal peptides through their reactive neo-N-termini. In detail, 
the first step of N-TAILS is to block all primary amines by either isotopic dimethylation or 
isobaric tagging (e.g. iTRAQ). Subsequent protease digestion of the modified proteins gives 
rise to N-terminal peptides and internal peptides. Each internal peptide contains a reactive 
neo-N-terminus that facilitates its capture by a commercially available polymer (HPG-ALD, 
100 kDa) through amine-reactive chemistry. The captured internal peptides can be removed 
from the N-terminal peptides by ultrafiltration. As a result, the protein N-termini are 
selected for LC-MS/MS analysis. 
N-TAILS was initially developed to identify protease substrates since proteolytic products can 
be enriched together with protein N-termini. After the negative selection, proteolytic 
products are identified by quantitative proteomics, which compares the relative abundance 
of differentially labelled peptides between control and protease-treated samples (Demir et 
al., 2017). This approach has been successfully applied to reveal both in vitro and in vivo 
proteolytic processing events. For instance, matrix metalloproteinases (MMPs) have been 
extensively investigated by N-TAILS in vitro, which identified 146 substrates of MMP-2 and 
novel substrates of MMP-9 and MMP-10, albeit in lower numbers (Prudova et al., 2010, 
Schlage et al., 2014). Similarly, N-TAILS identified prothrombin and eight components of the 
complement system as in vivo substrates of macrophage-specific MMP-12, thus linking this 
protease to inflammation (Bellac et al., 2014). In addition, Klein et al. (2015) applied N-TAILS 
to study immortalised B cells from a patient with a homozygous mutation of paracaspase 
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MALT1. This study reported HOIL1 protein as a novel substrate of MALT1, and that MALT1 
functioned via HOIL1 cleavage to negatively regulate the nuclear factor (NF)-κB signalling.  
In addition to proteolytic processing, N-TAILS has also been heavily involved in the global 
analysis of protein N-termini and their PTM states in various biological systems. For instance, 
N-TAILS successfully identified 1,400 protein N-termini from human erythrocytes, with 68 % 
of them derived from alternative sites for translation initiation or proteolytic processing 
(Lange et al., 2014b). Dental pulp and plants represent additional biological systems that 
have also been subject to N-TAILS analysis (reviewed in Demir et al., 2017). Due to the 
relatively wide use of N-TAILS, the applications of this method are certainly not exhaustively 
covered here. 
By analogy with N-TAILS, a negative selection strategy can be devised by combining other 
amine-reactive chemistry (to block all primary amines) with the capture of internal peptides. 
The PTAG (phospho-tagging) strategy exploits the AP of phosphopeptides to deplete internal 
peptide and thus enrich for protein N-termini (Mommen et al., 2012). This strategy consists 
of protein dimethylation (to block all primary amines), protease digestion, phosphorylation 
of internal peptides (through amine-reactive chemistry), and TiO2 affinity chromatography 
(to remove phosphopeptides). Consequently, the dimethylated protein N-termini are 
negatively selected. 
Prior to the advent of N-TAILS and PTAG, the Beynon group at the University of Liverpool 
developed a negative selection strategy based on a similar concept (McDonald et al., 2005). 
In detail, this approach (here referred to as “NHS-Sepharose”) involves the blocking of both 
protein N-termini and K residues by (isotopic) acetylation. Here the use of isotopes affords 
discrimination between endogenous and chemical acetylation. The acetylated proteins are 
then digested with a protease. Initially, the resulting internal peptides are chemically tagged 
via the reaction between neo-N-termini and an amine-reactive biotin tag. The biotin tag 
mediates the removal of internal peptides by immobilised biotin-binding proteins such as 
avidin or streptavidin. This procedure has since been simplified: the internal peptides are 
now directly depleted using NHS-activated Sepharose, which reacts with primary amines to 
form a stable amide bond (McDonald and Beynon, 2006). Despite its early invention, this 
technique has not been widely adopted in N-terminalomics to reduce sample complexity. 
Therefore, its full potential remains largely unknown.  
Binding of biotin to avidin or streptavidin is one of the strongest non-covalent interactions 
between a protein and its ligand (Green, 1975). Biotin is a water-soluble vitamin, and it 
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serves as a cofactor for mammalian carboxylases that are critical to metabolic processes 
including fatty acid synthesis (reviewed by Said, 2012). Avidin is a tetrameric biotin-binding 
protein (67 kDa) from chicken egg-white. Each subunit (128 amino acid residues) of chicken 
avidin binds to a biotin molecule with an exceptionally high affinity, i.e. Kd ≈ 10-15 M (Marttila 
et al., 2000). In contrast, streptavidin (56 kDa) is a bacterial avidin homologue from 
Streptomyces avidinii. Streptavidin and avidin share modest sequence homology (38 %) but 
highly similar protein structures (Dundas et al., 2013). Compared to chicken avidin, 
streptavidin is not glycosylated and more acidic, but with a similar binding affinity (Kd ≈ 10-14 
M). 
Both avidin and streptavidin maintain their stability and functions over a wide range of pH 
and temperature, and tolerate genetic mutations (Gonzalez et al., 1999, Dundas et al., 2013). 
Therefore, biotin-(strept)avidin interaction has been heavily utilised in molecular biology and 
biotechnology. At present, there are a series of avidin and streptavidin variants that are 
commercially available. These include NeutrAvidin, a deglycosylated avidin that exhibits 
reduced nonspecific binding (Marttila et al., 2000), and monomeric avidin, which allows 
gentle elution of the bound biotin molecules due to a much lower affinity (Henrikson et al., 
1979). 
1.3.2 Positive selection strategies 
In contrast to negative selection, protein N-termini can in principle be directly enriched using 
positive selection strategies. Generally, such strategies exploit chemical or enzymatic 
reactions that discriminate between α- and ε-amino groups. Due to the extent of 
endogenous Nt-acetylation of eukaryotic proteins, such strategies are more suitable for 
studying proteolytic processing. Positive selection strategies are represented by the 
Subtiligase approach, which was developed by the Wells lab at the University of California at 
San Francisco (Mahrus et al., 2008). Subtiligase is an engineered enzyme highly specific for 
α-amino groups but not the ε-ones. The absolute specificity has been exploited by the Wells 
lab to transfer a biotin tag from synthetic peptide ester substrates to free (neo-)N-termini 
(Figure 1.7C). The peptide ester itself consists of four components: an ester linkage (for 
subtiligase-catalysed ligation to α-amino groups), a biotin tag (for AP), a tobacco etch virus 
(TEV) protease cleavage sequence (for releasing the captured peptides), and an α-
aminobutyric acid (Abu) mass tag (for confident identification by MS). 
As described in the latest protocol, slight variations exist between in vivo and in vitro 
Subtiligase experiments (Wiita et al., 2014). Nevertheless, the approach at its core involves 
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the initial enzymatic biotinylation of protein N-termini and proteolytic products at their neo-
N-termini. After the removal of excess biotin reagents (i.e. the synthetic peptide ester) 
through protein precipitation, the biotinylated protein N-termini/proteolytic products are 
captured by immobilised NeutrAvidin through biotin-avidin interaction. On-bead tryptic 
digestion is then performed on the captured proteins to release unwanted internal peptides. 
The captured peptides are finally eluted through TEV protease digestion for LC-MS/MS 
analysis.  
Identification of caspase substrates has greatly benefited from this strategy, as the first 
Subtiligase experiment reported > 1,000 proteins caspase substrates in apoptotic cells 
(Mahrus et al., 2008). This study initiated the compilation of specific substrates of different 
caspases using this strategy (Agard et al., 2010, Agard et al., 2012). Subtiligase has also been 
employed to profile protein N-termini in human blood (Wildes and Wells, 2010). This study 
identified 772 N-termini in human blood, of which 28 % were derived from cleavage by 
aminopeptidases. 
N-CLAP (N-terminalomics by chemical labeling of the α-amine of proteins) and O-
methylisourea are two additional positive selection strategies. N-CLAP employs Edman 
degradation chemistry that specifically cleaves off the N-terminal amino acid residue from a 
protein (Xu et al., 2009). An N-CLAP experiment starts with the modification of both α- and 
ε-amino groups with phenyl isothiocyanate (PITC). The PITC-modified N-terminal residues 
are then removed from the rest of the proteins following the addition of trifluoroacetic acid 
(TFA), which triggers cleavage of the peptide bond between PITC-modified N-termini and 
their adjacent residues. The resulting neo-N-termini of the remaining proteins can be 
exploited for biotin tagging and AP via biotin-avidin interaction (Xu and Jaffrey, 2010).  
Similarly, O-methylisourea exhibits selective reactivity towards the ε-amino groups of K 
residues under defined conditions. The Salvesen group (2011) at Cornell University thus 
developed a positive selection approach based on selective guanidination with O-
methylisourea. This approach blocks K ε-amino groups to a large extent, leaving the free 
protein N-termini available for biotin tagging and AP (after tryptic digestion). Furthermore, 
selective guanidination was incorporated into another positive selection approach taking 
advantage of thiol-specific AP (Kim et al., 2013). However, the use of O-methylisourea is not 
ideal as it incompletely modifies proteins (Cohen, 1968). In addition, this compound is not 
absolutely specific for ε-amino groups. Guanidination of N-terminal α-amino groups has 
been observed in proteins with N-terminal G or other residues due to reduced steric 
protection (Beardsley et al., 2000). 
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Although the last decade has seen many technological breakthroughs in N-terminalomics, 
there is clearly ample room for innovation, especially in the positive selection branch. It 
owes primarily to the difficulty in developing chemical reactions that can discriminate 
between α- and ε-amino groups. In view of the initial reports from Sonomura et al. (2009a), 
selective transamination of protein N-termini seemed to be a promising reaction for the 
development of a positive selection approach. The following section will provide an in-depth 
description of this chemical reaction. 
1.4 Transamination of protein N-termini 
In nature, transamination refers to the transfer of an amino group from amino acids to α-
ketoacids, most notably to α-ketoglutarate. This reaction is catalysed by a large variety of 
aminotransferases that contain a prosthetic group called pyridoxal-5’-phosphate (PLP). PLP 
is also required for other enzymatic reactions on amino acids, including decarboxylation, 
racemisation, and β-elimination (Toney, 2005). Enzymatic transamination is an intrinsic 
component of the metabolism of amino acids (Berg et al., 2012). On the other hand, the 
development of chemical transamination of protein N-termini was primarily contributed by 
Dixon (1964), who developed this reaction based upon earlier work on free amino acids (Mix 
and Wilcke, 1960).  
1.4.1 Selective transamination of protein N-termini and other transamination 
routes 
As previously described, selective modification of the N-terminal α-amino group is 
hampered by the presence of ε-amino groups on the side chains of K residues, which are 25-
fold more abundant on average (the lysine problem; Mahrus et al., 2008). From a historical 
perspective, there have been several chemical reactions that target the α-amino group at 
the N-terminus. The selectivity of such modifications was achieved (to a limited extent) 
through the careful control of reaction pH, on the basis that α- and ε-amino groups have 
slightly different pKa values (see section 1.3; Reid, 1951, Baker et al., 2006). On the other 
hand, specific types of N-terminal amino acid residues have been successfully targeted via 
their functional groups on the side chain: proteins with an N-terminal cysteine (C) were 
modified with thioesters, whereas N-terminal S and T residues were converted to reactive 
aldehydes using periodate (Dixon and Weitkamp, 1962, Dawson et al., 1994). It was possible 
to further convert the reactive aldehydes to G residues (Fields and Dixon, 1968). 
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In spite of these individual cases of success, it is desirable to devise a general strategy that 
targets virtually all types of amino acid residues at protein N-termini. This combination of 
broad spectrum with high specificity may be achieved by an N-terminal modification if it 
directly involves the neighbouring peptide bond, which ε-amino groups lack. With this in 
mind, a selective transamination reaction was developed to modify protein N-termini with 
three essential components: an amino group acceptor, a heavy metal cation, and a high 
concentration of base (reviewed in Dixon and Fields, 1972). Although there is considerable 
flexibility in the choice of reagents, the preferred reaction system uses glyoxylate as the 
amino acceptor, copper(II) as the metal  ion (e.g. using CuSO4), and pyridine as the base 
(Dixon, 1984). Substitution of pyridine with sodium acetate results in a milder reaction 
condition, which in principle allows the reaction to proceed without protein denaturation. 
 
Figure 1.8 Schematic diagram of the selective transamination of protein/peptide N-termini (adapted 
from Dixon, 1984). The negatively charged oxygen of an amino acceptor (e.g. glyoxylate) is first 
juxtaposed with the carbonyl oxygen of the first amino acid residue of a protein or peptide ○P  via a 
divalent metal cation. The presence of a base (B) then allows the formation of an imine which, 
following a sequence of proton transfer events, is hydrolysed thereby converting the α-amine to a 
reactive carbonyl group. 
As depicted in Figure 1.8, divalent metal ions catalyse the reaction by first chelating both the 
carbonyl group in the peptide bond and the carboxyl group of glyoxylate, which results in 
imine formation between the N-terminal α-amino group and glyoxylate. Following a series of 
proton transfer events (mediated by the base and the peptide bond), the imine is hydrolysed 
to complete the conversion of the α-amine to a reactive carbonyl group. This newly formed 
carbonyl group is amenable to further chemical derivatisation. 
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Dixon’s pioneering work inspired other researchers to develop transamination of protein N-
termini from different perspectives. For the sake of clarity, only the Dixon’s method will be 
referred to as “selective transamination” in this thesis. The 21st century has seen the 
resurgence in the development and use of protein Nt-transamination. For instance, the 
Francis group at the University of California at Berkeley evaluated the potential of two 
molecules for transamination: PLP and N‑methylpyridinium-4-carboxaldehyde (Rapoport’s 
salt, RS). As mentioned before, PLP is a natural cofactor for a great many enzymes that 
catalyse the transformation of amino acids in metabolism. Gilmore et al. (2006) reported 
that, under optimised conditions (e.g. pH 6.5, 37 °C, 20 h), treatment with PLP alone led to 
Nt-transamination on a variety of proteins with up to 80 % reaction yield. Using a library-
based screening strategy, an N-terminal AKT motif (A = alanine) was later determined to 
improve the yield of PLP-mediated transamination (Witus et al., 2010). 
The same screening strategy was also implicated in the development of RS-mediated Nt-
transamination. Witus et al. (2013) reported that synthetic peptides with an N-terminal 
glutamate (E) residue were generally amenable to this reaction under mild conditions (pH 
6.5, 1 h). In the peptide library, over 80 % of the peptides with an N-terminal EE motif were 
transaminated. By elevating the reaction temperature to 37 °C, the N-termini of human IgG1 
antibody were successfully transaminated, especially on the heavy chain. It was also shown 
that the antigen binding property of IgG1 antibody was not disrupted by transamination and 
subsequent carbonyl modification. 
Although both the PLP and RS routes have been successfully employed to modify protein N-
termini, the authors did report their respective limitations. For instance, the PLP route 
typically takes up to 24 h to complete. In addition, elevating the temperature does shorten 
the reaction time but at the cost of protein denaturation. In addition, the reaction yield is 
highly variable and depends on the identity of the N-terminal residue, and the desired 
product is often mixed with unwanted PLP adducts (Rosen and Francis, 2017). With respect 
to the RS route, the reaction scope is largely limited to proteins with an N-terminal E residue. 
Furthermore, a proline (P) residue at the second position adversely affects the efficiency of 




1.4.2 Applications of Nt-transamination 
An outstanding feature of protein Nt-transamination is its versatility in potential applications. 
This reaction selectively destroys the N-terminal α-amino group, but introduces a reactive 
carbonyl group instead. Generally the carbonyl group is not naturally present in proteins, 
thus it can be exploited to further introduce desired functionalities. Owing to this flexibility, 
selective transamination has been utilised in a wide range of biochemical studies. Initially, 
this reaction was applied by Dixon and Moret (1964) to specifically remove the N-terminal 
residue from a protein of interest. In detail, the novel carbonyl group (introduced by 
transamination) was further derivatised with a dual-functional nucleophile (e.g. O-
phenylenediamine). Subsequently, the nucleophile would attack the neighbouring peptide 
bond to release the N-terminal residue. Scission of the N-terminal residue allowed the 
researchers to determine the relevance of the N-terminal residue in the function of pig 
corticotropin, bacterial cytochrome C, and human serum albumin (Dixon and Moret, 1964, 
Dixon and Moret, 1965, Sarkar et al., 1978). 
In contrast to the early work that focuses on the biochemistry of protein N-termini, recent 
studies take advantage of the unique carbonyl group for site-specific protein labelling (i.e. 
protein bioconjugation). Such studies typically employ alkoxyamine compounds (e.g. O-
benzylhydroxylamine, BnONH2) to form an oxime bond with the carbonyl group. For instance, 
BnONH2 has been involved in the development of both the PLP and RS routes of Nt-
transamination. In these studies, BnONH2 was primarily used to validate the transamination 
products and to determine the reaction yields. Other alkoxyamine derivatives facilitated the 
bioconjugation of polyethylene glycol (PEG) polymers and fluorescent probes to protein N-
termini (reviewed in Rosen and Francis, 2017). The application of Nt-transamination has also 
been extended to MS-based peptide sequencing. In such studies, selective transamination is 
combined with further carbonyl modifications to negatively select either the N- or C-
terminal peptide of target proteins (Figure 1.9).  
To enrich for N-terminal peptides, selective transamination was performed to block the N-
terminal α-amino group prior to further modification with an alkoxyamine compound 
(Sonomura et al., 2009a). After digestion with a specific protease (LysN), the internal 
peptides all started with a K residue. These internal peptides were captured by amine-
reactive groups that were immobilised on glass. The N-terminal peptides did not contain any 
reactive primary amine and thus resisted capture. On the other hand, selection of C- 
terminal peptides required LysC protease digestion and peptide transamination, which 




Figure 1.9 Schematic diagram of the negative selection of protein N-termini (a) or C-termini (b) by 
selective transamination (adapted from Sonomura et al., 2009a, Sonomura et al., 2009b). DITC: p-
phenylenediisothiocyanate. 
(Sonomura et al., 2009b). Subsequently, the C-terminal peptides were blocked through 
oxime formation. The selected N- or C-terminal peptides were sequenced by MS in the end. 
In addition to oxime formation, the unique carbonyl group is also amenable to hydrazone 
formation, reductive amination, and Pictet-Spengler reaction. For instance, Sonomura et al. 
(2011) provided an upgraded transamination strategy to select endogenously modified 
protein N-termini. This method takes advantage of an immobilised hydrazine derivative to 
directly scavenge the transaminated internal peptides through hydrazone bond formation. 
Naturally blocked protein N-termini do not undergo selective transamination due to the 
absence of a reactive α-amino group, and are thus selected for MS analysis.  
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On the other hand, Sasaki et al. (2008) reported Nt-biotinylation on horse heart myoglobin 
through the PLP route of transamination and the Pictet-Spengler reaction. In this study, the 
newly introduced carbonyl group was modified with a biotin-derivatised tryptamine under 
mild conditions (pH 6.5, 37 °C). The carbonyl group underwent cyclic condensation to form a 
ring structure that contained a stable C-C bond, and this reaction did not cause any major 
change in protein structure. The Bertozzi group at Stanford University further improved the 
Pictet-Spengler reaction through rational design of tryptamine analogues, leading to a 50 % 
increase in reduction efficiency (Agarwal et al., 2013). Similar to the study by Sasaki et al. 
(2008), the improved reaction also enabled Nt-biotinylation of horse heart myoglobin as a 
proof-of-concept. In addition, a fluorescent dye was selectively attached to the N-terminal  
carbonyl group of modified human IgG1 antibody. 
1.4.3 Alternative amine-reactive chemistry  
In addition to the transamination of N-termini, several chemical modifications have also 
been proposed to target primary amines including the α-amino groups at protein N-termini. 
As illustrated in Figure 1.10, N-succinimidyl S-acetylthioacetate (SATA) and citraconic 
anhydride (CA) represent two types of amine-reactive compounds that do not discriminate 
between α- and ε-amino groups. SATA is a dual-functional compound that reacts with 
primary amines through the NHS group and introduces a thiol group in a protected form. As 
described in section 1.3.2, Kim et al. (2013) employed SATA to introduce a protected thiol 
group at protein N-termini as all the ε-amino groups of K residues had been blocked by 
guanidination with O-methylisourea. Following protease digestion, the protected thiol group 
was liberated with hydroxylamine and then reacted with thiopropyl Sepharose for positive 
selection of N-terminal peptides. 
 
Figure 1.10 The chemical structures of N-succinimidyl S-acetylthioacetate (SATA, left) and citraconic 
anhydride (CA, right; modified from Hermanson, 1996). 
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On the other hand, CA reacts with primary amines in a reversible manner, forming an amide 
bond under alkaline conditions (pH 7 – 9) that readily dissociates at pH 3 – 4 (Dixon and 
Perham, 1968). It was employed by the Zhou and Vogelstein groups in the development of a 
protein bioconjugation technique called PRINT (PRotect, INcise, Tag; Sur et al., 2015). This 
technique requires a rational design of recombinant proteins, which will contain an N-
terminal affinity tag (e.g. His-tag) followed by a TEV protease cleavage site. After expression 
and purification, the recombinant proteins are modified with CA to temporarily block both 
α- and ε-amino groups. Digestion with TEV protease exposes a reactive α-amino group, 
which can be modified through amine-reactive chemistry. For instance, recombinant tumor 
necrosis factor-α (TFT-α) protein was subject to PRINT for Nt-PEGylation. Without alterations 
in biological activity, this modification conferred higher stability and reduced toxicity to the 
recombinant TFT-α.  
In contrast to the above compounds, several reagents exhibit high selectivity for the N-
terminal α-amino group over the ε-amino groups on K side chains. These include ketenes, N-
succinimidyloxycarbonylmethyl tris(2,4,6-trimethoxyphenyl)phosphonium bromide (TMPP), 
O-aminophenols, and 2-pyridinecarboxaldehyde (2PCA). Chan et al. (2012) demonstrated 
the feasibility of using an alkyne-functionalised ketene to modify the N-termini of both 
synthetic peptides and proteins. This reaction was shown to have a broad substrate scope, 
which is similar to selective transamination. All 20 natural amino acids except histidine (H) 
could be modified with modest to excellent specificity when positioned at the N-terminus of 
a peptide. In addition, this N-terminal modification introduced a novel alkyne group, which 
could facilitate further functionalisation via click chemistry. 
TMPP is another commonly used reagent for labelling protein N-termini. Not only specific for 
the α-amino groups, TMPP modification is also beneficial to peptide identification by MS 
(Huang et al., 1997). Hence, this compound was used in a gel-based approach to assist in 
robust identification of protein N-termini (Deng et al., 2015). However, this method is 
relatively labour-intensive and low throughput. TMPP has been further combined with 
selective transamination or COFRADIC for negative selection and high-throughput 
identification of N-terminal peptides (Sonomura et al., 2011, Bland et al., 2014b). However, 
the potential of TMPP has yet to be fully exploited due to a lack of strategies for AP. A TMPP-
specific antibody was recently reported (Bland et al., 2014a), but it has neither been 
thoroughly scrutinised nor is it commercially available to our knowledge.  
The Francis group reported both oxidative coupling with O-aminophenols and 2PCA 
condensation as N-terminal labelling approaches. The oxidative coupling approach involves 
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the oxidation of O-aminophenols by K3Fe(CN)6 and in situ reaction of the oxidised 
intermediates with protein α-amino groups (Obermeyer et al., 2014). Meanwhile, 2PCA 
undergoes cyclic condensation with the N-terminal α-amino groups to form an 
imidazolidinone product (MacDonald et al., 2015). However, it was reported that the 
oxidative coupling approach favoured the N-terminal P residue, whereas the imidazolidinone 
products from 2PCA condensation were relatively unstable at 37 °C (reviewed in Rosen and 
Francis, 2017). 
Although some of the above approaches are efficient and specific towards protein N-termini, 
selective transamination presents several advantages: first, all the reagents in this method 
are easily accessible; second, it is versatile in introducing further functionalities; finally, this 
reaction proceeds efficiently. Although this reaction has been employed to negatively select 
the N-terminal peptide of individual proteins, its potential in proteomic research has yet to 
be fully realised. The present work attempts to develop a positive selection strategy based 
on selective transamination. In N-terminalomics, one crucial element of method 
development is choosing a suitable biological system: small-scale experiments need to be 
scaled up on complex protein mixtures. Proteins extracted from Jurkat T-lymphocytes 
represent such suitable biological system. For the sake of completeness, the following 
section is devoted to introducing Jurkat T-lymphocytes.  
1.5 Jurkat T-lymphocytes as a model system 
1.5.1 T-cell biology and the Jurkat model system  
Jurkat T-lymphocytes (T-cells, Clone E6-1) are a cancerous cell line, established from a 
patient with acute T-cell leukaemia in the 1970s (Figure 1.11; Schneider et al., 1977). Initially, 
Jurkat T-cells gained interest from immunologists for their inducible production of a large 
quantity of interleukin-2 (IL-2; Gillis and Watson, 1980). There had been a huge demand for 
IL-2 to maintain T-cell cultures in laboratory, owing to the ability of this cytokine to support 
T-cell survival and proliferation (Abbas et al., 2018). Jurkat T-cells soon became a major 
source of IL-2 as well as a valuable model system for T-cell research. 
Under physiological conditions, T-cells are responsible for cell-mediated immunity. Together 
with the humoral immunity mediated by B-lymphocytes (B-cells), cell-mediated immunity 
constitutes the adaptive immune system, a major part of immune defences in vertebrates. 
The principal functions of such immune systems are to protect the host against foreign 




Figure 1.11 Reference images of Jurkat T-cells (source: ATCC, http://www.atcc.org/products/all/TIB-
152). Left: low-density; right: high-density; scale bar = 100 µm.  
immunologic memory. In contrast to innate immunity that serves as a first line of defence, 
adaptive immunity is characterised by higher potency, antigen specificity, structural diversity, 
and immunologic memory. It was acquired later in evolution and is a hallmark of vertebrates 
(Liongue et al., 2011). 
T-cells, such as Jurkat T-lymphocytes, bind to their cognate antigens via a T-cell receptor 
(TCR). Each T-cell expresses a characteristic TCR that recognises a single antigen. Co-
receptors are also present on the surface of T-cells. For instance, the CD3 (cluster of 
differentiation 3) co-receptor is non-covalently associated with TCR, forming the TCR-CD3 
complex (Figure 1.12). T-cells respond to antigens that are displayed on the surface of 
antigen-presenting cells (APCs), rather than those existing in soluble, cell-free form. Upon 
entry to the host, antigens may be directly captured by APCs. These cells employ specialised 
cell surface proteins, the major histocompatibility complex (MHC), to present small peptides 
derived from the captured antigens to the correct T-cells. There are two classes of MHC 
molecules: Class I is responsible for presenting intracellular antigens to T cells that express 
the CD8 co-receptor, whereas Class II presents extracellular ones to T cells expressing the 





Figure 1.12 Composition of the T-cell receptor (TCR)-CD3 complex, which consists of the TCR, two 
heterodimers (γε and δε) and a ζζ homodimer of CD3. All cytosolic domains of CD3 proteins contain 
immunoreceptor tyrosine-based activation motifs (ITAMs). ITAMs become phosphorylated upon TCR 
ligation and trigger downstream signalling (Abbas et al., 2015). CD3: cluster of differentiation 3. 
In secondary lymphoid organs (e.g. lymph nodes and spleen), naïve T-cells browse peptide-
MHC complexes on the surface of APCs and become activated after having encountered the 
correct complex. One of the major contributions from Jurkat T-cells is the two-signal 
hypothesis of T-cell activation. Weiss et al. (1984) determined that neither a monoclonal 
antibody (i.e. OKT3) against the CD3 co-receptor within the TCR-CD3 complex nor a phorbol 
ester alone could induce Jurkat T-cells to express a high level of IL-2, but the combination of 
both boosted IL-2 production. As a result, a simplified model of T-cell activation was put 
forward consisting of two signals. The first signal (signal 1), derived from the ligation of the 
TCR-CD3 complex, and the second (signal 2) from phorbol esters. After nearly 35 years of 
research, the two-signal hypothesis has been refined now: signal 1 is indeed from the 
ligation of the TCR with a peptide-MHC complex, which is facilitated by the CD4 or CD8 co-
receptor; signal 2 comes from the interaction between a T-cell costimulatory receptor (e.g. 
CD28) and the B7 proteins on APCs (Abraham and Weiss, 2004). These two signals work in 
synergy to fully activate T-cells, to maintain the survival of activated T-cells, and to promote 
their proliferation (i.e. clonal expansion) and differentiation (Abbas et al., 2018). 
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1.5.2 Jurkat proteomics 
Since its establishment some forty years ago, Jurkat cell line has been extensively employed 
in the studies on T-cell signalling. Into the post-genomic era, the use of Jurkat T-cells has 
been extended to the field of proteomics. The proteomic analysis by Kang et al. (2005) 
represents one of the early attempts to profile global protein expression in Jurkat T-cells. In 
this study, two LC separations (SCX and RP-HPLC) were online coupled to MS/MS analysis, 
leading to the identification of 681 proteins. With technological improvements, Geiger et al. 
(2012) identified nearly 8,000 proteins in Jurkat T-cells using a combination of off-line SCX 
and online RP-HPLC, followed by MS/MS analysis with an LTQ-Orbitrap instrument. Given 
the importance of protein phosphorylation in T-cell signalling, the global analysis of PTMs is 
heavily emphasised in Jurkat proteomics. For instance, a time-course analysis of T-cell 
activation identified more than 5,500 phosphopeptides from 2,008 Jurkat proteins (Nguyen 
et al., 2016). This study also highlighted the importance of phospholipase C-gamma1 (PLCγ1) 
in T-cell signalling by comparing the regulated phosphorylation events between the wild-
type and a PLCγ1 mutant of Jurka T-cells. 
With respect to N-terminalomics, Jurkat T-cells have been involved in the development of 
both positive and negative selection methods, including N-terminal COFRADIC, Subtiligase, 
and N-CLAP. In the initial publication of N-terminal COFRADIC (Van Damme et al., 2005), the 
Gevaert lab reported the use of this technique to directly identify > 58 caspase cleavage sites 
in apoptotic Jurkat cells. Similarly, the Wells lab  demonstrated the utility of Subtiligase by 
identifying nearly 300 putative caspase substrates in apoptotic Jurkat cells (Mahrus et al., 
2008). Additionally, Jurkat proteins were employed in the development of N-CLAP as a 
model system to study NME, signal peptide removal, and caspase cleavage during apoptosis 
(Xu et al., 2009). In summary, Jurkat T-cells have already become the backbone of the 
research on cell-mediated immunity, reflected by the > 17,000 references for “Jurkat” 
(source: PubMed, 12 Jan. 2018). It is expected that Jurkat T-cells will continue to provide 
valuable insights into T-cell biology. They will also continue to serve as a valuable reagent 




1.6 Aims of the present work 
The present study aims to employ a range of synthetic peptides, individual proteins, and 
protein extracts from Jurkat T-cells as model systems to critically evaluate and optimise an 
existing negative selection approach (NHS-Sepharose) in N-terminalomics. This work also 
attempts to explore the potential of selective transamination as a positive selection 
approach. Furthermore, the present work also aims to employ this reaction to improve 
proteome coverage in standard shotgun proteomics. A detailed break-down of the said aims 
is shown below: 
 To critically evaluate the utility of the NHS-Sepharose approach in selecting the N-
terminal peptide of individual proteins for LC-MS/MS analysis. 
 To optimise the NHS-Sepharose approach by systematically refining the experiment 
parameters. 
 To evaluate the performance of SATA and CA modifications as amine-reactive 
chemistries to complement the NHS-Sepharose approach. 
 To develop selective transamination as an N-terminalomic approach for tagging the N-
termini of synthetic peptides, individual proteins, and Jurkat proteins. 
 To evaluate the performance of this approach to positively select protein N-termini for 
LC-MS/MS analysis. 





Chapter 2. Materials and Methods 
2.1 Materials 
The Jurkat T-lymphocyte cell line (ATCC TIB-152™; Schneider et al., 1977) was provided by Dr 
Hebin Liu and Dr Rong Rong (XJTLU, China). Gibco™ RPMI 1640 medium, PBS (pH 7.4, for cell-
culture), and TAE buffer (Tris-acetate-EDTA, 50X) were from Thermo Fisher Scientific, 
whereas foetal bovine serum (FBS) was purchased from Bovogen Biologicals. Penicillin-
Streptomycin was from Sigma-Aldrich, whereas cell culture flasks (T-25 and T-75) and 
Costar® 96-well plate were obtained from Corning. DNase I, 100 bp DNA ladder and DNA gel 
loading dye (6X) were from New England Biolabs, whereas GelRed® nucleic acid gel stain was 
purchased from Biotium. 
EZ-Link™ hydrazide-biotin, alkoxyamine-PEG4-biotin, alkoxyamine-PEG4-SS-PEG4-biotin, 
Pierce™ sulfo-NHS (N-hydroxysuccinimide) acetate, NHS-activated magnetic beads, N-
succinimidyl S-acetylthioacetate (SATA), citraconic anhydride (CA), Zeba™ desalting columns 
(7K MWCO), NeutrAvidin agarose, and monomeric avidin agarose were all purchased from 
Thermo Fisher Scientific. NHS-activated Sepharose™ 4 Fast Flow was obtained from GE 
Healthcare. Pyridine and copper(II) sulfate (CuSO4) were products of Alfa Aesar. DL-
Dithiothreitol (DTT), iodoacetamide, guanidine hydrochloride (HCl), 2,4-
dinitrophenylhydrazine (DNPH), and urea were acquired from Amresco. Amicon® 
ultrafiltration units (3K MWCO) and ZipTip® C18 pipette tips were from Merck Millipore, 
whereas trypsin and endoproteinase Glu-C were obtained from Promega. 
Biotin and dinitrophenol rabbit monoclonal antibodies were purchased from Cell Signaling 
Technology, whereas IRDye® 680LT donkey anti-rabbit IgG antibody was from LI-COR. 
NuPAGE™ Bis-Tris precast gels (10 %, 12-well), antioxidant, SeeBlue Plus2 pre-stained 
standard (3 – 198 kDa), and the Colloidal Blue staining kit were products of Thermo Fisher 
Scientific. 5X sodium dodecyl sulfate (SDS) sample buffer, protein molecular weight (MW) 
marker (14.4 – 116 kDa), and phenylmethanesulfonyl fluoride (PMSF, 100 mM) were from 
Beyotime, and nitrocellulose membrane was purchased from Pall Life Sciences. 
Synthetic human adrenocorticotropic hormone (ACTH, amino acid sequence: SYSMEHFRWG) 
and rat renin substrate (DRVYIHPFHLLYYS) were provided by Chinese Peptide Company (CPC). 
Bovine serum albumin (BSA), chicken egg-white lysozyme (lysozyme C), QuantiPro™ 
bicinchoninic acid (BCA) assay kit, Tris(2-aminoethyl)amine (polymer-bound), O-
benzylhydroxylamine (BnONH2), and all other chemicals were obtained from Sigma-Aldrich. 
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2.2 Cell culture 
Cryopreserved Jurkat T-lymphocytes (5 × 106 cells/ml) were quickly thawed in a water bath 
at 37 °C, prior to addition of 5 ml of RPMI 1640 medium containing 5 % (v/v) FBS and 1 % 
(v/v) Penicillin-Streptomycin (10,000 units/ml), and then collection by centrifugation at 200 x 
g for 3 minutes (min). After the removal of the supernatant, the pellet was resuspended in 5 
ml of the complete medium, transferred to a T-25 cell culture flask and grown in a 37 °C 
incubator with 5 % CO2 for two days. Cells were then sub-cultured by adding 10 ml of fresh 
complete medium and incubated in the 37 °C incubator until the cell density had reached 0.5 
x 106/ml, which was measured using a haemocytometer. Cells were transferred to a T-75 cell 
culture flask and further passaged every two days to a final volume of 80 ml while 
maintaining the cell density. 
2.3 Protein extraction 
Protein samples were prepared from Jurkat T-cells by the means of ultra-sonication. After 
cell counting with a haemocytometer, Jurkat T-cells (1x 107) were transferred from a T-75 
flask to a 50 ml centrifuge tube where they were collected by centrifugation at 600 x g for 3 
min. The cell pellet was washed three times with ice-cold PBS and then resuspended in 1 ml 
of ice-cold PBS with 1 mM PMSF. The cells were lysed on ice using a Q700 sonicator 
(QSonica). The ultra-sonication program was set as follows: 30 kHz, 60 cycles, ON time per 
cycle = 3 seconds (s), OFF time per cycle = 10 s. The cell lysate was then centrifuged at 
15,000 x g, 4 °C for 10 min to remove cell debris, and the supernatant was divided into 
aliquots (200 μl each) and stored at -80 °C for further use. 
2.4 Protein quantitation 
Protein samples, including BSA, lysozyme C, and protein extracts from Jurkat T-cells, were 
quantified by either the BCA or NanoDrop™ A280 assay. For BCA assays, a BSA protein solution 
was prepared at a concentration of 1000 µg/ml. Protein standards were prepared from the 
BSA solution through serial dilution with ddH2O to a concentration of 0, 0.5, 5, 10, 20, or 30 
μg/ml. Jurkat or individual protein samples were also diluted 100-, 250-, or 500-fold. The 
BCA assay was carried out on triplicates of the protein standards and the diluted samples 
(150 μl) in a 96-well plate according to the manufacturer’s protocol. The absorbances of the 
protein standards and the diluted samples were then measured at 562 nm using a Varioskan 
LUX microplate reader (Thermo Fisher Scientific). A standard curve of protein concentration 
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was produced from the readings of the protein standards, based on which the concentration 
of each protein sample was determined. 
For NanoDrop™ A280 assays, a buffer of choice (1 μl) was directly spotted onto a NanoDrop™ 
2000 instrument (Thermo Fisher Scientific), and its absorbance at 280 nm was set as blank. 
Jurkat or individual protein samples (1 μl) were then added and the absorbance was 
measured to estimate protein concentration. 
2.5 Negative selection of protein N-termini by NHS-Sepharose method 
Individual protein samples were prepared in 20 mM Na2CO3 buffer (pH 8.5) at a 
concentration of 1 µg/µl. The amino (N)-terminal peptide of each protein was negatively 
selected using the “NHS-Sepharose method” as previously described (McDonald and Beynon, 
2006). Briefly, 100 µg of lysozyme C or BSA was acetylated with 1 mg of sulfo-NHS acetate 
for 2 hours (h). The acetylated proteins were then incubated with 5 mg of Tris(2-
aminoethyl)amine, polymer-bound for 1 h to quench the reaction. Then proteins were then 
purified from residual reactants by TCA (trichloroacetic acid) precipitation. In detail, 1/4 of 
the sample volume of 100 % (w/v) TCA solution was added, well mixed by vortexing, and 
incubated on ice for 1 h. The proteins were then precipitated by centrifugation at 15,000 x g 
for 15 min and the pellet was extensively washed three times with ice-cold diethyl ether. 
Finally, the pellet was resuspended in 20 mM Na2HPO4 (pH 7.5) to a protein concentration of 
1 μg/μl, as measured by a NanoDrop™ A280 assay.  
The purified proteins were denatured and reduced with 5 mM DTT for 1 h at 65 °C, alkylated 
with 15 mM iodoacetamide for 30 min in the dark, and finally digested with trypsin (for BSA) 
or Glu-C (for lysozyme C) at a 1:50 ratio (w/w, enzyme to protein) at 37 °C overnight. The 
digested samples (50 µg) were diluted with an equal volume of PBS (pH 7.5) and incubated 
with 100 μl of NHS-activated Sepharose twice, first at room temperature (RT) for 4 h then at 
4 °C overnight, to negatively select N-terminal peptides. 
2.6 Systematic refinement of NHS-Sepharose approach 
Various experiment parameters were systematically and independently modified to optimise 
the NHS-Sepharose method: I. 100 µg of proteins were acetylated with 100 µg of sulfo-NHS 
acetate for 2 h, and then incubated with 10 mg of Tris(2-aminoethyl)amine, polymer-bound 
for 1 h; II. 50 µg of the digested samples (in PBS, pH 7.5) were incubated with 300 μl of NHS-
activated magnetic beads at RT for 2 h; III. the digested samples were incubated with 100, 
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200, or 300 μl of NHS-activated Sepharose at RT for 4 h; IV. the digested samples were 
incubated with 100 μl of NHS-activated Sepharose at RT for 1, 2, 3, 4 or 8 h, or at 4 °C for 3, 6, 
9, 12 or 24 h; V. the digested samples were incubated with 100 µl of NHS-activated 
Sepharose in PBS (pH 7.5, 8, or 8.5) at RT for 4 h; VI. the digested samples were incubated 
first with 8 M urea or 6 M guanidine HCl for 1 h then with 100 μl of NHS-activated Sepharose 
at RT for 4 h; VII. the digested samples were incubated with 200 μl of NHS-activated 
Sepharose twice (first at RT for 4 h then at 4 °C for 12 h), three times (two 4-h incubation at 
RT then at 4 °C for 12 h), or four times (two 4-h incubation at RT and two 12-h incubation at 
4 °C). 
Finally, BSA or lysozyme C was subjected to an optimised NHS-Sepharose protocol that 
integrated the above changes: 100 µg of the proteins were acetylated with 100 µg of sulfo-
NHS acetate for 2 h and the reaction was quenched with 10 mg of Tris(2-aminoethyl)amine, 
polymer-bound for 1 h; following TCA precipitation, the acetylated proteins were tryptic 
digested as described above; 50 µg of the digested samples were incubated with 8 M of urea 
or 6 M guanidine HCl for 1 h, and then treated with 200 μl of NHS-activated Sepharose at pH 
8.5 four times (two 4-h incubations at RT and two 12-h incubations at 4 °C). 
2.7 Blocking of primary amines with SATA or CA  
Protein extracts from Jurkat T-cells were first treated with DNase I at a ratio of 10 units/ml 
(enzyme to protein sample) at 37 °C for 1 h to remove genomic DNA. The reaction was 
quenched by incubating the samples with 5 mM EDTA (final concentration) at 65 °C for 10 
min. The Jurkat protein samples were then buffer exchanged into PBS (pH 7.5) or 20 mM 
Na2CO3 buffer (pH 8.5) without protease inhibitors through ultrafiltration. In detail, the 
protein samples were added to a 3K (MWCO) centrifugal unit and centrifuged at 13,000 x g 
(4 °C) for 3 × 15 min, each with the addition of 500 µl PBS or Na2CO3 buffer, to complete 
buffer exchange. The protein samples (1 μg/μl) were incubated with SATA in PBS at a ratio of 
50 nmol/µg (SATA to protein) for 1 h. The urea solution (8 M) was then added drop-wise to 
the SATA-modified proteins to dissolve any observed precipitates. Alternatively, the protein 
samples (1 μg/μl) were incubated with CA in in Na2CO3 buffer at a ratio of 20 nmol/µg (CA to 
protein) for 1 h. The modified proteins were further buffer exchanged into PBS (pH 7.5) by a 




2.8 Transamination  
The N-terminal amino group of a protein or peptide was selectively converted into a carbonyl 
group via a transamination reaction. First, model protein samples (lysozyme C or BSA) were 
prepared by dissolving the protein powder in 0.1 M MES buffer (pH 6.0) with 4 M urea at a 
concentration of 2 μg/μl. The protein samples were then denatured, reduced, and alkylated 
as described previously prior to protein transamination. In contrast, Jurkat protein samples 
were denatured, reduced, and alkylated immediately after protein extraction. After 
solubilisation with 6 M guanidine HCl, the Jurkat proteins were buffer exchanged into 0.1 M 
MES buffer (pH 6.0) with 4 M guanidine HCl using Zeba™ desalting columns. In detail, the 
protein samples were added to the columns that had been conditioned with the said buffer. 
The columns were then centrifuged at 1,000 x g at 4 °C for 2 min to complete buffer 
exchange. The Jurkat proteins were diluted afterwards to a concentration of 2 μg/μl for 
protein transamination.  
For peptide-level transamination, the Jurkat proteins were first digested with trypsin to yield 
Jurkat peptide samples at a concentration of 2 μg/μl (see section 2.12). In contrast, synthetic 
peptide samples (human ACTH or rat renin substrate) were prepared in a similar way to the 
model protein samples but without the addition of guanidine HCl. Both peptide samples 
were subjected to transamination as described below. 
The protein or peptide samples (2 μg/μl) were incubated with an equal volume of the 2X 
“salt-free” reaction mixture (20 % (v/v) pyridine, 0.4 M glyoxylic acid, 12 mM CuSO4) at RT 
for 2 h to complete transamination (Sonomura et al., 2009a). This reaction condition was 
adopted in lieu of the 2X “salt-based” reaction mixture (6.6 M sodium acetate, 1 M sodium 
glyoxylate, 0.1 M CuSO4, and 1 M acetic acid; Papanikos et al., 2001), which produced a 
similar result for the synthetic peptides but was not compatible with the protein samples 
due to precipitation issues. 
For further modification of the introduced carbonyl groups, the transaminated proteins were 
buffer exchanged into 20 mM phosphate buffer (pH 6.5) with 2 M guanidine HCl using Zeba™ 
columns. On the other hand, the transaminated peptides were purified using ZipTip® C18 
pipette tips, vacuum dried using a SpeedVac™ concentrator (Thermo Fisher Scientific), and 




2.9 Chemical tagging of the transaminated proteins or peptides  
The newly formed N-terminal carbonyl group was selectively modified with BnONH2, 
carbonyl-reactive biotins, or DNPH. For modification with BnONH2, the transaminated 
proteins (1 μg/μl) were reacted with 50 mM BnONH2 (final concentration) in 20 mM 
phosphate buffer with 2 M guanidine HCl (pH 6.5) at 37 °C for 2 h. The modified proteins 
were buffer exchanged into PBS (pH 7.5) using Zeba™ columns. For biotinylation, the 
transaminated proteins or peptides (1 μg/μl) were reacted with 5 mM hydrazide-biotin, 
alkoxyamine-PEG4-biotin, or alkoxyamine-PEG4-SS-PEG4-biotin (final concentration) under the 
same conditions, and then buffer exchanged using Zeba™ columns. For modification with 
DNPH, the protein samples were precipitated by the TCA method immediately after 
transamination. DNPH (0.2 %, w/v) in 2 N HCl was added to the pellet and tubes were then 
agitated for 15 min in the dark. The modified proteins were precipitated again with TCA, and 
then dissolved in 6 M guanidine HCl to a concentration of 1 μg/μl (measured by NanoDrop™ 
A280 assays). In contrast, the transaminated peptides were modified with BnONH2 or 
carbonyl-reactive biotins under the same conditions but then directly desalted using ZipTip® 
C18 pipette tips for liquid chromatography–tandem mass spectrometry (LC-MS/MS). 
2.10 Enrichment of the biotinylated proteins  
The biotinylated proteins (1 μg/μl in PBS, pH 7.5) were subjected to affinity purification (AP) 
together with three control groups: native-state proteins (i.e. without either transamination 
or biotinylation), transaminated proteins without biotinylation, and proteins only treated 
with biotin. 50 μl of NeutrAvidin or monomeric avidin agarose beads (50 % slurry in storage 
solution) were first conditioned according to the manufacturer’s instructions. The beads 
were then ready to receive one of the four samples, diluted with PBST (0.1 % (v/v) Tween-20 
in PBS, pH 7.5) to 500 μl, and incubated at RT with end-over-end turning for 1 h. The beads 
were collected by centrifugation at 500 x g for 2 min, washed first with 3 × 200 μl PBST, and 
then washed with 3 × 200 μl PBS. The NeutrAvidin beads were boiled in 50 μl of 1X SDS 
sample buffer for 5 min to elute proteins bound to the beads. In contrast, the monomeric 
avidin beads were treated with 40 μl of 0.1 M glycine (pH 2.8) to elute proteins, which was 
immediately neutralised with 10 μl of 1 M Tris HCl (pH 8.5). An aliquot of each sample was 
added with 5X SDS sample buffer and boiled for 10 min prior to sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS-PAGE). 
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2.11 Gel electrophoresis and immunoblotting 
To check genomic DNA removal, an aliquot of Jurkat protein samples were mixed with 1/5 
volume of DNA gel loading dye (6X) and loaded onto a 1 % (w/v) agarose gel. Gel 
electrophoresis was performed in TAE buffer at 100 V for 1 h. The agarose gels were stained 
with 1X GelRed®. Finally, DNA bands were visualised under ultraviolet (UV) light using a Gel 
Doc™ XR+ imager (Bio-Rad). 
For SDS-PAGE, protein samples were prepared in 1X SDS sample buffer and boiled for 10 min. 
15 μl of each sample (0.5 μg/μl) was loaded onto a 10 % precast gel, together with protein 
standards. Gel electrophoresis was performed in 3-(N-Morpholino)propanesulfonic acid 
(MOPS) running buffer (2.5 mM MOPS, 2.5 mM Tris, 0.005 % SDS, 0.05 mM EDTA, pH 7.7, 
supplemented with 1/400 volume of NuPAGE™ antioxidant) at 200 V for 50 min. The gels 
were stained with Colloidal Blue for 3 h and then destained with ddH2O overnight. 
Western blotting was employed to inspect the chemical tagging step before AP. After SDS-
PAGE, proteins were transferred from the gel to a nitrocellulose membrane in transfer buffer 
(25 mM Tris, 192 mM glycine, 20 % (v/v) methanol, pH 8.3) on ice at 100 V for 1 h. Proteins 
transferred to the membrane were stained with Ponceau S to assess transfer efficiency, and 
then destained with PBST. The membrane was incubated in blocking solution (5 % (w/v) non-
fat milk in PBST) at RT for 1 h, and then blotted with biotin- or dinitrophenol-specific primary 
antibodies (rabbit, 1:1,000 diluted in blocking solution) at 4 °C overnight. Following 3 x 15-
min washing with PBST, the membrane was incubated with IRDye® 680 LT anti-rabbit IgG 
secondary antibody (donkey) at RT for 1 h, and then washed three times with PBST for 15 
min each. Finally the membrane was scanned by an Odyssey® infrared imaging system (LI-
COR) to detect proteins tagged with biotin. 
Additionally, dot blotting was employed to rapidly identify proteins tagged with biotin or 
dinitrophenol groups. 5 μl of the tagged protein sample (1 μg/μl) was directly spotted onto a 
nitrocellulose membrane, together with three control samples as described previously. 
Sample loading was checked using Ponceau S stain before the membrane was subjected to 




2.12 Sample preparation  
Protein samples were subjected to the preparation procedure as described previously (if not 
already done): proteins were denatured and reduced with 5 mM DTT at 65 °C for 1 h, and 
then alkylated with 15 mM iodoacetamide for 30 min in the dark. The samples were then 
diluted with a buffer of choice (e.g. PBS), to lower the concentration of guanidine HCl to < 1 
M, and digested with trypsin or Glu-C at a 1:50 ratio (w/w, enzyme to protein) at 37 °C 
overnight. Protein digests were lyophilised afterwards in a SpeedVac™ concentrator to 
complete dryness and resuspended in 0.5 % (v/v) formic acid for ZipTip® desalting. 
2.13 LC-MS/MS  
Protein digests and peptide samples (100 ng) were analysed using an EASY-nLC 1000 system 
coupled online to an LTQ-Orbitrap Elite™ (Thermo Fisher Scientific). Synthetic peptides and 
the digests of individual proteins were first loaded onto an Acclaim™ PepMap™ C18 trap 
column (0.075 mm × 150 mm, particle size = 3 μm, pore size = 100 Å, Thermo Fisher 
Scientific), and then separated on an analytical column (Acclaim™ PepMap™ C18, particle 
size = 2 μm) using a 60-min binary gradient consisting of 0.1 % (v/v) formic acid in ddH2O 
(solvent A) and 0.1 % (v/v) formic acid in acetonitrile (solvent B). The gradient was as follows: 
0 – 5 % solvent B in 1 min, 5 – 25 % B over 45 min, 25 – 40 % B in 5 min, 40 – 95 % B in 2.5 
min, and finally held at 95 % B for 6.5 min. In contrast, Jurkat protein digests were eluted 
from the trap column and analysed on a MonoCap™ C18 HighResolution 3000 column (0.1 
mm x 3,000 mm, through-pore size = 2 μm, mesopore size = 15 nm, GL Sciences) at a flow 
rate of 300 nl/min with the following gradient: 0 – 10 % solvent B in 5 min, 10 – 45 % B in 360 
min, and 45 – 90 % B in 10 min. 
Data acquisition was set at data-dependent mode: in each cycle, one MS1 scan (full mass 
spectrum) was recorded with 10 MS2 scans (tandem mass spectra) corresponding to the 10 
most intense precursor ions. Full mass spectra were acquired at a resolution (R) of 60,000 
from 150 to 2,000 m/z. Precursor ions were fragmented by Higher-energy Collisional 
Dissociation (HCD) to produce tandem mass spectra. Dynamic exclusion was set to 30 s, and 
+1 charged ions were rejected for fragmentation. The normalised collision energy for HCD 
was set to 35 %, the isolation window was 2.0 m/z, and the activation time was 0.1 ms. 




2.14 Data analysis 
Orbitrap RAW data were manually inspected using Xcalibur Qual Browser (Thermo Fisher 
Scientific) before being converted into peak lists by Mascot Distiller (Matrix Science) in 
Mascot generic format (MGF). These data were then searched against the decoy sequences 
of synthetic peptides/individual proteins (manually entered), or those from the Swiss-Prot 
database (taxonomy = Homo sapiens), using Mascot Daemon 2.4. Protein search settings 
were as follows: trypsin or Glu-C protease specificity with up to two missed cleavages for 
protein digests; “None Cutting Enzyme” for peptides; cysteine (C) carbamidomethylation 
(+57.02 Da) as fixed modification; methionine (M) oxidation (+15.99 Da), N-terminal/lysine 
(Nt/K) acetylation (+42.01 Da), Nt/K modification with SATA (+115.99 Da) or CA (+ 112.02 
Da), Nt-transamination (-1.03 Da), N-terminal tagging with BnONH2 (+104.03 Da), hydrazide-
biotin (+239.10 Da), alkoxyamine-PEG4-biotin (+415.18 Da), or alkoxyamine-PEG4-SS-PEG4-
biotin (+825.33 Da) as variable modifications (depending on the subject of each study); 
charge states were set as +2 and +3 only; peptide and MS/MS tolerance were set at 10 ppm 
(parts per million) and 0.5 Da, respectively.  
In searching for unsuspected modifications of synthetic peptides/model proteins due to 
transamination (see sections 4.2.2 & 4.2.3), automatic error-tolerant searches were also 
performed in Mascot Daemon 2.4 as specified by the software provider. On the other hand, 
protease specificity was set to semi-trypsin in an effort to identify neo-N-termini in Jurkat 
protein samples (see section 5.3).   
All the RAW, MGF, and Mascot search results were archived in the local network storage 
system, ReadyNAS NV+ v2 (NETGEAR). The data of Jurkat shotgun proteomics and Jurkat 
peptide transamination have been deposited to the ProteomeXchange Consortium via the 
PRIDE partner repository (Vizcaíno et al., 2015) with the dataset identifier PXD009340 and 
PXD009427, respectively.  
2.15 Data mining 
Mascot search results were only accepted if the false discovery rate (FDR) was < 5 %. In 
general, Mascot data were further processed in R to select significant peptide hits with a 
peptide expectation (E)-value ≤ 0.05, and to remove duplicate peptide hits. “One-hit 
wonders” (proteins identified by a single peptide) were further removed from the protein 
identification data in order to comply with the “two-peptide rule” (i.e. a protein msut be 
identified on the basis of ≥ 2 significant peptide hits; Bradshaw et al., 2006). For the 
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transaminated Jurkat peptides, peptide hits with an E-value > 0.05 and duplicate hits were 
both removed but one-hit wonders were included in the initial results. This decision was 
based on the claim by Gupta and Pevzner (2009) that excluding one-hit wonders actually 
lowers the sensitivity of proteomics and that a large proportion of one-hit wonders are 
indeed expressed. Due to the high mass accuracy and resolution of LTQ-Orbitrap Elite™, 
peptide hits with an E-value ≤ 0.05 are highly reliable. In error-tolerant searches, a peptide 
hit was only accepted if the peptide score was no less than 13, which corresponds to a P-
value ≤ 0.05.  
The final data of peptide detection and protein identification were statistically analysed and 
visualised using R. In particular, the isoelectric point (pI) and hydrophobicity index of Jurkat 
peptides were computed in R using the Peptides package (Osorio et al., 2015). Gene 
Ontology (GO) term enrichment and pathway analysis were performed using the DAVID 
Bioinformatics Resources v6.8 (Huang et al., 2008).  
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Chapter 3. Critical assessment of the NHS-Sepharose approach for 
recovery of N-terminal peptides 
3.1 Introduction 
The identification of either protein amino (N)-termini or proteolytic processing events 
increasingly relies on the techniques of positional proteomics, which target peptides with 
defined positions after protease digestion in standard shotgun proteomics (Eckhard et al., 
2016). The two major categories of peptides investigated by such techniques are protein N- 
and carboxyl (C)-termini. At present, the focus is primarily on protein N-termini since primary 
amines are more reactive than carboxyl groups (Plasman et al., 2013). A group of techniques 
have been developed to selectively recover such peptides through the semi-unique 
chemistry of primary amines. Such techniques (also known as N-terminalomics) can be 
further divided into two types of strategy: “negative selection”, including combined 
fractional diagonal chromatography (COFRADIC; Staes et al., 2011) and N-terminal amine 
isotopic labeling of substrates (N-TAILS; Kleifeld et al., 2010), and “positive selection”, such as 
the Subtiligase method (Mahrus et al., 2008). 
At the University of Liverpool, the Beynon group has also developed a negative selection 
strategy that removes internal peptides after proteolysis, thereby allowing the capture of 
protein N-termini (McDonald et al., 2005). This promising method employs an acetylation 
reaction that blocks both α-amino groups (protein N-termini) and the ε-amino groups of 
lysine (K) residues on intact proteins. Following protease digestion of the acetylated proteins, 
the method uses N-hydroxysuccinimide (NHS)-activated Sepharose (an amine-specific 
coupling reagent in immobilised form) to remove peptides with free N-termini from the 
mixture (Figure 3.1). However, this method (referred to as the “NHS-Sepharose” approach 
hereafter) has not been as fully exploited in contrast to other negative selection techniques. 
As suggested by Dr Xumin Zhang, complete removal of internal peptides could not be 
achieved using the NHS-Sepharose approach (2016, personal communication). In light of this 
statement, we aimed to assess the feasibility of this method using commercially available 
proteins (see section 3.2.1).  
It was further envisaged that the experimental conditions used in the NHS-Sepharose 
approach could be refined to improve the efficiency of peptide removal, which would in turn 
promote a wider use of this method. Seven experiment parameters to be refined were 
empirically determined. First, it was suspected that the acetylation reagent, when in a large 
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molar excess, might carry over to the subsequent reaction steps (e.g. protease digestion) and 
thus negatively impact the outcome of peptide removal. Next, the coupling reagent of choice 
is integral to this method and often requires fine-tuning for specific applications (e.g. Mejía-
Manzano et al., 2016). Furthermore, the pH, temperature, incubation times, reagent 
quantity, and clean-up method are also conceivable targets for refinement. For instance, the 
specificity of the coupling reaction toward different amino groups can be altered by lowering 
the pH from 8.5 to 6.5 (Selo et al., 1996).  
Therefore, the present study also aimed to assess the scope for improvement by 
systematically refining seven experiment parameters of the NHS-Sepharose approach: I. the 
amount of acetylation reagents; II. the type of coupling reagents; III. the amount of coupling 
reagents; IV. the duration of the coupling reaction; V. coupling reaction pH; VI. the repeat 
number of the coupling reaction; VII. the use of chaotropic agents (to account for any 
hydrophobic effect, see section 3.2.2). An optimised protocol of this method was further 
coupled to alternative reactions with primary amines. Finally, a shotgun proteomic study was 
conducted to assess the feasibility of the optimised method (with alterative reactions) on a 







Figure 3.1 Schematic of the NHS-Sepharose approach, which employs acetylation of primary amines 
and amine-reactive resin (i.e. NHS-activated Sepharose) to negatively select the N-terminal peptides 
of proteins after proteolysis (modified from McDonald et al., 2005). Furthermore, with the use of 
isotopic labels this approach allows discrimination between naturally and chemically acetylated N-
termini. NHS: N-hydroxysuccinimide; MS/MS: tandem mass spectrometry.   
54 
 
3.2.1 Implementation of the NHS-Sepharose approach 
The experimental protocol for the NHS-Sepharose approach was initially tested on chicken 
egg-white lysozyme (lysozyme C, Swiss-Prot ID: LYSC_CHICK/P00698) in conjunction with Glu-
C protease digestion. Lysozyme C is a bacteriolytic enzyme consisted of 129 amino acid 
residues (Figure 3.2). The protein precursor contains an 18-residue signal peptide, which is 
cleaved off after protein synthesis; as a result the mature protein starts with an N-terminal K 
residue (Canfield, 1963). 
 
Figure 3.2 Protein sequence of the mature lysozyme C. The sequence shown in red was matched to 
the experimental data by Mascot database search (see Table 3.1). 
A test experiment was first performed to identify the predicted N-terminal peptide after Glu-
C digestion. The peptides were subjected to liquid chromatography–tandem mass 
spectrometry (LC-MS/MS) analysis. Mascot Distiller software was then utilised to convert the 
collected data to peak lists, which were searched against a decoy version of the protein 
sequence of lysozyme C using Mascot Daemon. As shown in Table 3.1, there were 15 Glu-C 
generated peptides of lysozyme C identified with high confidence (E-value ≤ 0.05), leading to 
100 % protein sequence coverage (Figure 3.2).  
The authentic N-terminal peptide of lysozyme C was identified as lysine – valine – glycine – 
arginine – cysteine (carbamidomethylated) – glutamate (KVFGRCE) after Glu-C digestion. The 
N-terminal peptide eluted at 12.75 minute (min) during LC separation (Figure 3.3). It was 
detected as a precursor ion at m/z = 448.23 with two positive charges (z = 2), which 
corresponds to a molecular weight (MW) of 894.44 Da (Figure 3.4). The sequence of this 
peptide was obtained by matching the tandem mass spectrum for the precursor ion to the in 
silico predicted m/z values for all possible fragment ions. The tandem mass spectrum was 
obtained via Higher-energy Collisional Dissociation (HCD), which produces predominantly 
the b- and y-series fragment ions. HCD-produced fragment ions can be assigned to their 




Table 3.1 Identification of Glu-C generated peptides of lysozyme C by a Mascot database searcha. 
Peptide-Spectrum Match (Start – End) m/z MW Score E-value 
KVFGRCE (1 – 7) + Carbamidomethyl (C) 448.2275 894.4382 36 0.00023 
KVFGRCELAAAMKRHGLD (1 – 18)                                    
+ Carbamidomethyl (C) 
687.0315 2058.0615 33 0.0005 
LAAAMKRHGLD (8 – 18) 591.8257 1181.6339 45 2.9E-5 
LAAAMKRHGLDNYRGYSLGNWVCAAAKFE                         
(8 – 35) + Carbamidomethyl (C) 
1066.8644 3197.5651 33 0.00045 
NYRGYSLGNWVCAAAKFE (19 – 35)                              
+ Carbamidomethyl (C) 
1017.9816 2033.9418 61 8.7E-7 
SNFNTQATNRNTD (36 – 48) 741.8341 1481.6495 83 5.6E-9 
SNFNTQATNRNTDGSTD (36 – 52) 921.8981 1841.7776 51 7.6E-6 
GSTDYGILQINSRWWCND (49 – 66)                               
+ Carbamidomethyl (C) 
1092.9968 2183.9695 17 0.021 
YGILQINSRWWCND (53 – 66)                                          
+ Carbamidomethyl (C) 
912.9313 1823.8413 59 1.4E-6 
GRTPGSRNLCNIPCSALLSSD (67 – 87)                               
+ 2 Carbamidomethyl (C) 
759.0386 2274.0845 48 1.4E-5 
GRTPGSRNLCNIPCSALLSSDITASVNCAKKIVSD 
(67 – 101) + 3 Carbamidomethyl (C) 
941.2290 3760.8658 59 1.4E-6 
ITASVNCAKKIVSD (88 – 101)                                              
+ Carbamidomethyl (C) 
753.4059 1504.7919 46 2.5E-5 
ITASVNCAKKIVSDGNGMNAWVAWRNRCKGTD 
(88 – 119) + 2 Carbamidomethyl (C) 
895.6915 3578.7293 88 1.6E-9 
GNGMNAWVAWRNRCKGTD (102 – 119)                       
+ Carbamidomethyl (C) 
698.3235 2091.9479 50 9.4E-6 
VQAWIRGCRL (120 – 129)                                                
+ Carbamidomethyl (C) 
629.8483 1257.6764 21 0.0078 
a Orbitrap RAW data were processed and searched in Mascot twice, with cysteine (C) 
carbamidomethylation set as either a fixed or variable modification. Both Mascot searches produced 
the same result, which was then edited to show a single PSM representing each peptide identified 
with high confidence (E-value ≤ 0.05). The doubly charged ion at m/z = 448.23 (see Fig. 3.4) was 
matched to the carbamidomethylated N-terminal peptide KVFGRCE. PSM: peptide-spectrum match; 




Figure 3.3 Total ion current chromatogram (TIC) of lysozyme C peptides produced by Glu-C protease 
digestion and separated on a C18 column (Acclaim™ PepMap™) for mass spectrometric analysis. Peaks 
in the chromatogram correspond to putative proteolytic peptides. The peak eluting at RT = 12.75 min 
is analysed below (Fig. 3.4). RT: retention time; NL: normalised intensity level; min: minute. 
Figure 3.4 Full mass spectrum of the peptide eluting at RT = 12.75 min. The major peak in the graph is 
a doubly charged ion (z = 2) with a mass-to-charge value (m/z) = 448.23. RT: retention time; NL: 





As shown in Figure 3.5 and Table 3.2, this tandem mass spectrum contains five matched y-
ions (y2 – y6), which correspond to the carboxyl parts of the peptide KVFGRCE. The matched 
b1-ion was excluded as the b1-ion of an unmodified N-terminal residue is never seen 
(Maleknia and Johnson, 2011). A unique feature of this peptide is the presence of both an α-
amino group and an ε-amino group on the N-terminal K residue, without endogenous N-
terminal (Nt)-acetylation. In principle, this chemical property requires the addition of two 
acetyl groups (–COCH3) in order to fully block the protein N-terminus. 
 
Figure 3.5 Tandem mass spectrum of the precursor ion at m/z = 448.23 (z = 2). This ion corresponds to 
the N-terminal peptide of lysozyme C (amino acid sequence: KVFGRCE). The spectrum was matched to 
this peptide based on the in silico prediction of fragment ions (shown in Table 3.2). RT: retention time; 
NL: normalised intensity level. 
Table 3.2 Fragment ions (in silico predicted) of the peptide KVFGRCE. Fragment ions matched to the 
experimental data are shown in reda. 
a Matched b1 ion (m/z = 129.1022) was excluded since the unmodified N-terminal b1 ion is never 
detected and the matched ion may correspond to an iminium ion of the lysine (K) residue.     
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Having experimentally established the N-terminal peptide of lysozyme C, the next step was 
to examine the effect of primary amine acetylation. Accordingly, the protein was incubated 
with the acetylation reagent (sulfo-NHS acetate) for 2 hours (h) prior to quenching with 
Tris(2-aminoethyl)amine, polymer bound. Following precipitation, the protein was 
denatured, reduced, alkylated, and then proteolysed with Glu-C. Finally, the proteolytic 
peptides were analysed by LC-MS/MS. A control experiment was performed where lysozyme 
C was digested with Glu-C without acetylation. 
As shown in Table 3.3 (and later in Figure 3.9), 86 % of the lysozyme C sequence was 
identified in the acetylation experiment based on the high-confidence (E-value ≤ 0.05) match 
of 12 peptides generated by Glu-C digestion. The acetylated N-terminal peptide was 
identified as a doubly charged ion at m/z = 490.23, which corresponds to a MW of 978.46 Da 
(Figure 3.6). By comparing the results between the control and acetylation experiments, the 
N-terminal peptide KVFGRCE was shown to exhibit a mass shift of +84.02 Da (from 894.44 to 
978.46 Da) after acetylation. As the MW of an acetyl group is 42.01 Da, this mass shift 
corresponds to the addition of two acetyl groups (Table 3.3).  
Table 3.3 also shows that the vast majority of primary amines on lysozyme C were acetylated 
after the treatment with sulfo-NHS acetate. The N-terminal peptide was only identified in 
the form of single or double acetylation on the N-terminal K residue. This result suggests a 
high efficiency of acetylation at the N-terminus of lysozyme C since peptide ions with the 
free N-terminus were not detected. On the other hand, most of the internal peptides of 
lysozyme C were susceptible to acetylation if a K residue was present. The only exception 
was the internal peptide ITAVNCAKKIVSD that contains two adjacent K residues. Only one of 
the K residues in this peptide was acetylated, suggesting a negative effect of the adjacent K 










Table 3.3 Glu-C generated peptides of acetylated lysozyme C as identified by a Mascot database 
searcha.  
Peptide-Spectrum Match (Start – End) m/z MW Score E-value 
KVFGRCE (1 – 7) + Acetyl (N-term); 
Carbamidomethyl (C)  
469.2306 936.4487 16 0.023 
KVFGRCE (1 – 7) + Acetyl (N-term); Acetyl (K); 
Carbamidomethyl (C)  
490.2346 978.4593 21 0.0083 
KVFGRCELAAAMKRHGLD (1 – 18)                                 
+ Acetyl (N-term); 2 Acetyl (K); 
Carbamidomethyl (C) 
729.0373 2184.0932 50 1.0E-5 
LAAAMKRHGLD (8 – 18) + Acetyl (K) 408.8887 1223.0444 31 0.00074 
LAAAMKRHGLD (8 – 18) 
+ Acetyl (K); Oxidation (M) 
400.2178 1239.6394 25 0.0031 
LAAAMKRHGLDNYRGYSLGNWVCAAAKFE 
(8 – 35) + 2 Acetyl (K); Carbamidomethyl (C) 
1094.8626 3281.5862 14 0.035 
NYRGYSLGNWVCAAAKFE (19 – 35)                        
+ Acetyl (K); Carbamidomethyl (C) 
1038.9734 2075.9523 20 0.0092 
SNFNTQATNRNTD (36 – 48) 741.8313 1481.6495 69 1.3E-7 
SNFNTQATNRNTDGSTD (36 – 52) 921.8875 1841.7776 60 9.2E-7 
YGILQINSRWWCND (53 – 66)                                          
+ Carbamidomethyl (C) 
912.9254 1823.8413 37 0.00022 
GRTPGSRNLCNIPCSALLSSD (67 – 87)                            
+2 Carbamidomethyl (C) 
759.0316 2274.0845 53 4.7E-6 
ITASVNCAKKIVSD (88 – 101) + Acetyl (K); 
Carbamidomethyl (C) 
774.4073 1546.8025 14 0.037 
GNGMNAWVAWRNRCKGTD (102 – 119) 
+ Acetyl (K); Carbamidomethyl (C) 
712.3232 2133.9585 22 0.0057 
VQAWIRGCRL (120 – 129)                                               
+ Carbamidomethyl (C) 
629.8416 1257.6764 21 0.0078 
a Orbitrap RAW data were processed and searched in Mascot twice, with cysteine (C) 
carbamidomethylation set as either a fixed or variable modification. Both Mascot searches produced 
the same result, which was then edited to show a single PSM representing each peptide identified 
with high confidence (E-value ≤ 0.05). PSM: peptide-spectrum match; m/z: mass-to-charge ratio; MW: 
molecular weight; E-value: peptide expectation value. 
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Figure 3.6 Full mass spectrum of the peak at RT = 29.39 min, which contained peptides from 
acetylated lysozyme C. The doubly charged ion at m/z = 490.23 is the major peak in this graph, which 
was derived from the acetylated N-terminal peptide of lysozyme C (see Fig. 3.7). RT: retention time; 
NL: normalised intensity level; m/z: mass-to-charge ratio; min: minute. 
As shown in Figure 3.7, the tandem mass spectrum for the precursor ion at m/z = 490.23 
contains five y-ions (y2 – y6) that were matched to the in silico predicted values (Table 3.4). 
The m/z values of these five y-ions were identical to those derived from the native N-
terminal peptide previously shown in Figure 3.5 and Table 3.2. Hence it was inferred that 
only the N-terminal residue was modified by acetylation, as N-terminal modifications should 
not change the m/z of y-ions. In addition, only the N-terminal K residue in this peptide 
possesses free amino groups that are susceptible to acetylation. Two acetyl groups were 
added to the N-terminal residue instead of just one due to the fact that the N-terminal K 
residue contains two free amino groups. One of them corresponds to the α-amino group at 
the N-terminus while the other corresponds to the ε-amino group present on the side chain 
of a K residue, which happens to be the N-terminal amino acid residue of the mature 
lysozyme C. In conclusion, acetylation can be employed to block the N-terminus of lysozyme 
C and K side chains. 
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Figure 3.7 Tandem mass spectrum of the precursor ion at m/z = 490.23 (z = 2). This ion corresponds to 
the acetylated N-terminal peptide of lysozyme C (amino acid sequence: KVFGRCE). The spectrum was 
matched to this peptide based on the in silico prediction of fragment ions (shown in Table 3.4). RT: 
retention time; NL: normalised intensity level; m/z: mass-to-charge ratio. 
Table 3.4 Fragment ions (in silico predicted) of the acetylated peptide KVFGRCE. Fragment ions 





Having established the efficiency of primary amine acetylation, the next step was to examine 
the efficiency of enrichment for the acetylated N-terminal peptide after removal of Glu-C 
generated internal peptides. Such peptides possess a free α-amino group at their N-termini, 
and in theory can be removed using amine-reactive chemistry. The reagent of choice was 
NHS-activated Sepharose, which is an immobilised amine-reactive resin. The hypothesis of 
this experiment was that the acetylated N-terminal peptide of lysozyme C would remain 
detectable by LC-MS/MS after treating the entire pool of Glu-C generated peptides with this 
resin; in contrast, other internal peptides would be removed by the resin and hence 
undetectable. 
The N-terminal peptide enrichment was carried out according to McDonald and Beynon 
(2006). Following acetylation of lysozyme C and treatment of Glu-C generated peptides with 
NHS-activated Sepharose, the supernatant was collected, desalted, and analysed by LC-
MS/MS. By comparing the base peak chromatograms between the control and treated 
samples, the vast majority of the peptides from acetylated lysozyme C have diminished after 
the treatment with NHS-activated Sepharose (Figure 3.8). As shown by Mascot search 
results, 86 % of the lysozyme C sequence was identified in the control sample, with 11 high-
confidence peptide matches (Table 3.5). The number of peptide matches decreased to 3 in 
the treated sample, constituting only 18 % of protein sequence coverage (Figure 3.9). 
The three identified peptides were the acetylated N-terminal peptide (KVFGRCE, with two 
acetyl groups) and two internal peptides (SNFNTQATNRNTD and SNFNTQATNRNTDGSTD) 
that both started with the same amino acid residue (S36). Repeated identification of such 
peptides suggests that it was either of high abundance due to highly efficient proteolysis by 
Glu-C, or ionised particularly efficiently in the electrospray process. Alternatively, the two 
internal peptides might have “masked” their N-termini or bind non-covalently to the 
authentic N-terminal peptide (KVFGRCE). 
Due to the presence of internal peptides when the original NHS-Sepharose protocol was 
followed, the conclusion is as follows: the NHS-Sepharose approach is capable of removing 
the vast majority of internal peptides after protease digestion of acetylated proteins; 
however certain internal peptides may remain with the authentic N-termini. Without prior 
knowledge, these internal peptides may be misidentified as protein N-termini. Therefore, 
this approach requires further improvement or modification before it can be employed for 





Figure 3.8 Comparison of the base peak chromatograms before (in black) and after (in blue) treatment 
with N-hydroxysuccimide (NHS)-activated Sepharose. Peaks in these graphs correspond to putative 





Figure 3.9 Comparison of the sequence coverage of acetylated lysozyme C before and after treatment 




Table 3.5 Comparison of the Glu-C generated peptides of acetylated lysozyme C before and after 
treatment with NHS-activated Sepharosea. 
Peptide-Spectrum Match 
(Start – End) 
m/z MW Score E-value 
Duplicate         
PSM No. 
Before treatment 
KVFGRCE (1 – 7) + Acetyl (N-term); 
Carbamidomethyl (C) 
469.2317 936.4487 32 0.0006 12 
KVFGRCE (1 – 7) + Acetyl (N-term); 
Acetyl (K); Carbamidomethyl (C) 
490.2360 978.4593 32 0.00065 23 
KVFGRCELAAAMKRHGLD (1 – 18) 
+ Acetyl (N-term); 2 Acetyl (K); 
Carbamidomethyl (C) 
729.0370 2184.0932 30 0.0011  
LAAAMKRHGLD (8 – 18) + Acetyl (K) 408.8887 1223.0444 51 7.7E-6 1 
SNFNTQATNRNTD (36 – 48) 741.8313 1481.6495 69 1.3E-7  
SNFNTQATNRNTDGSTD (36 – 52) 921.8875 1841.7776 60 9.2E-7 22 
YGILQINSRWWCND (53 – 66)                            
+ Carbamidomethyl (C) 
912.9256 1823.8413 26 0.0025  
GRTPGSRNLCNIPCSALLSSD (67 – 87)      
+ 2 Carbamidomethyl (C) 
759.0336 2274.0845 29 0.0012 1 
ITASVNCAKKIVSD (88 – 101)                 
+ Acetyl (K); Carbamidomethyl (C) 
774.4073 1546.8025 14 0.037  
GNGMNAWVAWRNRCKGTD                         
(102 – 119) + Acetyl (K); 
Carbamidomethyl (C) 
712.3243 2133.9585 24 0.0044  
VQAWIRGCRL (120 – 129)                                    
+ Carbamidomethyl (C) 
629.8446 1257.6764 14 0.037  
After treatment 
KVFGRCE (1 – 7) + Acetyl (N-term); 
Acetyl (K); Carbamidomethyl (C) 
490.2354 978.4593 16 0.023 1 
SNFNTQATNRNTD (36 – 48) 741.8319 1481.6495 74 4.2E-8 1 
SNFNTQATNRNTDGSTD (36 – 52) 921.8926 1841.7776 65 3.3E-7 22 
a Orbitrap RAW data were processed and searched in Mascot twice, with cysteine (C) 
carbamidomethylation set as either a fixed or variable modification. Both Mascot searches produced 
the same result, which was then edited to show a single PSM each representing one of the 11 
significantly identified peptides (E-value ≤ 0.05). NHS: N-hydroxysuccinimide; m/z: mass-to-charge 
ratio; MW: molecular weight; E-value: peptide expectation value; Duplicate PSM No.: number of 




3.2.2 Method improvement by refining experimental conditions 
The presence of contaminating internal peptides has impeded the use of the NHS-Sepharose 
approach to selectively identify protein N-termini. To overcome this problem, false-positive 
peptides such as SNFNTQATNRNTDGSTD of lysozyme C should be further characterised. The 
outcome of such peptide characterisation may help to fine-tune experimental conditions, 
thereby leading to a reduced number of false-positive peptides and improved N-terminal 
enrichment. 
Therefore, an investigation was carried out by Hao Zhang (H.Z.) in collaboration with a Final 
Year Project student, Zimeng Zhang (Z.Z.). This investigation had two primary aims: I. to 
determine if specific physico-chemical properties are shared by the false-positive peptides; 
and II. to lower the number of such contaminating peptides by adjusting relevant experiment 
parameters. As with previous experiments, peptides that resulted from Glu-C digestion of 
the acetylated lysozyme C were treated with NHS-activated Sepharose for N-terminal 
enrichment. In addition, bovine serum albumin (BSA, Swiss-Prot ID: ALBU_BOVIN/P02769) 
was subjected to acetylation and tryptic digestion, and the resulting peptides were treated 
similarly. H.Z. and Z.Z. jointly performed the experiments in I, and Z.Z. analysed the resulting 
data. The experiments and data analysis in II were carried out primarily by Z.Z. with help 
from H.Z. 
BSA is also a suitable candidate for this investigation because tryptic digestion of the 
acetylated BSA produced a 10-residue N-terminal peptide DTHKSEIAHR (with one missed 
cleavage), which was readily detected by LC-M/MS (Table 3.6). The tandem mass spectrum  
Table 3.6 Acetylated N-terminal peptide of BSA (amino acid sequence: DTHKSEIAHR), as identified by 
a Mascot database searcha. 
Peptide-Spectrum Match  
(Start – End) m/z MW Score E-value 
Duplicate 
PSM No. 
DTHKSEIAHR (1 – 10)  398.5389 1192.5949 48 1.7E-5 1 
DTHKSEIAHR (1 – 10) + Acetyl (N-term) 412.5425 1234.6054 59 1.2E-6 5 
DTHKSEIAHR (1 – 10) + Acetyl (K) 412.5417 1234.6054 58 1.5E-6 5 
DTHKSEIAHR (1 – 10) + Acetyl (N-term); 
Acetyl (K) 
639.3154 1276.6160 63 5.2E-7 19 
a A single PSM is shown for each significantly identified peptide (E-value ≤ 0.05). m/z: mass-to-charge 
ratio; MW: molecular weight; E-value: peptide expectation value; Duplicate PSM No.: number of 




Figure 3.10 Tandem mass spectrum of the precursor ion at m/z = 639.31 (z = 2), which corresponds to 
the acetylated N-terminal peptide of BSA (amino acid sequence: DTHKSEIAHR). The spectrum was 
matched to this peptide based on the in silico prediction of fragment ions (see Table 3.7). RT: 
retention time; NL: normalised intensity level; m/z: mass-to-charge ratio. 
 
Table 3.7 Fragment ions (in silico predicted) of the peptide DTHKSEIAHR. Fragment ions matched to 






for this peptide shows that the m/z of nine y-ions were matched to the in silico predicted 
values. The b-series fragment ions are derived from the amino parts of a peptide and hence 
their m/z values are directly affected by N-terminal modifications. The nature of this 
modification is then determined according to the mass shift calculated by comparing the 
mass of each b-ion between a peptide and its modified counterpart. In this case, three b-ions 
were matched: the b3 ion gained a mass shift of +42.01 Da, whereas both the b6 and b8 ions 
gained a mass shift of +84.02 Da. Taken together, these results indicate the addition of two 
acetyl groups, one at the N-terminus and the other on the K residue at the fourth position.  
As described in Chapter 2 (Materials and Methods), lysozyme C or BSA was acetylated, 
proteolysed (Glu-C for lysozyme C and trypsin for BSA), and treated with NHS-activated 
Sepharose for N-terminal enrichment. The purpose of choosing different proteases for 
different proteins was to generate N-terminal peptides appropriate for MS analysis in terms 
of sequence length. To identify possible means to further remove internal peptides, seven 
experiment parameters were manipulated (e.g. the use of different coupling reagents or 
chaotropic agents). At the data analysis stage, the sequence coverage results before and 
after treatment with NHS-activated Sepharose were employed to calculate a normalised 
efficiency of internal peptide removal (Equation 3.1). The normalised efficiency in each 
parameter alteration was then compared to determine the most appropriate strategy to 
improve the NHS-Sepharose approach. Details in each parameter alternation are described 
together with their respective results.  
 
Equation 3.1 Equation to calculate Normalised Efficiency of removing internal peptides. SCbefore 
represents the sequence coverage before treatment with N-hydroxysuccinimide (NHS)-activated 
Sepharose (control sample); SCafter is the sequence coverage after the treatment (treated sample); SCN-
peptide corresponds to the percentage of the N-terminal peptide in the entire protein sequence (i.e. the 
ideal percentage that a perfect result would achieve with no false-positives). 
In the case of removing internal peptides of acetylated lysozyme C, the previously identified 
internal peptide SNFNTQATNRNTDGSTD was still present after treatment with NHS-activated 
Sepharose. On the other hand, the acetylated N-terminal peptide of BSA was identified 
together with multiple internal peptides after the treatment (Table 3.8). Several conjectures 
were therefore put forward to explain this observation. First, such false-positive peptides 
were produced in higher abundance than others (e.g. due to favourable cleavage sites), so 
that these peptides were more frequently detected by MS. Second, these false-positive 
69 
 
peptides share certain common physico-chemical features, which prevented the efficient 
removal by NHS-activated Sepharose (e.g. non-covalent binding to N-terminal peptides). 
Third, these peptides were more efficiently ionised than other peptides hence were more 
readily detectable in a mass spectrometer.  
Table 3.8 Contaminating tryptic peptides of acetylated BSA, as identified by a Mascot database search 
after treatment with NHS-activated Sepharosea. 
Peptide-Spectrum Match 
(Start – End) m/z MW Score E-value 
Duplicate 
PSM No. 
CASIQKFGER (199 – 208) + Acetyl (K); 
Carbamidomethyl (C)  
619.3031 1236.5921 26 0.0025  
ALKAWSVAR (209 – 217) + Acetyl (K)  522.3036 1042.5923 55 3.4E-6 2 
VHKECCHGDLLECADDR (240 – 256)                  
+ Acetyl (K); 3 Carbamidomethyl (C)  
719.3020 2154.8881 48 1.5E-5 1 
RHPEYAVSVLLR (336 – 347) 720.4081 1438.8045 82 6.0E-9 26 
LAKEYEATLEECCAK (348 – 362)                      
+ Acetyl (K); 2 Carbamidomethyl (C)  
928.9211 1855.8331 20 0.01  
KVPQVSTPTLVEVSR (413 – 427) 820.4692 1638.9305 30 0.001 1 
KVPQVSTPTLVEVSR (413 – 427)                   
+ Acetyl (K)  
841.4739 1680.9410 16 0.023  
CCTKPESER (436 – 444) + Acetyl (K);                          
2 Carbamidomethyl (C) 
604.7554 1207.4961 42 6.5E-5  
LCVLHEKTPVSEK (459 – 471)                              
+ Acetyl (K); Carbamidomethyl (C)  
527.9473 1580.8232 40 0.00011 1 
VTKCCTESLVNR (472 – 483)                        
+ Acetyl (K); 2 Carbamidomethyl (C)  
754.8639 1507.7123 55 3.4E-6  
CCTESLVNR (475 – 483)                                         
+ 2 Carbamidomethyl (C) 
569.7515 1137.4907 19 0.013  
a Orbitrap RAW data were processed and searched in Mascot twice, with cysteine (C) 
carbamidomethylation set as either a fixed or variable modification. Both Mascot searches produced 
the same result, which was then edited to show a single PSM for each of the 11 internal tryptic 
peptides identified with high confidence (E-value ≤ 0.05). NHS: N-hydroxysuccinimide; m/z: mass-to-
charge ratio; MW: molecular weight; E-value: peptide expectation value; Duplicate PSM No.: number 
of duplicate peptide-spectrum matches (PSM). 
These conjectures were first addressed by comparing the signal intensity (expressed as 
normalised intensity level, NL) between contaminating (i.e. false-positive) and other 
proteolytic peptides in the RAW data of control samples (without treatment with NHS-
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activated Sepharose). In quantitative proteomics, NL measurement is a crude yet convenient 
method to approximate peptide abundance as compared to isotopic labelling approaches. 
The signal intensity of a given peptide ion is correlated with its abundance despite 
sometimes questionable accuracy. However, there was no distinct difference in the 
abundance between contaminating and other proteolytic peptides according to the results 
of NL comparison. 
Next, the hydrophobicity of the first two amino acid residues in each contaminating peptide 
was evaluated in an attempt to identify common physico-chemical properties shared by 
these peptides. The hydrophobicity of peptide N-terminus was measured by counting the 
average number of hydrophobic residues at the first two positions of each peptide. Often in 
protein post-translational modifications (PTMs) and artificial chemical modifications, the 
reactivity of the target amino acid residue is critically influenced by the following residue. For 
instance, methionine aminopeptidases (MetAPs) specifically excise the N-terminal 
methionine (M) residue when it is followed by an alanine (A), C, G, proline (P), serine (S), 
threonine (T), or V residue (Bonissone et al., 2013). On the other hand, a P residue at the 
second position disfavours the tryptic digestion at K/R residues (Olsen et al., 2004) or the 
Rapoport’s salt (RS)-mediated transamination at the N-terminus of a peptide (Witus et al., 
2013). Therefore, it was hypothesised in the present study that both the N-terminus and the 
second residue might influence the removal of contaminating peptides.  
As shown in Figure 3.11, there is a trend of increased hydrophobicity at the N-termini of 
contaminating peptides compared to other peptides despite the statistical insignificance (P-
value > 0.05 as calculated by a Student’s t-test). In a protein, the hydrophobicity of amino 
acid residues contributes to its structure formation. For instance, hydrophobic residues often 
reside in the middle of integral membrane proteins, forming lipid-interacting domains. 
Therefore, the presence of hydrophobic residues at the N-termini of these contaminating 
peptides might prevent interaction with NHS-activated Sepharose by burying the free α-
amino groups. Alternatively, the hydrophobic N-termini of these peptides might associate 
with each other through hydrophobic interactions. Again, this would sterically hinder access 
by NHS-activated Sepharose. 
Following the determination of common properties shared by contaminating peptides, a 
range of experiment parameters were altered individually to explore the means to remove 
internal peptides more efficiently. The altered parameters include: the amount of acetylation 
reagents, the type of coupling reagents, the amount of coupling reagents, coupling duration, 




Figure 3.11 Average number of hydrophobic amino acid residues at the N-termini of contaminating or 
other proteolytic peptides (the first amino acid position, the second position, or the sum of both). In 
each group, a Student’s t-test was performed between the contaminating and other peptides with no 
statistical significance reported (P-value > 0.05). Error bars indicate standard deviation.  
The amount of sulfo-NHS acetate (i.e. the acetylation reagent) was the first parameter 
explored in this study. The original strategy employed 1 mg of the acetylation reagent to 
block free amines at protein N-termini. However, the N-termini of several internal peptides 
were also acetylated according to LC-MS/MS results. This observation led to the conjecture 
that the amount of acetylation reagents was excessive in the original protocol, thereby 
resulting in “carry-over” and hence the acetylation of internal peptides after protease 
digestion. Accordingly, the amount of sulfo-NHS acetate was decreased from 1 mg to 100 μg. 
In addition, the “carry-over” problem may be solved by ensuring thorough removal of the 
acetylation reagent prior to protease digestion. As a result, the amount of the quenching 
reagent (Tris(2-aminoethyl)amine, polymer-bound) was concomitantly increased from 5 mg 
to 10 mg. The coupling reaction between NHS-activated Sepharose and proteolytic peptides 
was not modified.   
As reflected by the protein sequence coverage, internal peptides were present in both 
lysozyme C and BSA samples when the original NHS-Sepharose protocol was followed (Figure 
3.12A & B). Interestingly, the experiments on lysozyme C and BSA produced different results 
with respect to the effect of reducing the amount of acetylation reagents: the normalised 
efficiency of internal peptide removal was elevated in lysozyme C samples, but the efficiency 




Figure 3.12 Effect of the amount of acetylation reagent on the removal of internal peptides of 
lysozyme C (A) or BSA (B). (C) Normalised coupling efficiency calculated for both proteins.  
The discrepancy in these results may be a product of multiple factors. At the reduced 
amount, the acetylation reagent might no longer interfere with the subsequent coupling 
step, as reflected by the increased coupling efficiency in lysozyme C samples. This result 
agrees with our conjecture. On the other hand, reducing the amount of acetylation reagents 
might lead to less acetylation of BSA on K side chains. As trypsin digests proteins at the C- 
terminal side of K and R residues when not followed by a P residue, less acetylation at K 
residues could result in the yield of more tryptic peptides in BSA samples. The amount of 
tryptic peptides of BSA exceeded the coupling capacity of NHS-activated Sepharose, so that 
internal peptide removal was not improved in BSA samples. 
Second, two different types of amine-reactive beads (NHS-activated Sepharose and NHS-
activated magnetic beads) were employed in parallel to remove internal peptides of 
lysozyme C or BSA after digestion with their respective proteases. The two beads were then 
compared in terms of the coupling efficiency. This study aimed to determine whether this 
coupling reagent is a limiting factor in this approach. As the name implies, the second 
coupling reagent also possesses an NHS ester group that specifically conjugates with a 
primary amine to form a stable amide bond and releases the NHS group. However, the 
reactive group is on the surface of magnetic beads that enable convenient bead separation 
by use of a strong neodymium magnet instead of centrifugation. The experiment with the 
magnetic beads was performed exactly the same as the original NHS-Sepharose protocol, 
apart from replacing NHS-activated Sepharose with the magnetic beads. 
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As shown in Figure 3.13, the sequence coverage of lysozyme C was lowered to a similar 
extent by both NHS-activated Sepharose and the magnetic beads. In contrast, treatment 
with the magnetic beads did not lead to a decrease in the sequence coverage of BSA. When 
converted to the normalised efficiency of removing internal peptides, these results clearly 
showed that NHS-activated Sepharose outperformed the magnetic beads. Therefore, NHS-
activated Sepharose was chosen as the coupling reagent in the following experiments.  
 
Figure 3.13 Efficacy of two different coupling reagents (NHS-activated Sepharose or magnetic beads) 
for removing the internal peptides of lysozyme C (A) or BSA (B), reflected as the changes in sequence 
coverage after coupling. (C) Normalised efficiency of removing internal peptides calculated for the two 
beads. NHS: N-hydroxysuccinimide. 
The binding capacity of these beads is determined by the concentration of reactive NHS 
groups on bead surface. In addition, their binding capacity may also be affected by the 
spacer arm that bridges the beads and the NHS groups. The spacer arm has been shown to 
help overcome steric hindrance (Cuatrecasas et al., 1968) and to influence electrostatic and 
non-electrostatic interactions (DePhillips et al., 2004). However, the manufacturers of these 
two beads have not disclosed information regarding the concentration of reactive groups or 
the length of spacer arm. Such information could help researchers to choose or design 
coupling reagents with a higher binding capacity. 
The third explored experiment parameter was the amount of the coupling reagent (NHS-
activated Sepharose), based on the hypothesis that the abundance of proteolytic peptides 
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might exceed the binding capacity of the coupling reagent. Proteolytic peptides of lysozyme 
C was incubated with different volumes of the coupling reagent at 0, 100, 200, or 300 μl in 
four parallel experiments. The hypothesis was that use of the largest amount of the coupling 
reagent would result in the lowest number of internal peptides. Figure 3.14 shows that the 
normalised efficiency did increase in direct proportion to the increased amount of the 
coupling reagent. Among all four experiment groups, the largest volume of coupling reagent 
(300 μl) exhibited the highest binding capacity, in agreement with the hypothesis. Therefore, 
the increase of the amount of coupling reagent improves the removal of internal peptides by 
the NHS-Sepharose approach. Further increase (beyond 300 μl) was not tested in this 
experiment because the reagent consumption would be significant. However, it may afford 
further improvements to the NHS-Sepharose approach.  
 
Figure 3.14 (A) Effect of the amount of coupling reagent (NHS-activated Sepharose) on the removal of 
internal peptides of lysozyme C. (B) Normalised coupling efficiency calculated for each group. NHS: N-
hydroxysuccinimide. 
The next explored experiment parameter was the time of incubation with the coupling 
reagent, which potentially affected the outcome of removing internal peptides. In this 
experiment, tryptic peptides of BSA were incubated with 100 μl of the coupling reagent at 
either room temperature (RT) or 4 °C for varying amounts of time. The RT group was set at 1, 
2, 3, 4, or 8 h; whereas the 4 °C group was at 3, 6, 9, 12, or 24 h. Upon conversion from the 
sequence coverage data, no linear correlation was observed between the normalised 
efficiency of internal peptide removal and the incubation time (Figure 3.15). However, there 
was a deduced trend of increase in the normalised efficiency from 1-h to 4-h in the RT group 
and from 3-h to 12-h in the 4 °C group, respectively. The normalised efficiency then dropped 
from 4-h to 8-h in the RT group and from 12-h to 24-h in the 4 °C group, respectively. 
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Possible explanations for this fluctuation may reside in the underlying mechanism of the 
reaction between NHS esters and primary amines. As explained previously, NHS-activated 
Sepharose couples with internal peptides through a conjugation reaction between NHS 
esters and primary amines at the N-termini of these peptides, forming stable amide bonds 
while releasing NHS (Figure 3.16A). Simultaneously, the NHS groups are self-decomposing 
through a hydrolysis reaction (Figure 3.16B). Water molecules (in this case from phosphate 
buffered saline, PBS) compete with primary amines at peptide N-termini for the reactive NHS 
groups. With extended incubation time, a larger fraction of NHS esters were hydrolysed 
instead of conjugating with primary amines, leading to a decreased coupling efficiency. 
Alternatively, the stable amide bonds or the spacer arm may break down during incubation, 
releasing the coupled internal peptides. 
 
Figure 3.15 Effect of incubation time at room temperature (RT, A) or 4 °C (C) on the removal of 
internal peptides of BSA. Normalised coupling efficiency calculated for each group of incubation time 




Figure 3.16 Illustrated reaction mechanism of the conjugation between primary amines and N-
hydroxysuccinimide (NHS) esters (A) or the hydrolysis of NHS esters (B). ○R  standards for reagent 
whereas ○P  standards for protein. 
The pH value is critical to the coupling reaction between NHS-activated Sepharose and free 
α-amino groups at peptide N-termini. To improve the NHS-Sepharose approach, this 
experiment parameter was explored in this study as well. The NHS-amine reaction was 
usually performed at neutral to slight basic conditions. In the original protocol, the coupling 
step takes place in an amine-free buffer (i.e. PBS) at pH 7.5. Four parallel experiments were 
performed where lysozyme C or BSA was acetylated and proteolysed without coupling with 
NHS-activated Sepharose, or incubated with the beads at pH 7.5, 8, or 8.5. This study aimed 
to evaluate the differences in the normalised coupling efficiency among the three pH values. 
For lysozyme C, a steady decrease in sequence coverage was observed when the pH was 
elevated from 7.5 to 8.5. The difference in the sequence coverage was statistically significant 
between pH 7.5 and 8.5 (P-value = 0.0084 as determined by one-way analysis of variance, 
ANOVA). Therefore, the normalised efficiency appeared to correlate positively with the pH of 
the coupling reaction. This correlation was less evident for BSA, but the normalised efficiency 
at pH 8 or 8.5 was still higher than that at pH 7.5 (Figure 3.17). The increase in pH might 
enhance the coupling reaction possibly through maintaining a structure of peptides that 
confers higher accessibility by NHS esters. Alternatively, higher pH might elevate the 
reactivity of primary amines as nucleophiles. However, it needs to be emphasised that much 
higher pH can adversely affect the NHS-amine conjugation since the hydrolysis of NHS esters 




Figure 3.17 Effect of coupling reaction pH on the removal of internal peptides of lysozyme C (A) or BSA 
(B). (C) Normalised coupling efficiency calculated for both proteins. The statistical analysis in A was 
performed using one-way analysis of variance (ANOVA) with the Bonferroni correction (the 
significance level was set at 0.05). Error bars indicate standard deviation; ** indicates P-value ≤ 0.01. 
Based on the previous finding that contaminating peptides tend to have more hydrophobic 
N-termini, the next step in this study was to investigate the influence of chaotropic agents on 
removing internal peptides by NHS-activated Sepharose. Chaotropic agents such as urea or 
guanidine hydrochloride (HCl) are compounds that disrupt non-covalent interactions, 
including hydrogen bonds that maintain protein structures and hydrophobic interactions 
between proteins (Makhatadze and Privalov, 1992, Lim et al., 2009). Therefore, chaotropic 
agents are typically employed to unfold proteins and solubilise hydrophobic proteins. In the 
present study, high concentrations of urea and guanidine HCl were added to the existing 
NHS-Sepharose protocol based on the hypothesis that these chaotropic agents would 
improve the removal of contaminating peptides. Lysozyme C and BSA were incubated with 8 
M urea or 6 M guanidine HCl for 1 h prior to the coupling with NHS-activated Sepharose. For 
both proteins, the removal of internal peptides without adding chaotropic agents served as a 
control group.  
The addition of urea appeared to further reduce the sequence coverage of lysozyme C after 
the treatment with NHS-activated Sepharose, although no statistical significance was 
reached (P-value > 0.05 as calculated by one-way ANOVA). The same experiment was 
repeated with BSA and produced a similar result, leading to the conclusion that the addition 
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of urea consistently increased the normalised coupling efficiency for both proteins. In 
contrast, guanidine HCl was unable to exert the same effect, with only a marginal 
improvement of the normalised efficiency for BSA. Therefore, urea served as a superior 
chaotropic agent over guanidine HCl in removing contaminating peptides of lysozyme C and 
BSA. This conclusion conflicts with previous findings that guanidine HCl is generally more 
effective than urea in inducing protein unfolding and denaturation (Myers et al., 1995, Lim et 
al., 2009). Nevertheless, the removal of contaminating peptides was improved by chaotropic 
agents, which supports the previous hypothesis that the contaminating peptides may 
physically associate with protein N-termini through hydrophobic interactions or that the N-
termini of these peptides are inaccessible to the coupling reagent due to their relative 
hydrophobicity. 
 
Figure 3.18 Effect of different chaotropic agents (8 M urea or 6 M guanidine hydrochloride) on the 
removal of internal peptides of lysozyme C (A) or BSA (B). (C) Normalised efficiency calculated for both 
proteins. The statistical analysis in A was performed using one-way analysis of variance (ANOVA) with 
Bonferroni correction (the significance level was set at 0.05). Error bars indicate standard deviation. 
The alteration of the number of coupling reactions was the last experiment parameter 
explored in this systematic study. In the original protocol, proteolytic peptides of lysozyme C 
or BSA were treated with two batches of NHS-activated Sepharose: the first at RT for 4 h and 
the second at 4 °C overnight. This number was increased in the present study to 3 or 4, and 
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the amount of NHS-activated Sepharose was also doubled in each coupling step. The 
hypothesis was that an increase in the number of coupling reactions would further reduce 
the number of contaminating peptides till the saturation of free α-amino groups on internal 
peptides with the NHS groups on the beads. 
As shown in Figure 3.19, the removal of internal peptides was highly efficient as a result of 
more repeats of coupling. The normalised coupling efficiency was already at 100 % for 
lysozyme C and ~ 90 % for BSA with two repeats of coupling, probably due to the doubled 
amount of the coupling reagent in this investigation. For BSA, an even higher efficiency (> 
90 %) was achieved after four repeats of coupling. Consequently, it is concluded that an 
increase in the number of coupling reactions positively affected the removal of 
contaminating peptides. However, a higher coupling efficiency was achieved at the cost of 
more handling time and reagent consumption. A balance between performance and 
feasibility is thus required in order to promote the use of this approach.  
 
Figure 3.19 Effect of the number of coupling reactions on the removal of internal peptides of lysozyme 
C (A) or BSA (B). (C) Normalised coupling efficiency calculated for both proteins.  
In light of the outcome of altering seven experiment parameters, an integrated method was 
developed in order to remove internal peptides of BSA with the highest efficiency. The 
protocol of this integrated method is as follows: 100 μg of BSA was acetylated with a reduced 
amount of sulfo-NHS acetate (100 μg) and the reaction was quenched with an increased 
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amount of quenching reagents (10 mg). After tryptic digestion, 50 μg of tryptic peptides 
were incubated with either 8 M urea or 6 M guanidine HCl for 1 h, or directly treated with 4 x 
200 μl of NHS-activated Sepharose at pH 8.5: two 4-h incubations at RT and two 12-h 
incubations at 4 °C. The sample without incubation with chaotropic agents served as a 
“normal coupling” control. The other 50 μg of BSA peptides served as a “before coupling” 
control, i.e. no treatment with NHS-activated Sepharose. In addition, the data acquired using 
the original NHS-Sepharose method (see Table 3.8) were also included for comparison. 
Without the use of chaotropic agents, this integrated method was shown to efficiently 
remove the internal peptides of BSA. As shown in Figure 3.20, the normalised efficiency of 
this method is 20 % higher than that using the original protocol. The addition of either urea 
or guanidine HCl could further increase the normalised efficiency to 100 %. In conclusion, 
this integrated method removed all of the contaminating peptides for BSA, and could be 
tested on other model proteins or a complex mixture of proteins. 
 
Figure 3.20 (A) Outcome of the integrated NHS-Sepharose methods (with or without chaotropes), 
reflected as the changes in sequence coverage of BSA after coupling. The integrated methods 
incorporated alterations in the following experiment parameters: a reduction in the amount of 
acetylation reagents, an increase in the amount of quenching reagents, a 1-h incubation with 
chaotropic agents (either 8 M urea or 6 M guanidine hydrochloride), an increase in the amount of 
coupling reagents, and a doubling of the coupling times (see section 3.2.2). The “before coupling” 
control shows the sequence coverage of BSA before internal peptide removal. The “original protocol” 
group refers to implementation of the original NHS-Sepharose method described by McDonald and 
Beynon (2006). The “normal coupling” control corresponds to the use of the integrated method 




3.2.3 Use of SATA and CA as an alternative approach to select protein N-termini 
As discussed in Chapter 1, the N-termini of proteins possess highly informative biological 
data, as they indicate the protein coding region of a gene, protein half-lives, and sometimes 
biological functions of these proteins (Varshavsky, 2011, Varland et al., 2015). The 
importance of protein N-termini is partly attributed to the PTMs that take place at protein N-
termini, including N-terminal methionine excision (NME), Nt-myristoylation, and Nt-
acetylation (reviewed in Giglione et al., 2015). As a result, analysis of N-terminal PTMs is an 
integral part of proteomic research. On the other hand, free protein N-termini (without any 
PTM) are of equal biological importance and thus require comprehensive analysis. As 
described previously, the original NHS-Sepharose approach has been tested on individual 
model proteins and improved by systematic refinement of experimental conditions. This 
approach combines two chemical reactions, amine acetylation and NHS-amine conjugation, 
to enrich for N-terminal peptides with high efficiency (for lysozyme C and BSA). However, it 
does not distinguish free N-termini with the acetylated ones due to the use of sulfo-NHS 
acetate. 
The present section describes the work to expand the use of the NHS-Sepharose approach to 
identify protein N-termini by replacing sulfo-NHS acetate with alternative amine-reactive 
chemicals. Two such reagents, N-succinimidyl S-acetylthioacetate (SATA) and citraconic 
anhydride (CA), were selected for method development as they form stable amide bonds 
with primary amines. In principle, such chemical modifications are also compatible with 
internal peptide removal by NHS-activated Sepharose. The reaction mechanisms of SATA and 
CA are shown in Figure 3.21. These changes to the original protocol should enable the 
identification of both endogenous Nt-acetylation and free protein N-termini and their 
discrimination according to the attached chemical groups. 
As mentioned previously, the protocol of the NHS-Sepharose approach included the 
acetylation of intact proteins and protease digestion of the acetylated proteins, followed by 
coupling with NHS-activated Sepharose to remove internal peptides with free N-termini. This 
protocol was modified by blocking protein α- and ε-amino groups with either SATA or CA 
instead of sulfo-NHS acetate. In addition, individual model proteins (lysozyme C and BSA) 
were replaced by a complex mixture of proteins extracted from Jurkat T-lymphocytes. Details 
of Jurkat cell culture, protein extraction, and protein quantitation are described in Chapter 2. 




Figure 3.21 Illustrated mechanism of the reaction between N-succinimidyl S-acetylthioacetate (SATA; 
A) or citraconic anhydride (CA; B) and primary amines (modified from Hermanson, 1996).  
The first objective of this study was to obtain a comprehensive list of proteins extracted from 
Jurkat T-cells by shotgun proteomics. Without the reaction with SATA/CA or internal peptide 
removal by NHS-activated Sepharose, Jurkat proteins were denatured, reduced, alkylated, 
and digested with trypsin as described in Chapter 2. The tryptic peptides were then 
separated on a 3-meter monolithic column and analysed by MS. Using Mascot software 
package, the recorded RAW data were converted to a peak list, which was then searched 
against a decoy database (Swiss-Prot, taxonomy = Homo sapiens). The search parameters 
were set as follows: trypsin with maximally two missed cleavages, carbamidomethylation (C) 
as fixed modification, oxidation (M) and acetylation (Protein N-term/K) as variable 
modifications. The search results were further processed in R to generate a non-duplicate 
protein list. In total, 2,253 proteins were unambiguously identified from three biological 
replicates of Jurkat protein samples (N = 3; ProteomeXchange dataset ID: PXD009340). Table 
3.9 shows an example of the proteins identified by the Mascot database search. 
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Table 3.9 Representative proteins identified in Jurkat T-cell extracts by a Mascot database searcha. 
Protein Name Swiss-Prot ID Peptide No.b 
(E3-independent) E2 ubiquitin-conjugating     
enzyme 
UBE2O_HUMAN (Q9C0C9) 4 
1,2-dihydroxy-3-keto-5-methylthiopentene 
dioxygenase 
MTND_HUMAN (Q9BV57) 5 
10 kDa heat shock protein, mitochondrial     CH10_HUMAN (P61604) 37 
14-3-3 protein epsilon          1433E_HUMAN (P62258) 50 
14-3-3 protein eta                           1433F_HUMAN (Q04917) 26 
14-3-3 protein gamma               1433G_HUMAN (P61981) 37 
a Orbitrap RAW data were processed and searched against the decoy Swiss-Prot database (taxonomy 
= Homo sapiens). b Peptide No.: number of tryptic peptides identified with high confidence (E-value ≤ 
0.05) for each protein; E-value: peptide expectation value. 
In the next step, we aimed to investigate the feasibility of blocking free protein N-termini and 
K residues with SATA or CA. In principle, SATA and CA are similar to sulfo-NHS acetate in 
reacting with primary amines at both protein N-termini and K side chains. In addition, the 
unique chemical groups added to protein N-termini can be exploited to distinguish free N-
termini from endogenously acetylated ones. As described in Chapter 2, Jurkat proteins were 
treated with either SATA or CA, and a control sample was prepared by omitting the reaction 
step. In the case of SATA modification, 8 M urea solution was added to the modified proteins 
to dissolve pellets that resulted from protein precipitation. In contrast, no protein 
precipitation was observed after CA modification. Excess reactants were removed from the 
protein samples by ultrafiltration upon the completion of these reactions. The modified 
proteins were then reduced, denatured, alkylated, and digested with trypsin. 
The tryptic peptide samples were quickly analysed on 10 % NuPAGE™ Bis-Tris gels to confirm 
proteolysis. Details of sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) 
are described in Chapter 2. Before tryptic digestion, both the SATA- and CA-modified Jurkat 
protein samples yielded a range of protein bands on the polyacrylamide gel, which were 
absent in the samples of tryptic peptides as their MW were below the lower detection limit 
of SDS-PAGE (Figure 3.22). The tryptic peptide samples only yielded a single protein band 
that corresponds to trypsin (23.3 kDa) based on MW estimation. In conclusion, tryptic 




Figure 3.22 SDS-PAGE analysis of Jurkat proteins before and after tryptic digestion. Four different 
samples were separated on a 10 % NuPAGE™ Bis-Tris gel together with a protein molecular weight 
(MW) marker: I. SATA-modified proteins without tryptic digestion; II. CA-modified proteins without 
tryptic digestion; III. protein MW marker; IV. tryptic digested sample of the SATA-modified proteins; V. 
tryptic digested sample of CA-modified proteins. A single band in both lane IV and V corresponds to 
trypsin (red arrow). SDS-PAGE: sodium dodecyl sulfate–polyacrylamide gel electrophoresis; SATA: N-
succinimidyl S-acetylthioacetate; CA: citraconic anhydride. 
Subsequently, the tryptic peptides from SA- or CA-modified Jurkat proteins were treated with 
NHS-activated Sepharose to remove internal peptides and to enrich for protein N-terminal 
peptides. The enriched peptides were then subjected to LC-MS/MS analysis for spectral 
acquisition, and the resulting data were processed and searched against a decoy Swiss-Prot 
database (taxonomy = Homo sapiens). For data analysis of SATA-treated samples, SATA 
(Protein N-term/K) was included in the variable modifications in addition to oxidation (M) 
and acetylation (Protein N-term/K). In contrast, CA (Protein N-term/K) was included in the 
variable modifications for CA-treated samples. 
The SATA modification experiment involved 12 biological replicates (N = 12), and the 12 
resulting datasets were pooled to yield a total of 18,779 peptide-spectrum matches (PSMs).   
Overall, the 12 replicates allowed the identification of 2,801 tryptic peptides, 11 % of which 
(312) had been modified with SATA. Figure 3.23 shows the cumulative addition of unique 
tryptic peptides by each replicate. A 12-set Venn diagram visualising all the overlaps between 




Figure 3.23 Saturation curve of unique tryptic peptides detected by replicate analyses in the N-
succinimidyl S-acetylthioacetate (SATA) modification experiment. A logarithmic curve (blue) was fitted 
to the experimental data using R, and the total peptide number is reflected by the black straight line.    
to produce a Venn diagram for six replicates covering > 85 % of the total peptides can be 
found in Appendix 1. The 2,801 peptides in turn could be assigned to 397 Jurkat proteins 
under the “two-peptide rule” (i.e. a protein must be identified on the basis of ≥ 2 significant 
peptide hits). Importantly, 106 of the peptides were assigned as protein N-termini to 83 
proteins. These protein N-termini were further sorted in three different forms: Nt-acetylated, 
SATA-modified, and free. As shown in Table 3.10, 88 out of the 106 peptides were Nt-
acetylated, 4 were SATA-modified, and 14 were free of N-terminal PTMs. 
Table 3.10 Distribution of 106 peptides assigned as protein N-termini in the SATA modification 
experiment. The 106 peptides are divided into three groups: Nt-acetylated, SATA-modified, and free. 
N-terminal PTMs Nt-acetyl SATA Free Total 
Assigned peptides 88 4 14 106 
Identified proteins 74 3 12 83 (89)a 
a The number in parentheses indicates the sum of protein numbers from all three groups. It is higher 
than the true number of proteins with assigned N-termini since a single protein N-terminus could be 
identified in different PTM states. PTM: post-translational modification; SATA: N-succinimidyl S-




Table 3.11 gives a list of SATA-modified N-terminal peptides as identified by the Mascot 
database search. Three proteins were deemed to possess a protected sulfhydryl group (mass 
shift = +115.99 Da) at the N-terminus as a result of SATA modification. For example, the SATA-
modified peptide AGELADKKDR was assigned as the N-terminus of DDX23_HUMAN, a 
probable ATP-dependent RNA helicase. The tandem spectrum for this peptide is shown in 
Figure 3.24, where three b-ions and seven y-ions were identified by matching their m/z to 
the in silico predicted values (Table 3.12). The mass of each y-ion remained unchanged after 
SATA modification, whilst all the b-ions gained the mass shift corresponding to SATA 
modification.  
In addition, eukaryotic initiation factor 4A-III (Swiss-Prot ID: IF4A3_HUMAN) was shown to 
exist in two proteoforms with different N-termini (MATTATMATSGSAR or ATTATMATSGSARK). 
The co-existence of both N-terminal peptides was validated by further cross-referencing with 
the N-terminal annotation of IF4A3_HUMAN in the online Swiss-Prot database (Van Damme 
et al., 2012). In conclusion, SATA could be employed as an amine-reactive chemical to modify 
and thereby identify free N-termini of proteins such as DDX23_HUMAN and IF4A3_HUMAN. 
Table 3.11 SATA-modified N-terminal peptides as identified by a Mascot database searcha. 
Protein ID               
(Swiss-Prot) 
Peptide-Spectrum Match                     
(Start – End) 
m/zb MW Score E-value 
DDX23_HUMAN                      
(Q9BUQ8) 
AGELADKKDR (2 – 11)                                       
+ SATA (N-term) 
609.80 1217.57 30 0.049 
EF2_HUMAN                          
(P13639) 
VNFTVDQIR (2 – 10)                                                          
+ SATA (N-term) 
604.30 1206.57 31 0.0013 
IF4A3_HUMAN                        
(P38919) 
MATTATMATSGSAR (1 – 14)                                                            
+ SATA (N-term); 2 Oxidation (M)  
752.8095 1503.6004 23 0.015 
ATTATMATSGSARK (2 – 15)                                                       
+ SATA (N-term); Oxidation (M) 
743.3491 1484.6599 29 0.039 
a A single PSM is shown for each significantly identified peptide (E-value ≤ 0.05). b SATA: N-
succinimidyl S-acetylthioacetate; m/z: mass-to-charge ratio; MW: molecular weight; E-value: peptide 




Figure 3.24 Tandem mass spectrum of the SATA-modified N-terminal peptide of probable ATP-
dependent RNA helicase DDX23 (amino acid sequence: AGELADKKDR). The detected b- and y-ions are 
shown in green and red, respectively. SATA: N-succinimidyl S-acetylthioacetate; RT: retention time; NL: 
normalised intensity level. 
Table 3.12 Fragment ions (in silico predicted) of the N-succinimidyl S-acetylthioacetate (SATA)-







Based on the results from the SATA modification experiment, 21 % of the proteins were 
assigned with N-termini (83/397). The vast majority of the protein N-termini were Nt-
acetylated (83 %, 88/106), whereas the SATA-modified ones only constituted 4 % of the total 
set (4/106). In principle, all the free protein N-termini should be blocked with SATA after the 
reaction, otherwise they would be removed by NHS-activated Sepharose. Contrary to this 
assumption, 13 % of the identified N-terminal peptides were neither acetylated nor modified 
with SATA (i.e. free N-termini). The number of free N-termini was 2.5-fold higher than that of 
the SATA-modified N-termini. These observations suggested that SATA modification was not 
as efficient as chemical acetylation, and that NHS-activated Sepharose did not fully remove 
peptides with free N-termini. 
The same data analysis procedure was repeated on the Jurkat proteins treated with CA. A 
total of 12 CA-treated samples were analysed by LC-MS/MS and the resulting data were 
pooled to generate a list that contained 31,979 PSMs. Overall, 3,611 tryptic peptides 
(including 42 CA-modified ones) or 570 Jurkat proteins were identified from the combined 
list of PSMs. The cumulative addition of unique peptides by each replicate is shown in Figure 
3.25, which suggests that saturated peptide detection was achieved by 12 replicate analyses. 
As with the SATA data analysis, a Venn diagram was also drawn to visualise shared peptides 
for six replicate analyses covering > 95 % of the total peptides (see Appendix 1). 
 
Figure 3.25 Saturation curve of unique tryptic peptides detected by replicate analyses in the 
citraconic anhydride (CA) modification experiment. The curve in blue was fitted through a nonlinear 
regression analysis in R, and the total peptide number is reflected by the straight line in black.   
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Among the detected tryptic peptides, 311 were assigned as protein N-termini and such 
peptides were derived from 143 Jurkat proteins (Table 3.13). The identified N-terminal 
peptides were also divided into three groups according to N-terminal modifications: Nt-
acetylated, CA-modified, and free. With a number of 240, acetylated protein N-termini 
accounted for 77 % of all the identified N-terminal peptides; the rest 23 % were entirely free 
protein N-termini (71). It should be emphasised that N-terminal modification with CA could 
not be confirmed in this experiment: the efficiency of CA modification might be lower than 
that of SATA modification, or CA modification might have been reversed before LC-MS/MS 
analysis. As mentioned previously, the amide bond formed by CA modification may 
dissociate under acidic conditions, i.e. pH 3 – 4 (Dixon and Perham, 1968). Since tryptic 
peptides from the CA-treated samples were exposed to 0.5 % (v/v) formic acid solutions at 
the desalting step, this might have reversed the amide bond formation.  
Table 3.13 Distribution of 311 peptides assigned as protein N-termini in the CA modification 
experiment. The 311 peptides are divided into three groups: Nt-acetylated, CA-modified, and free. 
N-terminal PTMs Nt-acetyl CA Free Total 
Assigned peptides 240 0 71 311 
Identified proteins 117 0 36 143 (153)a 
a The number in parentheses indicates the sum of protein numbers from all three groups. It is higher 
than the true number of proteins with assigned N-termini since a single protein N-terminus could be 
identified in different PTM states. CA: citraconic anhydride; PTM: post-translational modification; Nt-
acetyl: N-terminal acetylation. 
Collectively, data from SATA- and CA-treated samples allowed a preliminary survey of 
different types of protein N-termini in Jurkat T-cells, despite the incomplete blocking by SATA 
or CA. All the data from both the SATA and CA experiments were merged to assign the 
identified protein N-termini to four different groups: SATA-modified, CA-modified, Nt-
acetylated, or free (Table 3.14). Overall, the N-termini of 229 Jurkat proteins were assigned, 
corresponding to 10 % of the total proteins identified in the shotgun experiment (229/2,253, 
Figure 3.26A). Nt-acetylated proteins accounted for 82 % of all the proteins with assigned N-
termini (188/229). In contrast, the N-termini of < 1 % of such proteins (1/229) were modified 
with SATA. In addition, free N-termini were directly assigned to 17 % of these proteins 
(40/229) without the aid of N-terminal modification with SATA/CA (Figure 3.26B). The 
complete list of proteins with an assigned N-terminus is shown in Appendix 2. 
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As SATA- and CA-modified N-terminal peptides were also derived from free protein N-
termini, these three groups together contributed to 18 % of all the Jurkat proteins with 
assigned N-termini (41/229). The ratio between the acetylated and free N-termini (82 % 
versus 18 %) is consistent with the estimation from other studies: 80 – 90 % of human 
cytosolic proteins are endogenously acetylated at the N-terminus (Kalvik and Arnesen, 2013, 
Giglione et al., 2015). However, the present survey on N-terminal modifications is incomplete 
as only 10 % of the identified proteins were assigned with N-termini. The present approach 
thus requires further improvements on the efficiency of both SATA/CA modification and 
peptide removal. A refined strategy can then be applied to validate and expand the current 
results of Jurkat N-terminalomic analysis. 
Table 3.14 Statistics of assigned N-termini of Jurkat proteins, which are classified by their PTM statesa. 
N-terminal PTMs SATA CA Nt-acetyl Free Total 
Assigned peptides 4 0 270 79 353 
Identified proteins 1 (3) 0 188 40 (54)  229 (245)b 
a Protein N-termini are divided into four groups: SATA-modified, CA-modified, Nt-acetylated, and free. 
b The number in parentheses indicates the sum of protein numbers from all four groups. It is higher 
than the true number of proteins with assigned N-termini since a single protein N-terminus could be 
identified in different PTM states. PTM: post-translational modification; SATA: N-succinimidyl S-
acetylthioacetate; CA: citraconic anhydride; Nt-acetyl: N-terminal acetylation. 
    
Figure 3.26 Statistics of Jurkat proteins with assigned N-termini. (A) The proportion of assigned 
protein N-termini (229) in the surveyed Jurkat proteome (2,253). (B) The distribution of the assigned 
protein N-termini with respect to N-terminal modifications: SATA (1), free (40), and Nt-acetylation 
(188). No CA-modified protein N-termini were detected. SATA: N-succinimidyl S-acetylthioacetate; CA: 




In positional proteomics, negative selection strategies are employed to remove interfering 
peptides in order to retain peptides with defined positions. In principle, such techniques are 
therefore ideal for the global identification of protein N-termini. Such proteomic studies will 
potentially detect discrepancies between genome-derived protein N-termini and 
experimental data due to alternative splicing, alternative translation initiation, PTMs, etc. 
Since top-down proteomics faces numerous technical challenges regarding MS 
instrumentation and data processing, proteolysis is still required for standard proteomic 
analysis (Catherman et al., 2014, Chen et al., 2018). As a result, authentic protein N-termini 
are overwhelmed by a vast mixture of peptides produced by protease digestion. These newly 
formed peptides are often termed as internal peptides or neo-peptides. One particular 
feature of these internal peptides is that they possess a free α-amino group at the newly 
formed N-terminus.  
As one of the most elegant negative selection strategies, the NHS-Sepharose approach 
enriches the N-terminal peptides of proteins by combining the acetylation of all protein 
amino groups before proteolysis and the removal of internal peptides by NHS-activated 
Sepharose afterwards. We intend to fully exploit the potential of this approach to study 
protein N-termini and further expand the use of this approach in studying protease 
substrates. The present study comprised three phases where the NHS-Sepharose approach 
was implemented on different protein samples with a gradually elevating complexity. The 
first phase was to select the N-terminal peptide of a well-characterised protein, lysozyme C, 
by strictly following the original protocol by McDonald and Beynon (2006). This experiment 
was an ideal entry point and also served to acquire the essential skills in LC-MS/MS and data 
analysis. 
In this experiment, lysozyme C was chosen from six model protein candidates including horse 
myoglobin, horse cytochrome C, BSA, yeast enolase, and rabbit phosphorylase b. The choice 
was made on the basis of two major facts. First, this protein commences with a free N-
terminus, whereas several other candidates are N-terminally blocked by endogenous 
acetylation. Only proteins with free N-termini will be useful in assessing the efficiency of the 
reaction with sulfo-NHS acetate. Second, proteolysis of lysozyme C with Glu-C yielded a 
mixture of proteolytic peptides (including a 7-residue N-terminal peptide, KVFGRCE) that 
could be completely identified by LC-MS/MS, corresponding to the 100 % sequence 
coverage. Complete sequence coverage was not achieved with other protein candidates.  
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The NHS-Sepharose approach consists of three major steps: intact protein blocking by 
acetylation, protease digestion, and removal of internal peptides by NHS-activated 
Sepharose. It was demonstrated through LC-MS/MS analysis that acetylation took place as 
expected at the N-terminus of lysozyme C. Two acetyl groups (MW: 42.01 Da each) were 
attached to the N-terminal K residue due to the detected mass shift of +84.02 Da. Acetyl 
groups were also added to K residues in other internal peptides according to LC-MS/MS 
results. All the above results suggest that primary amine acetylation is an efficient chemical 
reaction to block protein N-termini and K side chains. The KK motif of the peptide 
ITAVNCAKKIVSD is the only example of incomplete acetylation. Peptides with a KK motif have 
been shown to exhibit the lowest kinetic constant for tryptic digestion (Slechtova et al., 
2015). Three models were thus put forward to explain the inefficient tryptic digestion of such 
peptides: the lack of trypsin exopeptidase activity, the competition for the enzyme active 
site, and less favourable ionic interactions. The observation that the second K residue also 
inhibited K acetylation supports the latter two models.  
The 86 % sequence coverage also suggests that protease digestion with Glu-C proceeded to a 
satisfactory level. The efficiency of internal peptide removal was directly evaluated by 
comparing the sequence coverage of lysozyme C before and after the coupling with NHS-
activate Sepharose. The decrease in the sequence coverage from 86 % to 18 % suggests that 
the vast majority of Glu-C generated peptides were removed by the coupling reagent. The 
18 % sequence coverage corresponds to two peptides: the acetylated protein N-terminus 
(KVFGRCE) and an internal peptide (SNFNTQATNRNTDGSTD). In the present study, this 
internal peptide can be easily distinguished from the authentic protein N-terminus. However, 
the presence of internal peptides would undoubtedly interfere with the identification of true 
protein N-termini in an entirely different context, i.e. the analysis of unknown proteins or 
proteins without validated N-termini.  
The internal peptide SNFNTQATNRNTDGSTD was repeatedly and consistently identified in 
lysozyme C samples after the coupling with NHS-activated Sepharose. The three-dimensional  
(3D) structure of lysozyme C was therefore inspected to identify possible causes for the 
persistence of this peptide. One conjecture is that the internal peptide is physically 
associated with the protein N-terminus. However, the 3D structure analysis suggests that the 
peptide is highly accessible to external agents and should be removed by NHS-activated 
Sepharose after proteolysis (Figure 3.27). The analysis also shows that the D48 residue within 
the internal peptide is located in a loop structure and hence might not be cut efficiently by 




Figure 3.27 Schematic representation of the 3D structure of lysozyme C showing the location of 
peptide SNFNTQATNRNTDGSTD (36 – 52) in green, and highlighting the position of D48 in a loop 
within the peptide. The structure 4B0D (Cipriani et al., 2012) was retrieved from the Protein Data Bank 
(http://www.rcsb.org/pdb/home/home.do) and visualised using the programme RasWin. 
The second phase of this project was conducted in response to the detection of internal 
peptides after the negative selection of the N-terminal peptide of lysozyme C. In this 
experiment, BSA was digested with trypsin to serve as a comparator for testing the NHS-
Sepharose approach. Similar to lysozyme C, the results with BSA samples also suggest that 
the coupling reagent did not efficiently remove internal peptides. Instead of only one 
contaminating peptide from lysozyme C samples, several internal peptides of BSA remained 
in the aqueous phase after the coupling step. However, these contaminating peptides 
together offered an opportunity to study physico-chemical properties that are shared in 
common by these peptides. Although the sample size is small, it appears that the 
hydrophobicity of peptide N-termini (defined here as the first two amino acid residues) is 
associated with the persistence of these contaminating peptides in the samples of enriched 
protein N-termini. This finding guided subsequent studies to reduce the number of such 
peptides, with an emphasis on hydrophobicity-related solutions.  
The efforts to improve the NHS-Sepharose approach consist of seven individual changes to 
the existing protocol: reducing the amount of acetylation reagents, using an alternative 
coupling reagent (i.e. NHS-activated magnetic beads), increasing the amount of coupling 
reagents, extending the duration of coupling reactions, increasing the number of coupling 
reactions, increasing the pH of coupling reactions, and introducing chaotropic agents (e.g. 8 
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M urea or 6 M guanidine HCl). From the results obtained, some of these changes improved 
the outcome of coupling with NHS-activated Sepharose, leading to less contaminating 
peptides. Meanwhile, these changes exerted additive effects and were hence integrated into 
an optimised protocol (Table 3.15). Ultimately, it was possible to achieve a 100 % efficiency 
of internal peptide removal using this integrated method, whereas the authentic N-terminal 
peptide can still be readily detected by LC-MS/MS.  
Table 3.15 Comparison between the original and optimised protocols of the NHS-Sepharose 
approacha.  
Procedures Original protocol Optimised protocol 
Primary amine 
acetylation 
2-h reaction with 1 mg sulfo-NHS 
acetate in 20 mM Na2CO3 (pH 8.5) 
2-h reaction with 100 µg sulfo-NHS 
acetate in 20 mM Na2CO3 (pH 8.5) 
Quenching 
1-h incubation with 5 mg Tris(2-
aminoethyl)amine, polymer-bound 









1 x 4-h incubation at RT and 1 x 12-h 
at 4 °C, each with 100 µl NHS-
activated Sepharose in PBS, pH 7.5 
2 x 4-h incubations at RT and 2 x 12-
h at 4 °C, each with 200 µl NHS-
activated Sepharose in PBS, pH 8.5 
a Only experimental procedures that are different between the two protocols are listed here. NHS: N-
hydroxysuccinimide; RT: room temperature; PBS: phosphate-buffered saline. 
Despite this success, several limitations can be identified. First, certain results of this study 
have not been statistically validated. Due to time constraints, several experiments were 
conducted without biological replicates on the same proteins. This problem was partially 
compensated by using two different proteins (lysozyme C and BSA) for the same experiment. 
But it would be inappropriate to directly combine the results from these two proteins for 
statistical analysis. Future studies should focus on obtaining more biological replicates and 
employing a larger cohort of proteins for these experiments.  
The second limitation is the possibility of false negatives. LC-MS/MS analysis is intrinsically 
limited by the size of peptides to be identified. For example, peptides of less than five amino 
acid residues will not be identified by Mascot database searches. On the other hand, the m/z 
values of ionised peptides may fall out of the specified m/z range (150 – 2000) so that the 
peptides will not be recorded by the instruments. These issues can be partially alleviated by 
use of different proteases in parallel experiments. Different protease treatments could 
produce N-terminal peptides with different lengths, some of which may fall in the detection 
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range. In addition, the integrated method has more steps in the protocol (e.g. the incubation 
with chaotropic agents, more repeats of incubation with coupling reagents, etc.). These 
additional steps will lead to an inevitable sample loss and potentially the loss of authentic 
protein N-termini. 
In view of the above limitations, the refined NHS-Sepharose approach should better serve as 
a complementary strategy to validate the results obtained by other N-terminalomic 
approaches, such as COFRADIC, N-TAILS, and Subtiligase. Given sufficient time and resources, 
N-terminalomic studies would benefit from employing multiple approaches in parallel to 
validate and expand the obtained data. 
Due to the prevalence of endogenous Nt-acetylation in eukaryotic proteins, the original 
protocol by McDonald and Beynon (2006) takes advantage of isotopic chemistry to 
differentiate free and endogenously acetylated N-termini. However this strategy is 
impractical due to the expense of the reagents and the inconvenience of using radioisotopes. 
Without isotopic labelling, free protein N-termini are concealed by the reaction with sulfo-
NHS acetate and become indistinguishable from the endogenously acetylated ones. 
Therefore, the third phase of this project aimed to employ alternative amine-reactive 
chemistries to uniquely modify free protein N-termini for unambiguous identification. 
Ideally, these reactions should attach a protein N-terminal tag that is different to the acetyl 
group, and they should be as efficient as the reaction with sulfo-NHS acetate.  
SATA and CA are the two chemicals selected for this study. In principle, these two chemicals 
are capable of blocking primary amines on both protein N-termini and K side chains. After 
the modification of primary amines and coupling with NHS-activated Sepharose, proteolytic 
peptides with a protected sulfhydryl group (derived from SATA modification) or a terminal 
carboxyl group (derived from CA modification) at the N-terminus should be assigned to their 
cognate proteins as free N-termini. A complex mixture of proteins were employed for these 
experiments, which were extracted from Jurkat T-cells (immortalised human T-lymphocytes). 
Overall, 2,253 human proteins were unambiguously identified in a preliminary survey of the 
Jurkat proteome. These proteins were further treated with SATA or CA before tryptic 
digestion and coupling with NHS-activated Sepharose. The experiment results demonstrated 
that free N-termini and K side chains could be modified with SATA, leading to a mass shift of 




In total, 10 % of the surveyed Jurkat proteome was assigned with protein N-termini, 
including 188 Nt-acetylated proteins, 40 proteins with free N-termini, and one protein with 
N-terminal SATA modification. The ratio between Nt-acetylated proteins and proteins with 
free N-termini was 82 % to 18 %, which is consistent with the prediction (80 % to 20 %). 
However, these results also reflect the fact that neither SATA nor CA modification is 
comparable to chemical acetylation in terms of reaction efficiency. At the peptide level, only 
1 % of the assigned protein N-termini were modified with SATA and none with CA. In 
contrast, a large number of free protein N-termini were assigned after the coupling with 
NHS-activated Sepharose. This result indicates a deficiency in the removal of peptides that 
contained reactive primary amines, probably due to the limited coupling capacity of NHS-
activated Sepharose. Although the detection of free protein N-termini is undesirable, it did 
allow the profiling of protein N-terminal modifications in the surveyed Jurkat proteome. 
A major issue with the present study is that N-termini were only assigned to a small fraction 
(10 %) of the identified proteins. The lack of N-terminal information possibly arises from 
instrumental limitations and sample loss. As mentioned previously, MS only acquires data 
from peptides with appropriate length, hydrophobicity, and ionisability. Tryptic digestion 
potentially yields a large number of N-terminal peptides that do not meet these criteria. Use 
of multiple proteases (e.g. trypsin and Glu-C) in parallel experiments may improve the 
coverage of Jurkat proteome and N-terminal profiling.  
On the other hand, protein precipitation was observed during the reaction with SATA. This is 
likely caused by the removal of positive charges on both protein N-termini and K residues, 
which in turn may create charge neutrality on the modified proteins and ultimately protein 
precipitation. Therefore, a large fraction of SATA-modified proteins may not have been 
detected by LC-MS/MS as the precipitated proteins would have already been removed by 
centrifugation. Despite the efforts to minimise protein loss by introducing chaotropic agents 
(e.g. 8 M urea), the precipitated proteins were not completely dissolved. Future studies may 
benefit from using more potent chaotropic agents (or even MS-compatible detergents) that 
could more completely dissolve the precipitated proteins. 
The absence of CA-modified protein N-termini may not be solely attributed to the low 
efficiency of this reaction. As illustrated in Figure 3.21, CA modification is a reversible 
reaction at low pH. When reviewing the procedure of the NHS-Sepharose approach, a low pH 
step is identified where formic acid was introduced at 0.5 % (v/v) to facilitate peptide 
desalting. The terminal carboxylate attached by CA modification may thus be released from 
protein N-termini and K residues. In order to validate this conjecture, further experiments 
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need to be devised to modify or omit the desalting step. For instance, proteins can be buffer 
exchanged into volatile buffers (e.g. 50 mM ammonium bicarbonate) after CA modification 
to obviate the desalting step without damaging LC columns.   
To summarise, the present study was carried out to recover the N-terminal peptides of target 
proteins using the NHS-Sepharose approach. This study consisted of three phases that each 
aimed to tackle a specific problem: the initial phase assessed the efficacy of this approach 
with a single defined protein; the second phase improved the original approach based on the 
knowledge acquired from the first phase; the third phase sought to apply this approach (with 
alternative reagents) on a complex system to identify protein N-termini. Taken together, the 
results from all three phases reveal that acetylation is an efficient chemical reaction to block 
primary amines at protein N-termini and K residues. As an alternative blocking reaction, SATA 
modification enables the differentiation of free protein N-termini from the acetylated ones 
through a unique chemical tag attached to protein N-termini. However, N-terminal 
modification with another blocking reagent (i.e. CA) could not be achieved under the current 
experimental conditions. SATA and CA modifications are not equally efficient as acetylation in 
blocking primary amines. 
The most essential component of this approach is NHS-activated Sepharose, the coupling 
reagent used to remove internal peptides after proteolytic digestion. However, the coupling 
capacity of this reagent does not meet our expectation, as revealed by the results from all 
three phases. Initially, a specific internal peptide of proteolysed lysozyme C was identified 
after the coupling with NHS-activated Sepharose. The performance was then improved by 
altering several experiment parameters so that the internal peptides of proteolysed lysozyme 
C and BSA were completely removed by NHS-activated Sepharose. Nonetheless, 38 free 
protein N-termini were identified from the proteolysed Jurkat proteins after the coupling 
with NHS-activated Sepharose. Ideally, all internal peptides should be removed by this 
coupling reagent. These results suggest that the present coupling reagent is a major limiting 
factor in this approach. Future studies could focus on replacing NHS-activated Sepharose 
with other immobilised amine-reactive beads, such as HPG-ALD polymer used in the N-TAILS 
approach (Kleifeld et al., 2010).  
The results reported in this chapter clearly demonstrates that the success of a negative 
selection strategy lies in the complete blocking of both α- and ε-amino groups of proteins 
and the efficient removal of proteolytic peptides that possess free α-amino groups. Both 
objectives can be difficult to achieve, as reflected by the scarcity of SATA- or CA-modified 
protein N-termini and the presence of contaminating peptides after coupling with NHS-
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activated Sepharose. In contrast, positive selection strategies directly recover protein N-
termini without the need to remove internal peptides and hence should have a simpler 
experimental procedure. However, developing such strategies is more challenging because of 
the difficulties in distinguishing α- and ε-amino groups. The next chapter describes the 
efforts to develop a positive selection strategy based on a chemical reaction specific for 
protein α-amino groups.    
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Chapter 4. Feasibility of selective transamination for tagging the N-
termini of proteins 
4.1 Introduction 
In parallel to optimising a “negative selection” strategy that relies on the use of N-
hydroxysuccinimide (NHS)-activated Sepharose to identify free protein amino (N)-termini 
(i.e. the “NHS-Sepharose” approach), the feasibility of a “positive selection” strategy was 
also investigated. In N-terminalomics, positive selection strategies take advantage of the 
semi-unique chemistry of α-amino groups at protein N-termini for the enrichment of such 
peptides. These methods employ a variety of reagents to selectively modify the α-amino 
groups so that an affinity tag can subsequently be attached at this position. After proteolysis, 
the tagged N-terminal peptides are positively selected for proteomic identification. The 
advantage of positive selection strategies over their negative selection counterparts is that 
they obviate the need to remove internal peptides after proteolysis. This step is essential to 
negative selection strategies but has been identified as the major bottleneck in the NHS-
Sepharose approach.  
N-CLAP (N-terminalomics by chemical labeling of the α-amine of proteins), O-methylisourea, 
and Subtiligase represent the major approaches in the positive selection branch of N-
terminalomics. Similar to negative selection strategies, N-CLAP employs an indiscriminate 
chemical reaction (i.e. Edman degradation chemistry) to block both α-amino groups at 
protein N-termini and ε-amino groups on lysine (K) side chains (Xu et al., 2009). Different 
from negative selection strategies though, N-CLAP then selectively excises the blocked N-
terminal residues from the rest of the proteins and thus exposes the α-amino groups at the 
newly formed protein N-termini. The reactive α-amino group can be exploited to attach an 
amine-reactive biotin tag (e.g. NHS-SS-biotin) to the neo-N-terminus of the shortened 
protein for affinity purification (AP). On the other hand, the second approach specifically 
blocks ε-amino groups on K residues using O-methylisourea, leaving the α-amino group of a 
protein to be tagged with biotin (Yoshihara et al., 2008).  
Contrary to the above two approaches, Subtiligase does not require any modification of K ε-
amino groups. This approach utilises an engineered enzyme (i.e. subtiligase) to directly 
transfer a biotin-tagged peptide ester to the N-terminus of a protein in a single step 
(Yoshihara et al., 2008). After proteolysis, all three approaches employ immobilised avidin or 
streptavidin beads to capture the biotin-tagged peptides. The biotin tags used in these 
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approaches all contain a cleavable linker that allows subsequent release of the captured 
peptides for liquid chromatography–tandem mass spectrometry (LC-MS/MS) analysis. 
In theory, the vast majority of protein N-termini (~ 80 %) are discarded by these positive 
selection strategies due to endogenous N-terminal (Nt)-acetylation. The blocked N-terminal 
peptides will not be tagged with biotin nor captured by avidin/streptavidin beads during AP. 
As a result, the biotin-tagged protein N-termini will in principle be detected by LC-MS/MS 
with a higher opportunity. Furthermore, positive selection strategies are not hampered by 
the limited binding capacity of coupling reagents (e.g. NHS-activated Sepharose) since they 
do not require the binding and removal of abundant internal peptides. Although such 
strategies have advantages over their negative selection counterparts in terms of detection 
sensitivity and false-positive rates, their feasibility is still limited by multiple factors including 
sample size and reagent availability. For instance, the Subtiligase approach requires a large 
quantity of starting materials (i.e. ~ 100 mg of proteins) due to the relatively low tagging 
efficiency of this enzyme. Additionally, the proprietary enzyme and its tag substrate are not 
locally available. The advantages and disadvantages of each positive selection strategy are 
described in Table 4.1. 
Table 4.1 Comparison of three major positive selection strategies with respect to their strength and 
weaknessa. 
N-terminalomics Strength Weakness 
N-CLAPb Widely available and inexpensive reagents 
Extensive chemical modifications 
may lead to significant sample loss, 
indirect inference of true protein N-
termini, 
off-target N-terminal tagging may 
lead to false-positives 
O-methylisourea Relatively inexpensive reagents 
Complete lysine blocking may be 
difficult to achieve, 
off-target N-terminal tagging may 
lead to false-positives 
Subtiligase 
Absolute specificity towards α-
amines at the N-termini, 
single-step tagging of free N-termini 
that minimises sample loss, 
short handling time 
Relies on a proprietary enzyme with 
limited availability, 
requires a large quantity of proteins, 
limited reaction scope leads to false-
negatives 
a In general, positive selection strategies are more suitable to identify protease substrates instead of 
protein N-termini. All three strategies rely on the match of a single peptide (the N-terminal peptide) 
for protein identification. b N-CLAP: N-terminalomics by chemical labeling of the α-amine of proteins. 
101 
 
Given the current states of these approaches, we explored the feasibility of an alternative 
positive selection strategy based on another chemical reaction that is specific for α-amino 
groups. Selective transamination, mainly developed by H. B. Dixon in the 1960s, is the 
selective conversion of α-amino groups at protein N-termini to carbonyl groups (C=O) using a 
combination of small molecules (Dixon and Fields, 1972). In contrast, ε-amino groups are not 
modified as this reaction requires the presence of a peptide bond adjacent to the target 
amine. After selective transamination, the modified N-terminal residues were removed using 
a carbonyl-reactive compound to study the function of protein N-termini (Dixon and Moret, 
1964, Dixon and Moret, 1965). Although not pursued by Dixon, the carbonyl group 
introduced by this reaction is highly reactive and can be exploited for affinity tagging (e.g. by 
biotinylation). Recently, selective transamination has been utilised to block free protein N-
termini of model proteins with carbonyl-reactive compounds. After proteolysis with LysN, 
the blocked N-terminal peptides were negatively selected by amine-reactive glass (Sonomura 
et al., 2009a). To date, however, this reaction has not been applied to affinity tag free protein 
N-termini for positive selection. 
The present study aimed to develop a novel positive selection approach by combining 
selective transamination with carbonyl-specific tagging and AP. Similar to the critical 
evaluation and optimisation of the NHS-Sepharose approach (see Chapter 3), this positive 
selection approach was also established and tested on samples with an increasing 





4.2.1 Design of a transamination-based positive selection strategy 
In addition to the reaction developed by Dixon (1964), several transamination routes have 
been proposed more recently by M. B. Francis (2006, 2010). These reactions use either 
pyridoxal-5-phosphate (PLP) or N-methylpyridinium-4-carboxaldehyd (RS) to achieve the 
selective conversion of α-amino groups to carbonyl groups. However, the reaction developed 
by Dixon was chosen for the following reasons: I. the rate of transamination is higher using 
this method than the PLP-mediated reaction; II. this method can be applied to modify a wide 
variety of N-terminal residues whereas the RS-mediated reaction is largely limited to 
proteins with an N-terminal glutamate (E) residue; III. the reagents required by this method 
are readily available and more affordable. 
As illustrated in Figure 4.1, selective transamination of protein N-terminal residues involves 
three major components: an amino acceptor, a heavy metal ion as the catalyst, and a high 
concentration of base. The amino acceptor of choice is usually glyoxylate, whereas copper(II) 
sulfate is the preferred catalyst for this reaction. Initially sodium acetate was selected as the 
base, but it could be substituted by pyridine, especially for peptide transamination (Dixon 
and Fields, 1972). The reaction typically proceeds at pH 6 for 0.5 – 2 hours (h) at room 
temperature (Dixon and Fields, 1972, Papanikos et al., 2001, Sonomura et al., 2009a).  
 
Figure 4.1 Schematic illustration of selective transamination of protein or peptide N-termini (modified 
from Dixon, 1984). The negatively charged oxygen of an amino acceptor (e.g. glyoxylate) is first 
juxtaposed with the carbonyl oxygen of the first amino acid residue of a protein or peptide ○P  via a 
divalent metal cation. The presence of a base (B) allows the formation of an imine which, following a 




In the present experiments, peptides or proteins needed to be separated from other 
reactants after selective transamination for further modifications. Due to the differences in 
their physico-chemical properties, the modified proteins could be purified by gel-filtration 
chromatography whereas the modified peptides were only compatible with reversed-phase 
chromatography. The purified peptides/proteins were then subjected to affinity tagging of 
the newly introduced carbonyl groups. Biotin was selected as the affinity tag in the current 
strategy owing to the strength and selectivity of biotin-avidin interaction (Dundas et al., 
2013). In addition, a biotin tag can be tailored to specific tagging of the transaminated 
protein N-termini when linked to a carbonyl-reactive group. Two types of carbonyl-specific 
biotin were tested: hydrazide-based and alkoxyamine-based. Despite the differences in their 
functional groups, both types are commercially available for tagging carbonyl groups. In 
addition to the biotin tags, O-benzylhydroxylamine (BnONH2) was also employed in the 
current study since it is routinely used to block carbonyl groups that are introduced by 
different transamination routes (Gilmore et al., 2006, Witus et al., 2013). 
After biotin tagging or the modification with BnONH2, the peptide samples were 
conveniently analysed by LC-MS/MS to identify such modifications. In contrast, an 
immunoblotting approach (e.g. dot blotting) greatly simplified the detection of the biotin tag 
on intact proteins by use of an antibody against the biotin moiety. Next, the biotin-tagged 
proteins were either directly subjected to AP or digested with a protease to yield a mixture 
of peptides. Two variants of immobilised avidin beads were selected for the AP experiments: 
NeutrAvidin agarose and monomeric avidin agarose. As described in Chapter 1, the former 
binds to biotin with minimised nonspecific interactions (Marttila et al., 2000), whereas the 
latter only requires mild conditions for elution (Henrikson et al., 1979). 
For protein AP, the biotin-tagged proteins were directly treated with the immobilised avidin 
beads without protease digestion. The outcome of protein AP was conveniently evaluated 
using sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE). For AP at the 
peptide level, different proteases were chosen depending on the nature of the biotin-tagged 
proteins: Glu-C for chicken egg-white lysozyme (lysozyme C) and trypsin for bovine serum 
albumin (BSA). After protease digestion, the resulting peptides could be directly analysed by 
LC-MS/MS to locate the biotin tag. Alternatively, the peptide samples were incubated with 
either avidin resin to enrich for the biotin-tagged peptides. Finally, the enriched peptides 
were subjected to LC-MS/MS analysis for evaluating the outcome of peptide AP. The entire 




Figure 4.2 Schematic of a positive selection strategy for N-terminalomic studies (modified from Wehr 
and Levine, 2012). The proposed strategy is based on selective transamination and consists of five 
steps: I. selective transamination of protein N-termini; II. biotinylation or modification with O-
benzylhydroxylamine (BnONH2); III. protease digestion; IV. affinity purification (AP) using immobilised 
avidin resin; V. liquid chromatography–tandem mass spectrometry (LC-MS/MS) analysis. Dot blotting 
and sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) were employed to simplify 
the evaluation of carbonyl-specific biotinylation and AP, respectively. Peptide transamination was 
directly analysed by LC-MS/MS without protease digestion. The red labels indicate new chemical 




4.2.2 Experiments with model peptides 
Selective transamination was first tested on synthetic peptides, which do not require 
protease digestion in order to be detected by LC-MS/MS. There were two synthetic peptides 
available at the time when these experiments were initiated: human adrenocorticotropic 
hormone (ACTH) and rat renin substrate. Human ACTH is a decapeptide (amino acid 
sequence: SYSMEHFRWG), whereas rat renin substrate is composed of 14 amino acid 
residues (DRVYIHPFHLLYYS). These two peptides were subjected to selective transamination 
that in theory introduces a reactive carbonyl group. The transaminated peptides were then 
treated with an alkoxyamine-based biotin tag, which is specific for carbonyl groups and 
hence should be attached to the N-termini of the transaminated peptides. In parallel to the 
biotinylation experiments, the carbonyl-reactive compound BnONH2 was also employed to 
modify the transaminated peptides. The purpose of this treatment was to independently 
evaluate peptide transamination and validate the results of biotinylation. 
Through LC-MS/MS analyses, these two peptides were examined in detail to assess the 
extent of the transamination reaction, the position of the newly introduced carbonyl group, 
and the chemical reactivity of this group. Such analyses were conducted on peptide samples 
at various time points: before transamination, after transamination, and after the treatment 
with BnONH2/biotin. As described in Chapter 2, peak lists were compiled from Orbitrap RAW 
data and then searched against the decoy sequence of each peptide (SYSMEHFRWG or 
DRVYIHPFHLLYYS). Variable modifications including Nt-transamination (-1.03 Da), N-terminal 
tagging with BnONH2 (+104.03 Da), or Nt-biotinylation (+825.33 Da) were set in order to 
identify these N-terminal modifications. 
Prior to selective transamination, both human ACTH and rat renin substrate were directly 
analysed by LC-MS/MS for quality control. Human ACTH was eluted at 35.67 minute (min) 
during LC separation (1-h gradient), whereas rat renin substrate was eluted at 38.74 min 
(retention time, RT). Both peptides were detected by MS as a single peak (Figure 4.3). 
The corresponding full mass spectra were inspected for peptide identification. For human 
ACTH, a full mass spectrum (RT = 35.83 min) exhibited two major peaks: the peak with the 
higher intensity was a doubly charged ion with a mass-to-charge ratio (m/z) of 650.28, 
whereas the peak with the lower intensity was a triply charged ion at m/z = 433.86 (Figure 
4.4A). By calculation, both peaks were derived from the same molecule, with a monoisotopic 





Figure 4.3 Base peak chromatograms of the model peptides human ACTH (A) and rat renin substrate 
(B). Both peptides were detected as a single peak in LC-MS/MS analyses. ACTH: adrenocorticotropic 
hormone; LC-MS/MS: liquid chromatography–tandem mass spectrometry; RT: retention time; NL: 
normalised intensity level; min: minute. 
Similarly, the full mass spectrum (RT = 38.74 min) of rat renin substrate also revealed two 
major peaks with m/z of 608.31 and 911.97, respectively (Figure 4.4B). Both ions were 
derived from the same molecule with a monoisotopic mass of 1821.92 Da, which matched 
the expected MW of rat renin substrate.  
In addition to manual inspection of the full mass spectra, MS/MS data of human ACTH and 
rat renin substrate were processed and searched against their respective peptide sequences 
using the Mascot software. As shown in Table 4.2, both peptides were successfully identified 
by Mascot database searches. Therefore, the two peptide samples were confirmed as human 





Figure 4.4 Full mass spectra of human ACTH (RT = 38.74 min) and rat renin substrate (RT = 35.93 min). 
For human ACTH (A), two major peaks are the doubly charged ion at m/z = 650.28 and the triply 
charged ion at m/z = 433.86. For rat renin substrate (B), two major peaks are the doubly charged ion 
at m/z = 911.97 and the triply charged ion at m/z = 608.31. ACTH: adrenocorticotropic hormone; RT: 
retention time; NL: normalised intensity level; m/z: mass-to-charge ratio; min: minute.   
Table 4.2 Mascot search results of the peptides human ACTH and rat renin substratea. 
Peptide-Spectrum Match                                         
(Start – End) 




SYSMEHFRWG (1 – 10)  650.2816 1298.5502 60 9.9E-7 19 
SYSMEHFRWG (1 – 10) + Oxidation (M) 658.2791 1314.5452 50 1.0E-5 23 
Rat renin substrate 
DRVYIHPFHLLYYS (1 – 14) 608.3150 1821.9202 31 0.00078 23 
a A single PSM is shown to represent each significantly identified peptide (E-value ≤ 0.05). ACTH: 
adrenocorticotropic hormone; m/z: mass-to-charge ratio; MW: molecular weight; E-value: peptide 




After the quality control, these two peptide samples were subjected to selective 
transamination. This reaction was carried out under two different conditions (“salt-free” or 
“salt-based”, see section 2.8), and both yielded the same reaction products as revealed by 
LC-MS/MS analyses. The “salt-free” condition was selected for all subsequent transamination 
experiments due to its compatibility with both peptide and protein samples. Therefore, only 
the data obtained using the “salt-free” transamination are described below. Base peak 
chromatograms showed that the transamination of human ACTH or rat renin substrate 
resulted in multiple peaks during LC separation (1-h gradient). For the reaction products of 
human ACTH, three major peaks were present at RT = 41.11, 41.85, and 42.99 min (Figure 
4.5A). In contrast, selective transamination of rat renin substrate yielded two major peaks at 
RT = 42.21 and 44.35 min, respectively (Figure 4.5B). 
Figure 4.5 Base peak chromatograms of human ACTH (A) and rat renin substrate (B) after 
transamination. Peaks in the chromatograms may correspond to the reaction products of each 





These peaks were further analysed using their corresponding full mass spectra. For human 
ACTH, the expected transamination product (MW: 1297.52 Da) was detected as a doubly 
charged ion at m/z = 649.77 (Figure 4.6A). In contrast, a high-intensity ion at m/z = 687.28 (z 
= 2) was also present. By calculation, the high-intensity ion was derived from a by-product 
with a MW of 1372.54 Da, corresponding to a mass shift of +74 Da. The intensities of these 
two ions were then compared using extracted ion chromatograms (XIC), which only monitor 
the specified targets. As shown in Figure 4.6B, the correct transamination product was only 
20 % of the +74 Da by-product in terms of signal intensity. 
 
Figure 4.6 Full mass spectrum (A) and extracted ion chromatogram (XIC; B) of the expected 
transamination product (red) and the +74 Da by-product (black) of human ACTH (adrenocorticotropic 
hormone). m/z: mass-to-charge ratio; RT: retention time; NL: normalised intensity level; min: minute.  
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Following manual inspection of the full mass spectra, the MS/MS data of the reaction 
products were subjected to a Mascot search against the sequence of human ACTH. As shown 
in Table 4.3, the correct reaction product was successfully identified by the Mascot search. 
However, native human ACTH was also identified, which suggested that selective 
transamination did not proceed to completion. In contrast, the +74 Da by-product was not 
identified since this unknown modification was not included in the search parameters. 
Table 4.3 Result of the Mascot database search for the transamination products of human ACTHa. 
Peptide-Spectrum Match                                    
(Start – End) 
m/z MW Score E-value 
Duplicate 
PSM No. 
SYSMEHFRWG (1 – 10)  650.2859 1298.5502 64 3.7E-7 7 
SYSMEHFRWG (1 – 10) + Oxidation (M) 658.2817 1314.5452 44 4.4E-5 5 
SYSMEHFRWG (1 – 10) + 
Transamination (N-term) 
649.7687 1297.5186 61 8.8E-7 11 
a A single PSM is shown to represent each significantly identified peptide (E-value ≤ 0.05). ACTH: 
adrenocorticotropic hormone; m/z: mass-to-charge ratio; MW: molecular weight; E-value: peptide 












For rat renin substrate, three major reaction products were detected in the full mass spectra. 
As shown in Figure 4.7, the three peaks were detected as triply charged ions at m/z = 593.31, 
632.98, and 607.98 (in the order of decreasing signal intensity). By calculation, the peak with 
the highest intensity (m/z = 593.31) was derived from a side product with a mass shift of -45 
Da. This product was likely produced by decarboxylation of the N-terminal aspartate (D) 
residue of rat renin substrate, which will be discussed in section 4.3. Consistent with the 
transamination of human ACTH, a +74 Da by-product (m/z = 632.98) was also detected with 
comparatively lower intensity. Finally, the peak with the lowest intensity (m/z = 607.98) 
corresponded to the expected reaction product (MW: 1820.77 Da). The correct reaction 
product was only one seventh of the decarboxylated peptide in terms of signal intensity. 
 
Figure 4.7 Full mass spectra of the expected transamination product and major by-products of rat 
renin substrate. (A) Full mass spectrum (RT = 44.10 min) of the correct product (m/z = 607.98, z = 3) 
and the -45 Da side product (m/z = 593.31, z = 3). (B) Full mass spectrum (RT = 45.86 min) of the +74 
Da by-product (m/z = 632.98, z = 3). RT: retention time; NL: normalised intensity level; m/z: mass-to-
charge ratio; min: minute. 
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The next step in the current experiments was to further modify the transaminated human 
ACTH and rat renin substrate with BnONH2. The aim of this treatment was to ascertain the 
nature and reactivity of the transamination products. For human ACTH, the treatment with 
this compound resulted in the presence of two peaks at RT = 49.56 and 51.13 min, 
respectively. These peaks are shown in an XIC (Figure 4.8A). The corresponding full mass 
spectra at both time points showed the same doubly charged ion at m/z = 702.30 (Figure 
4.8B). This ion was determined to result from the modified peptide with a mass shift of 
+104.03 Da. It matched the expected value of BnONH2 modification following selective 
transamination. 
 
Figure 4.8 (A) Extracted ion chromatogram (XIC) of human ACTH that was modified by successive 
transamination and oxime formation with BnONH2. (B) Corresponding full mass spectrum of the 
BnONH2-modified peptide (m/z = 702.30, z = 2) at RT = 49.56 min. ACTH: adrenocorticotropic 
hormone; BnONH2: O-benzylhydroxylamine; m/z: mass-to-charge ratio; RT: retention time; NL: 




For rat renin substrate, the treatment with this compound yielded two peaks at RT = 51.44 
and 52.88 min, respectively (Figure 4.9). Both peaks were shown by the corresponding full 
mass spectra to be a triply charged ion at m/z = 642.99 (Figure 4.10). This ion corresponded 
to a MW of 1925.95 Da, which was the expected value of the BnONH2-modified correct 
transamination product of rat renin substrate. This peptide was accompanied by an 
additional pair of peaks (RT = 51.44 and 52.40 min, respectively), which were detected as a 
triply charged ion at m/z = 628.33. This ion might correspond to the decarboxylated peptide 
that was further modified with BnONH2.  
 
Figure 4.9 Combined extracted ion chromatograms (XIC) of rat renin substrate, which was modified by 
successive transamination and oxime formation with BnONH2. The BnONH2-modified correct 
transamination product (m/z = 642.99, z = 3) is shown in read, whereas the BnONH2-modified -45 Da 
side product (m/z = 628.33, z = 3) is shown in black. BnONH2: O-benzylhydroxylamine; m/z: mass-to-





Figure 4.10 Full mass spectra of rat renin substrate that was modified by successive transamination 
and oxime formation with BnONH2. (A) The BnONH2-modified correct transamination product (m/z = 
642.99 or 963.97; in red). (B) The BnONH2-modified decarboxylated peptide (m/z = 628.33 or 942.00; 
in black). BnONH2: O-benzylhydroxylamine; m/z: mass-to-charge ratio; RT: retention time; NL: 











The MS/MS data of the BnONH2-modified transamination products were then subjected to 
Mascot searches against the corresponding peptide sequence. This established that the 
BnONH2 modification was located at the N-terminus of both the transaminated human ACTH 
and rat renin substrate (Table 4.4). Taken together, these results showed that the correct 
transamination products of human ACTH and rat renin substrate were both amenable to the 
carbonyl-specific modification with BnONH2. Therefore, both correct transamination 
products possessed a reactive carbonyl group at their N-termini. Furthermore, certain side 
products of transamination (e.g. decarboxylated rat renin substrate) might also exhibit the 
reactivity attributed to a carbonyl group. 
Table 4.4 Results of the Mascot database searches for BnONH2-modified human ACTH and rat renin 
substratea. 
Peptide-Spectrum Match                                      
(Start – End) 
m/z MW Score E-value 
Duplicate 
PSM No. 
BnONH2-modified human ACTH 
SYSMEHFRWG (1 – 10)  650.2870 1298.5502 64 3.8E-7 8 
SYSMEHFRWG (1 – 10) + BnONH2 (N-term) 702.2975 1402.5764 56 2.7E-6 7 
BnONH2-modified rat renin substrate 
DRVYIHPFHLLYYS (1 – 14) 608.3141 1821.9202 24 0.0042  
DRVYIHPFHLLYYS (1 – 14) + BnONH2                   
(N-term) 
642.9850 1925.9464 17 0.02 2 
a A single PSM is shown for each significantly identified peptide (E-value ≤ 0.05). ACTH: 
adrenocorticotropic hormone; BnONH2: O-benzylhydroxylamine; m/z: mass-to-charge ratio; MW: 
molecular weight; E-value: peptide expectation value; Duplicate PSM No.: number of duplicate 
peptide-spectrum matches (PSM). 
Having confirmed that the expected transamination product of both human ACTH and rat 
renin substrate possessed a reactive carbonyl group, they were then subjected to affinity 
tagging with alkoxyamine-based biotin (i.e. alkoxyamine-PEG4-SS-PEG4-biotin). Consistent 
with the BnONH2 modification, two adjacent peaks (RT = 49.47 and 50.38 min, respectively) 
were present in the XIC of the biotinylated human ACTH (Figure 4.11A). These two peaks 
contained a triply charged ion (m/z = 708.97) and a doubly charged ion (m/z = 1062.94) that 
both corresponded to a reaction product with a MW of 2123.89 Da (Figure 4.11B). In 
comparison with the native human ACTH, this product showed the expected mass shift 




Figure 4.11 Extracted ion chromatogram (XIC; A) and full mass spectrum (B) of the biotinylated human 
ACTH (adrenocorticotropic hormone). RT: retention time; NL: normalised intensity level; m/z: mass-to-
charge ratio. 
The position of the attached biotin tag was also confirmed by a Mascot database search, 
with Nt-biotinylation (+825.33 Da) included in the variable modifications (Table 4.5). After 
Higher-energy Collisional Dissociation (HCD) fragmentation of the precursor ion of the 
biotinylated human ACTH (m/z = 1062.94, z = 2), y-series fragment ions (y3 – y8) were 
identified in the tandem mass spectrum (Figure 4.12 & Table 4.6). These y-ions were 
identical to those derived from the native human ACTH, strongly suggesting that the biotin 
tag had been attached to the N-terminus of the peptide. In addition, the identified y-ions 
were accompanied by an intense peak at m/z = 270.13 (z = 1). This peak likely corresponded 
to a fragment ion that resulted from putative cleavage of the attached biotin tag itself during 
HCD fragmentation (discussed in section 4.3). 
Nonetheless, the Mascot search result indicated that neither transamination nor biotin 
tagging proceeded to completion, since both the native and transaminated human ACTH 
were also detected in the biotin-tagged sample. Meanwhile, the biotinylated rat renin 
substrate could not be directly identified by a Mascot search using the same parameters. An 
error-tolerant search was thus performed to account for possible side reactions in 
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transamination, which would confer additional mass shifts to the peptide. The logic behind 
the error-tolerant search was that the decarboxylated rat renin substrate was detected with 
high intensity and this side product likely possessed a reactive carbonyl group as well. 
Table 4.5 Result of the Mascot database search for biotinylated human ACTHa. 
Peptide-Spectrum Match                                       
(Start – End) 
m/z MW Score E-value 
Duplicate 
PSM No. 
SYSMEHFRWG (1 – 10)  650.2870 1298.5502 60 9.4E-7 4 
SYSMEHFRWG (1 – 10) + Biotin (N-term) 1062.9454 2123.8825 21 0.0084 2 
SYSMEHFRWG (1 – 10) + Transamination 
(N-term) 
649.7655 1297.5186 52 6.5E-6 5 
a A single PSM is shown for each significant peptide (E-value ≤ 0.05). ACTH: adrenocorticotropic 
hormone; m/z: mass-to-charge ratio; MW: molecular weight; E-value: peptide expectation value; 
Duplicate PSM No.: number of duplicate peptide-spectrum matches (PSM). 
 
Figure 4.12 Tandem mass spectrum of biotinylated human adrenocorticotropic hormone (ACTH, 
amino acid sequence: SYSMEHFRWG). The expected m/z values for all possible fragment ions are 
shown in Table 4.6. The annotated fragment ions are labelled in red. The fragment ion at m/z = 270.13 
(z = 1), which likely resulted from putative cleavage of the attached biotin tag, is denoted by ∆biotin. 
RT: retention time; NL: normalised intensity level; m/z: mass-to-charge ratio. 
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Table 4.6 Fragment ions (in silico predicted) of the biotin-tagged human ACTH (amino acid sequence: 
SYSMEHFRWG). Fragment ions matched to the experimental data are shown in red. ACTH: 
adrenocorticotropic hormone. 
 
The error-tolerant search did identify multiple peptide-spectrum matches (PSMs) that might 
represent the biotinylated rat renin substrate with additional mass shifts (Table 4.7). Among 
them, the doubly charged ion at m/z = 1302.64 was repeatedly detected. Compared to the 
expected biotinylation product, this putative peptide exhibited a further mass shift of -44 Da. 
Therefore, potentially it was formed by biotin tagging of the decarboxylated rat renin 
substrate. Additional search hits included the precursor ions at m/z = 1295.63 and 1310.64 (z 
= 2 for both). The former corresponded to a further mass shift of -58 Da that likely suggested 
a complete loss of the side chain (i.e. N-terminal D to G), whereas the latter (-28 Da) likely 
indicated the conversion from a carboxyl to a hydroxyl group (i.e. N-terminal D to S). 
Table 4.7 Result of the Mascot error-tolerant search for biotinylated rat renin substratea. 
Peptide-Spectrum Match                             
(Start – End) 
m/z MW ppm Score 
Duplicate 
PSM No. 
Native peptide (Reference) 
DRVYIHPFHLLYYS (1 – 14)                         911.9666 1821.9202 -0.89 54 9 
Putative biotinylated peptides 
DRVYIHPFHLLYYS (1 – 14) + Biotin 
(N-term); -58 Da 
1295.6305 2589.2470 -0.21 27  
DRVYIHPFHLLYYS (1 – 14) + Biotin 
(N-term); -44 Da          
1302.6391 2603.2627 1.07 30 3 
DRVYIHPFHLLYYS (1 – 14) + Biotin 
(N-term); -28 Da 
1310.6380 2619.2576 1.49 36 1 
a A single PSM is shown for each putative biotinylated peptide. The native peptide confidently 
identified in the same experiment is also included as reference. Peptide score ≥ 13 indicates identity. 
m/z: mass-to-charge ratio; MW: molecular weight; ppm: parts per million; Duplicate PSM No.: number 
of duplicate peptide-spectrum matches (PSM). 
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4.2.3 Experiments with model proteins 
Having partially established that peptides could be transaminated and subsequently tagged 
with biotin, the next step was to perform the same test on two model proteins (lysozyme C 
and BSA). Previously, these two proteins had already been analysed by LC-MS/MS in their 
native states (see Chapter 3). Their respective N-terminal peptides were also identified: a 7-
residue peptide (KVFGRCE) in lysozyme C and a decapeptide (DTHKSEIAHR) in BSA. Thus, 
these data will not be shown again. In the present studies, these model proteins were first 
subjected to “salt-free” transamination before treatment with BnONH2. This treatment was 
followed by protease digestion using Glu-C/trypsin and LC-MS/MS. Similar to the peptide 
test, Mascot database searches were conducted using individual protein sequences and a 
variable modification, i.e. the N-terminal BnONH2 modification (mass shift = +104.03 Da). 
As described in section 3.2.1, the N-terminal peptide of lysozyme C (KVFGRCE) in its native 
state was detected as a doubly charged ion at m/z = 448.23 (with the carbamidomethylated 
C residue). The m/z value of this peptide became 500.24 (z = 2) after transamination and the 
treatment with BnONH2. It corresponded to a mass shift of +104.03 Da, which was equal to 
the expected value. Figure 4.13 is a composite full mass spectrum that compares the m/z 
values between the native and BnONH2-modified N-terminal peptides. 
 
Figure 4.13 Composite full mass spectrum of the N-terminal peptide of lysozyme C (amino acid 
sequence: KVFGRCE) before and after transamination and modification with O-benzylhydroxylamine 
(BnONH2). NL: normalised intensity level; m/z: mass-to-charge ratio. 
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The BnONH2-modified N-terminal peptide (m/z = 500.24, z = 2) was then subjected to HCD 
fragmentation that generated a series of fragment ions. The resulting MS/MS data were 
analysed by a Mascot database search. A comparison of the fragment ions showed that the 
native and BnONH2-modified N-terminal peptides had identical y-series ions (Figure 4.14 and 
Table 4.8). Therefore, the mass shift of +104.03 Da could only be attributed to the intended 
modifications on the N-terminal K residue. Although b-series ions were not matched, these 
results strongly suggested that transamination and BnONH2 modification took place 
specifically at the N-terminus of lysozyme C. 
 
Figure 4.14 Tandem mass spectrum of the BnONH2-modified N-terminal peptide of lysozyme C (amino 
acid sequence: KVFGRCE) with the annotated fragment ions (red). BnONH2: O-benzylhydroxylamine; 
RT: retention time; NL: normalised intensity level; m/z: mass-to-charge ratio. 
Table 4.8 Fragment ions (in silico predicted) of the BnONH2-modified N-terminal peptide of lysozyme 
C (amino acid sequence: KVFGRCE). Fragment ions matched to the experimental data are shown in 




As described in section 3.2.2, the tryptic N-terminal peptide of native BSA is composed of 10 
amino acid residues: DTHKSEIAHR (with one missed cleavage). Through an LC-MS/MS 
analysis, this peptide was detected as a triply charged ion at m/z = 398.54 (Figure 4.15). After 
transamination and treatment with BnONH2, the modified N-terminal peptide was detected 
as a triply charged ion at m/z = 433.21. The m/z difference between these two ions was 
equivalent to a mass shift of +104.03 Da, matching the expected value due to BnONH2 
modification. 
 
Figure 4.15 Composite full mass spectrum of the N-terminal peptide of BSA (amino acid sequence: 
DTHKSEIAHR) before and after transamination and O-benzylhydroxylamine (BnONH2) modification. NL: 
normalised intensity level; m/z: mass-to-charge ratio. 
The BnONH2-modified N-terminal peptide was also identified by a Mascot database search. 
As shown in the corresponding tandem mass spectrum, a series of y-ions were detected 
after HCD fragmentation of the BnONH2-modified N-terminal peptide (4.16 and Table 4.9). 
These y-ions had identical m/z values with those from the native N-terminal peptide. This 
result was consistent with the findings in the lysozyme C experiment. In addition, two y-ions 
(y2 and y5) that could not be assigned by Mascot were found in the tandem mass spectrum 
by manual inspection. To summarise, both lysozyme C and BSA experiments showed that 




Figure 4.16 Tandem mass spectrum of the BnONH2-modified N-terminal peptide of BSA (amino acid 
sequence: DTHKSEIAHR). A table of the expected m/z values for all possible fragment ions is included 
below. The annotated ions are labelled in red, whereas putative fragment ions (not annotated by 
Mascot) are labelled in black. BnONH2: O-benzylhydroxylamine; RT: retention time; NL: normalised 
intensity level; m/z: mass-to-charge ratio. 
Table 4.9 Fragment ions (in silico predicted) of the BnONH2-modified N-terminus of BSA (amino acid 
sequence: DTHKSEIAHR). Fragment ions matched to the experimental data are shown in red. BnONH2: 
O-benzylhydroxylamine. 
 
Furthermore, an error-tolerant search also detected BnONH2 modification of the 
decarboxylated N-terminal peptide of BSA, which exhibited a further mass shift of -44 Da 
(Table 4.10). A comparison of the number of PSMs between the expected and 
decarboxylated N-terminal peptides suggested that decarboxylation might dominate over 
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transamination as far as the N-terminal D residue was concerned. The error-tolerant search 
also suggested that the BnONH2-modified peptide might be detected in the form of [M + H + 
Na]2+ (further mass shift = +22 Da) or [M + H + K]2+ (further mass shift = +38 Da). 
Table 4.10 Result of the Mascot error-tolerant for the BnONH2-modified N-terminal peptide of BSA
a. 
Peptide-Spectrum Match                     
(Start – End) 
m/z MW ppm Score 
Duplicate 
PSM No. 
BnONH2-modifed peptide (Reference) 
DTHKSEIAHR (1 – 10) + BnONH2 (N-term) 433.2122 1296.6211 -4.75 42 1 
Putative BnONH2-modifed peptides 
DTHKSEIAHR (1 – 10) + BnONH2 (N-term); 
-44 Da                                    
418.5492 1252.6313 -4.32 62 3 
DTHKSEIAHR (1 – 10) + BnONH2 (N-term); 
+22 Da                          
660.3050 1318.6030 -5.70 46  
DTHKSEIAHR (1 – 10) + BnONH2 (N-term); 
+38 Da 
668.2969 1334.5770 1.67 57  
a A single PSM is shown for each putative BnONH2-modified peptide together with the expected 
peptide identified in the same experiment as reference. Peptide score ≥ 13 indicates identity. BnONH2: 
O-benzylhydroxylamine; m/z: mass-to-charge ratio; MW: molecular weight; ppm: parts per million; 
Duplicate PSM No.: number of duplicate peptide-spectrum matches (PSM).  
The second stage of the protein test involved transamination and biotin tagging of lysozyme 
C and BSA. Initially, a hydrazide-based biotin tag (i.e. hydrazide-biotin) was employed in the 
test. After treatment of the transaminated proteins with hydrazide-biotin, the expected mass 
shift would be +239.10 Da (compared to the native peptides). Accordingly, MS/MS data of 
the biotin-treated lysozyme C and BSA samples were subjected to Mascot searches against 
their respective protein sequences, with Nt-biotinylation (+239.10 Da) set as one of the 
variable modifications. However, the Mascot database searches did not identify any 
biotinylated N-terminal peptide in either the lysozyme C or BSA samples despite the 
repeated attempts (N = 4) to locate the biotin tag.  
Error-tolerant searches were thus performed on the MS/MS data of either protein sample. In 
the case of lysozyme C, the error-tolerant search identified the putative biotinylated N-
terminal peptide with further mass shifts (Table 4.11). Among them, the further mass shifts 
of +43 and +57 Da were attributed to carbamylation (K) and carbamidomethylation (K), 
respectively. Such assignments might be genuine since the protein samples were indeed 
dissolved in urea and treated with iodoacetamide, which would lead to the said 
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modifications (see section 4.3). Other putative modifications included formylation (mass 
shift = +28 Da) and a complete loss of the K side chain (N-terminal K to G, mass shift = -71 
Da). Although such assignments remain to be verified, formylation has been reported as an 
experimental artefact due to prolonged exposure to formic acid (Zheng and Doucette, 2016). 
On the other hand, the N-terminal peptide of BSA was still not identified. Therefore, the 
error-tolerant searches did not provide definitive assignments of the N-terminal biotin tag. 
Table 4.11 Result of the Mascot error-tolerant search for the N-terminal peptide of transaminated 
lysozyme C, which was further treated with hydrazide-biotina. 
Peptide-Spectrum Match                     
(Start – End) 
m/z MW ppm Score 
Duplicate 
PSM No. 
Native peptide (Reference) 
KVFGRCE (1 – 10) + Carbamidomethyl (C) 448.2266 894.4382 0.44 44 31 
Putative biotinylated peptides 
KVFGRCE (1 – 10) + Carbamidomethyl (C); 
Biotin (N-term); -71 Da 
532.2249 1062.4375 -2.13 21  
KVFGRCE (1 – 10) + Carbamidomethyl (C); 
Biotin (N-term); +28 Da 
581.7587 1161.5059 -2.57 20 5 
KVFGRCE (1 – 10) + Carbamidomethyl (C); 
Biotin (N-term); +43 Da 
589.2644 1176.5168 -2.14 24  
KVFGRCE (1 – 10) + Carbamidomethyl (C); 
Biotin (N-term); +57 Da 
596.2726 1190.5325 0.39 22 9 
a Orbitrap RAW data of four replicate analyses were pooled and searched in Mascot twice, with 
cysteine (C) carbamidomethylation set as either a fixed or variable modification. Both Mascot 
searches produced the same result, which was edited to show a single PSM for each putative 
biotinylated peptide. The native peptide confidently identified in the same experiment is also included 
as reference. Peptide score ≥ 13 indicates identity. m/z: mass-to-charge ratio; MW: molecular weight; 
ppm: parts per million; Duplicate PSM No.: number of duplicate peptide-spectrum matches (PSM). 
In response to these negative results, another analytical method was employed to test the 
same set of samples at a different level. Dot blotting is a simple immunoblotting technique 
that detects proteins of interest using specific antibodies. Since this method does not require 
protein separation by electrophoresis, the time of analysis can be dramatically reduced. It is 
especially suitable for analysing single protein samples. In the present experiments, the 
model protein samples yielding negative results were re-analysed by dot blotting to check for 
the presence of a biotin signal. The protein samples of lysozyme C or BSA, which had been 
subjected to transamination and subsequently to biotin tagging, were analysed together 
with three negative controls: native protein, transamination-only, and biotinylation-only. 
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As shown in Figure 4.17, the results with the lysozyme C and BSA samples indicated that the 
biotin tag was successfully attached to both proteins after transamination and the treatment 
with hydrazide-biotin. The biotin signal was absent in either the native protein (Trans-, 
Biotin-) or transamination-only (Trans+, Biotin-) samples. In contrast, a strong biotin signal 
was detected in the treated samples (Trans+, Biotin+). Interestingly, a biotin signal was also 
detected in the biotinylation-only samples (Trans-, Biotin+), albeit to a much lesser extent. 
Given the equal loading across all four samples confirmed by Ponceau S staining, these 
results demonstrated that transamination introduced more carbonyl groups for hydrazide-
biotin to react with. The biotin signal in one of the negative controls (i.e. biotinylation-only) 
might reflect spontaneous protein carbonylation (see section 4.3). 
 
Figure 4.17 Dot blotting of lysozyme C and BSA, which were subjected to selective transamination and 
treatment with hydrazide-biotin. For each protein, three negative controls and the treated sample 
(from left to right) are: native protein, biotinylation-only, transamination-only, and both 
transamination and biotinylation. Protein loading was checked by Ponceau S staining before 
incubation with the biotin-specific antibody. Trans: transamination. 
Having confirmed that the biotin tag was successfully added to the model proteins after 
transamination, the next step in this test was to confirm the biotin tagging of protein N-
termini by LC-MS/MS. Since the previous experiments failed to do so using hydrazide-biotin, 
alkoxyamine-PEG4-biotin was employed instead. This reagent specifically attaches biotin to a 
carbonyl group by forming an oxime bond instead of a hydrazone bond (Figure 4.18). The 
experimental procedure was the same as previously described where the protein samples 




Figure 4.18 Illustrated mechanism of the carbonyl-specific biotinylation at protein N-terminus. The N-
terminal carbonyl group can be introduced by selective transamination. (A) Biotinylation of the 
carbonyl group through hydrazone bond formation. (B) Biotinylation of the carbonyl group through 
oxime bond formation. The linker region in alkoxyamine-PEG4-biotin is not shown. ○B : biotin; R: side 
chain of the N-terminal amino acid residue. 
As shown in Figure 4.19, the dot blotting analyses revealed that a strong biotin signal was 
detected in the treated samples (Trans+, Biotin+) of both lysozyme C and BSA. In contrast, 
the biotin signal was absent in two negative control samples: native protein (Trans-, Biotin-) 
and transamination-only (Trans+, Biotin-). Similar to the results with hydrazide-biotin, a weak 
signal of biotin was also detected in the biotinylation-only (Trans-, Biotin+) samples of both 
lysozyme C and BSA.  
 
Figure 4.19 Dot blotting analyses of lysozyme C and BSA tagged with alkoxyamine-PEG4-biotin after 
selective transamination. For each protein, three negative controls and the treated sample (from left 
to right) are: native protein, biotinylation-only, transamination-only, and both transamination and 
biotinylation. Protein loading was checked by Ponceau S staining before incubation with the biotin-
specific antibody. Trans: transamination. 
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In regard to the LC-MS/MS analysis, a Mascot database search identified the biotinylated N-
termini of both lysozyme C and BSA. For lysozyme C, the biotinylated N-terminal peptide was 
detected in the full mass spectrum (RT = 36.65 min) as a doubly charged ion at m/z = 655.81 
(Figure 4.20). The mass difference between the biotinylated peptide and its native 
counterpart was calculated to be 415.17 Da, matching the expected mass shift due to 
biotinylation. In addition, inspection of the corresponding tandem mass spectrum localised 
the biotin tag to the N-terminus of the peptide (Figure 4.21 and Table 4.12). It should be 
noted that, although Nt-biotinylation and biotinylation (K) were indistinguishable in this 
case, double biotinylation of the N-terminal peptide (at both the N-terminus and the K 
residue) was never detected when the Mascot search was repeated with biotinylation (K) set 
as a variable modification. 
Consistent with the findings in the previous test with human ACTH (Figure 4.12), the 
fragment ion that likely signifies the biotin tag cleavage (m/z = 270.13, z = 1) was once again 
present with high intensity. It was complemented by two singly charged ions (m/z = 876.40 
or 1041.50), which were putative remnants (left by the biotin tag cleavage) of the b*6 
fragment ion and the biotinylated peptide itself, respectively. Nevertheless, there were 
fragment ions (e.g. m/z = 435.23, z = 1) that could not be attributed to the biotin tag 
cleavage and hence remained to be elucidated. 
 
Figure 4.20 Full mass spectrum of the biotinylated N-terminal peptide of lysozyme C (amino acid 
sequence: KVFGRCE), which is shown as a doubly charged ion at m/z = 655.91. RT: retention time; NL: 




Figure 4.21 Tandem mass spectrum of the biotinylated N-terminal peptide of lysozyme C (amino acid 
sequence: KVFGRCE). A table of the expected m/z values for all possible fragment ions is shown in 
Table 4.12. The annotated b- and y-ions are labelled in green and red, respectively. Putative fragment 
ions (not annotated by Mascot) are labelled in black, including the singly charged ion at m/z = 270.13 
that likely resulted from putative cleavage of the attached biotin tag (denoted by ∆biotin). RT: 
retention time; NL: normalised intensity level; m/z: mass-to-charge ratio. 
Table 4.12 Fragment ions (in silico predicted) of the biotinylated N-terminal peptide of lysozyme C 







Similarly, the biotin-tagged N-terminal peptide of BSA was eluted at RT = 21.87 min and 
detected in the corresponding full mass spectrum as a doubly charged ion at m/z = 804.89 
(Figure 4.22). The calculated mass shift was equal to the expected value (415.17 Da), thus 
confirming the addition of the biotin tag. Although b-series fragment ions were not directly 
detected, the MS/MS data strongly suggested that this biotin tag was specifically attached to 
the N-terminal residue of this peptide (Figure 4.23 and Table 4.13). In keeping with the 
previous results, the intense peak at m/z = 270.13 (z = 1) was also detected. It likely signifies 
the cleavage of the attached biotin tag during HCD fragmentation (discussed in section 4.3). 
Furthermore, biotinylation (K) of the N-terminal peptide could not be detected when the 
Mascot search was repeated to include it in the list of variable modifications. 
It should be noted that the decarboxylated N-terminal peptide (mass shift = -44 Da) was 
likely also tagged with alkoxyamine-PEG4-biotin. The putative decarboxylated and 
biotinylated N-terminal peptide was identified as a doubly charged ion at m/z = 782.89, 
corresponding to a MW of 1563.78 Da. In conclusion, the results of both the lysozyme C and 
BSA tests indicated that transamination enabled the biotin tagging of the modified protein 
N-termini through oxime bond formation. 
 
Figure 4.22 Full mass spectrum of the biotinylated N-terminal peptide of BSA (amino acid sequence: 
DTHKSEIAHR), which was detected as a doubly charged ion at m/z = 804.89. RT: retention time; NL: 




Figure 4.23 Tandem mass spectrum of the biotinylated N-terminal peptide of BSA (amino acid 
sequence: DTHKSEIAHR). A table of the expected m/z values for all possible fragment ions is shown in 
Table 4.13. The annotated ions are labelled in red, whereas putative fragment ions (not annotated by 
Mascot) are labelled in black. In particular, the singly charged ion at m/z = 270.13, which likely 
resulted from putative cleavage of the attached biotin tag, is denoted by ∆biotin. RT: retention time; 
NL: normalised intensity level; m/z: mass-to-charge ratio. 
Table 4.13 Fragment ions (in silico predicted) of the biotinylated N-terminal peptide of BSA (amino 







The next major step of the present study was to enrich the biotin-tagged proteins by AP 
using immobilised avidin resins. Two types of such resins were employed in this test: 
NeutrAvidin agarose and monomeric avidin agarose. As described previously, NeutrAvidin is 
a deglycosylated form of the avidin protein (MW: 60 kDa), which consists of four identical 
subunits (MW: 15 kDa) each binding to a single biotin. Deglycosylation is claimed to reduce 
nonspecific binding (Marttila et al., 2000). In terms of the affinity for biotin, the dissociation 
constant (Kd) of NeutrAvidin is 10-15 M. On the other hand, monomeric avidin has a much 
lower affinity for biotin (Kd = 10-8 M), allowing for mild elution of the biotinylated molecules 
and recycling of this reagent (Henrikson et al., 1979).  
In the AP tests, the biotin-tagged BSA was incubated with NeutrAvidin agarose first. After 
extensive washing, the NeutrAvidin beads were boiled in SDS sample buffer to elute the 
bound proteins for SDS-PAGE analysis. Two sets of BSA samples (eight in total) were 
separated on a pair of 10 % polyacrylamide gels. The first gel consisted of the test sample 
(transamination and biotinylation) and three negative controls (native protein, 
transamination-only, and biotinylation-only) before AP, whereas the second gel contained 
the four equivalent samples after AP. Equal amounts of BSA were detected in all four samples 
before AP (Figure 4.24, left). The major protein band (MW: ~ 66 kDa) corresponded to BSA, 
whereas the additional bands were routinely detected impurities. 
Figure 4.24 Sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) of the biotinylated 
BSA before (left) and after (right) affinity purification with NeutrAvidin agarose. The position of 
NeutrAvidin monomers is also indicated. Trans: transamination; M: protein marker. 
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As shown in Figure 4.24 (right), the BSA band was mainly detected in the treated sample 
(Trans+, Biotin+) after AP. This result suggested that a biotin tag had been successfully 
attached to the transaminated BSA and that NeutrAvidin agarose was able to enrich the 
biotin-tagged protein. In keeping with the dot blotting results, the BSA band was also 
detected in the biotinylation-only sample (Trans-, Biotin+) but with lower intensity. This 
observation indicated that biotinylation could also take place spontaneously (i.e. without 
transamination), albeit to a lesser extent. Importantly, two additional bands were also 
detected in all four samples after AP. The major band of the two corresponded to a MW of 
15 kDa. A plausible explanation for this observation is that the harsh conditions for elution 
damaged the NeutrAvidin proteins, causing dissociation of the tetramers into mainly 
monomers (MW: 15 kDa) and possibly dimers (the minor band; MW: 30 kDa) too.  
Since the MW of NeutrAvidin monomers is similar to that of lysozyme C (14 kDa), it would be 
difficult to separate these two proteins by SDS-PAGE. NeutrAvidin agarose was thus replaced 
by monomeric avidin agarose to enrich for the biotinylated lysozyme C. Similarly, the result 
of SDS-PAGE showed that the protein band of lysozyme C was present in equal quantities 
across all the samples before AP but only detected in the treated sample (Trans+, Biotin+) 
after AP. In contrast, none of the control samples exhibited any detectable band after AP 
(Figure 4.25). This result demonstrated that monomeric avidin agarose was a viable option 
for AP of the biotinylated proteins owing to its desired specificity and the mild elution 
conditions, the latter of which eliminated potential inference from avidin monomers. 
Figure 4.25 Sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) of the biotinylated 
lysozyme C before (left) and after (right) affinity purification with monomeric avidin agarose. Trans: 
transamination; M: protein markers. 
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Following the success of AP at the protein level, monomeric avidin agarose was also 
employed to enrich the biotinylated N-terminal peptides of lysozyme C and BSA after 
protease digestion. However, the biotinylated N-terminal peptide was not detected by LC-
MS/MS after AP for either protein. Instead, the native N-terminal peptide of lysozyme C and 
a number of internal peptides were still detected, as reflected by the protein sequence 
coverage (Figure 4.26). These results might point to the difficulties in completely removing 
internal peptides even using a positive selection strategy.  
 
Figure 4.26 Sequence coverage of the putative biotinylated lysozyme C (upper) and BSA (lower) after 





It should also be noted that a plethora of confounding factors can influence the 
detection/non-detection of a peptide ion, including its abundance, ionisation/fragmentation 
efficiency, and so on (Li et al., 2010). These confounding factors manifest as the peptide 
“flyability” (a generic term used to describe the intrinsic detectability of the peptide), which 
has recently been mathematically interpreted using absolute quantitation data of the yeast 
proteome (Jarnuczak et al., 2016). Therefore, the contaminating internal peptides might 
have higher “flyability” and thus dominated the LC-MS/MS results even if they had been 
reduced in abundance after AP. Possibly due to the lower “flyability”, the biotinylated N-
terminal peptides might have been out-competed by the internal peptides for ionisation 
even if they had been enriched by AP, which in principle also explains the absence of such 
peptides in the LC-MS/MS results. 
In response to these negative results, error-tolerant searches were performed again to 
identify any biotinylated N-terminal peptide in the enriched samples. Potentially such 
peptides were undetectable due to unsuspected further modifications. Although there were 
no reliable search hits for the biotinylated N-terminal peptide of lysozyme C, the putative 
biotinylated N-terminal peptide was indeed identified in the BSA dataset (Table 4.14). 
Consistent with the previous results, a mass shift of -44 Da was fitted to the N-terminal 
peptide on top of the intended modification. It strongly supported the conjecture that the N-
terminal D residue of a protein or peptide was decarboxylated after transamination and 
could receive a carbonyl-reactive biotin tag. In addition, a further mass shift of -28 Da was 
also detected, likely indicating a partial loss of the D residue side chain. The outcome of this 
unsuspected modification was the conversion from a carboxyl to a hydroxyl group (i.e. N-




Table 4.14 Result of the Mascot error-tolerant search for the biotinylated N-terminal peptide of BSA 
after affinity purificationa. 
Peptide-Spectrum Match         
(Start – End) 
m/z MW ppm Score 
Duplicate 
PSM No. 
Internal peptides (Reference) 
LVNELTEFAK (42 – 51) 582.3142 1162.6234 -8.27 51  
CASIQKFGER (199 – 208)                                     
+ Carbamidomethyl (C) 
598.2927 1194.5815 -9.01 50 2 
Putative biotinylated N-terminal peptides 
DTHKSEIAHR (1 – 10) + Biotin                     
(N-term); -44 Da 
782.8916 1563.7828 -8.97 49 8 
DTHKSEIAHR (1 – 10) + Biotin                     
(N-term); -28 Da 
527.5950 1579.7777 -9.27 20  
a Orbitrap RAW data were processed and searched in Mascot twice, with cysteine (C) 
carbamidomethylation set as either a fixed or variable modification. Both Mascot searches showed 
the same result, which was edited to show a single PSM for each putative biotinylated N-terminal 
peptide. Two internal peptides that were confidently identified in the same experiment are also 
included as reference. Peptide score ≥ 13 indicates identity. m/z: mass-to-charge ratio; MW: molecular 






In addition to negative selection strategies such as NHS-Sepharose, N-terminalomics also 
employs positive selection strategies to retain peptides that can shed light on the identity of 
true protein N-termini. Similar to the Subtiligase and O-methylisourea methods that fall in 
this category, selective transamination also aimed to achieve the enrichment and 
identification of protein N-termini by exploiting the semi-unique reactivity of protein α-
amino groups. In principle, this reaction presents clear advantages over the other methods. 
Compared to N-CLAP and O-methylisourea, selective transamination modifies free protein N-
termini in a single step and does not target ε-amino groups on K side chains. Contrary to the 
Subtiligase method, selective transamination employs a simple combination of small 
molecules instead of a proprietary enzyme. 
To our knowledge, selective transamination has not been utilised at the proteome level to 
study protein N-termini (or for other purposes). A positive selection strategy was thus 
proposed by our group in view of the initial reports from Sonomura et al. (2009a) that this 
reaction could be employed for negative selection of the N-terminal peptides of several 
model proteins. To achieve the positive selection of N-terminal peptides, selective 
transamination was performed in conjugation with carbonyl-specific biotinylation and AP. 
Ultimately, this approach can be used to enrich and identify both free protein N-termini and 
protease cleavage products. 
As illustrated in Figure 4.2, the proposed scheme of this approach consisted of five major 
stages: I. conversion of N-terminal α-amino groups to carbonyl groups through selective 
transamination; II. attachment of biotin affinity tags to the resulting carbonyl groups using 
carbonyl-specific biotin reagents; III. digestion of the biotinylated proteins into peptide 
mixtures using appropriate proteases; IV. enrichment of the biotinylated peptides using 
immobilised avidin resins; V. identification of protein N-termini by LC-MS/MS.  
The proposed approach shared several similarities with other positive selection strategies. 
For instance, all the positive selection strategies take advantage of the biotin-avidin 
interactions to enrich for N-terminal peptides, despite that biotinylation is achieved through 
different chemistries. Ideally, selective transamination should be directly followed by AP that 
exploits the newly introduced carbonyl group. However, this is currently limited by the 
choice of carbonyl-specific reagents. As an immobilised carbonyl scavenger, tosylhydrazine 
glass represents one of the few options for direct capture of peptides with carbonyl groups 
(Sonomura et al., 2011). But this reagent is not easily accessible and can only be used in a 
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negative selection fashion (i.e. permanent depletion of peptides with carbonyl groups). In 
contrast, biotin tags are widely used for AP because of the highly specific and tight binding 
between biotin and (strept)avidin, as well as the well-defined measures to elute the 
captured proteins/peptides afterwards. Furthermore, biotin tags are readily available in 
several carbonyl-specific forms. Accordingly, immobilised avidin/streptavidin beads are used 
for AP in all positive selection strategies, including our proposed scheme. 
To evaluate the feasibility of selective transamination for tagging protein N-termini and AP, 
systematic tests were conducted at two different levels – peptide and protein. First, synthetic 
peptides were employed to characterise the reaction products of transamination in a timely 
fashion. In addition, the peptide test also served to analyse the products of further carbonyl 
modifications, including biotin tagging. The peptide test paved the way for the subsequent 
experiments using individual model proteins, which were divided into two parts. The first 
part of the protein test employed dot blotting and SDS-PAGE to assess the biotin tagging and 
AP of intact proteins. The second part was equivalent to the peptide test, but the synthetic 
peptides were replaced by a mixture of proteolytic peptides from the digested model 
proteins. LC-MS/MS was the primary technique to assess the biotin tagging of protein N-
termini and AP. 
It should be noted that the order in which the experiment results were presented in this 
chapter does not necessarily reflect the chronological order in which the experiments were 
carried out. In the current study, the peptide test was conducted in response to the failure to 
identify the N-termini of model proteins that were tagged with hydrazide-biotin. Initially, this 
biotin reagent was preferred due to the simplicity and low cost. However, the biotinylated 
protein N-termini could not be identified by standard Mascot database searches after the 
treatment with hydrazide-biotin. As a result, this biotin tag was replaced by two 
alkoxyamine-based reagents. A thiol-cleavable biotin tag (alkoxyamine-PEG4-SS-PEG4-biotin) 
was employed for the peptide test but then deemed unsuitable for the protein test due to 
the following reason: this reagent is incompatible with the full denaturation of proteins, 
which requires the use of DL-dithiothreitol (DTT) to reduce disulfide bonds; DTT can also 
cleave off the biotin tag by reducing the thiol-cleavable linker. Consequently, alkoxyamine-
PEG4-biotin (without the thiol-cleavable linker) was used instead for the protein test.  
Human ACTH (amino acid sequence: SYSMEHFRWG; MW: 1298.55 Da) and rat renin 
substrate (DRVYIHPFHLLYYS; MW: 1821.92 Da) are two synthetic peptides employed in the 
peptide test. According to the base peak chromatograms, selective transamination converted 
each peptide to a mixture of reaction products. In principle, selective transamination leads 
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to a net mass shift of -1.03 Da due to the removal of both the α-amino group and a hydrogen 
atom and then the addition of an oxygen atom to the α-carbon (Figure 4.27A). For both 
peptides, the correct transamination product was detected with the expected mass shift of -
1.03 Da. However, the +74 Da by-products were also identified after the transamination of 
both peptides. As described by Sonomura et al. (2009b), formation of such by-products “can 
be explained by the addition of glyoxylate (before dehydration to the Schiff base)” where 
glyoxylate is the amino acceptor and the Schiff base is suggested as a +56 Da by-product 
(Figure 4.27B). Another side product of rat renin substrate was also identified with a mass 
shift of -45 Da, which may be explained by the decarboxylation of the N-terminal D residue 
(Figure 4.27C; Gilmore et al., 2006). It should be noted that the decarboxylated peptide has 
also undergone transamination (mass shift = -1.03 Da), which explains the net mass shift of -
45 Da instead of -44 Da (due to decarboxylation alone). 
 
Figure 4.27 Chemical structures of the products of selective transamination on proteins/peptides. (A) 
The expected product of selective transamination with a mass shift = -1.03 Da. (B) The by-products 
resulting from glyoxylate addition (mass shift = +74 Da) and then Schiff base formation (mass shift = 
+56 Da). (C) The decarboxylation side product (mass shift = -45 Da, for N-terminal aspartate residue 




Prior to biotin tagging, another carbonyl-reactive compound, namely BnONH2, was first 
employed to survey the chemical reactivity of the transaminated peptides. In previous 
studies on selective transamination, treatments with alkoxyamine compounds such as 
BnONH2 were routinely performed to block the reactive carbonyl groups as they readily 
dimerised through aldol reactions (Papanikos et al., 2001). After selective transamination 
and treatment with BnONH2, both human ACTH and rat renin substrate exhibited the 
expected mass shift (+104.03 Da) when compared to their native counterparts. As revealed 
by XIC, both the BnONH2-modified human ACTH and rat renin substrate were detected as a 
pair of peaks with slightly different signal intensities, which was likely due to the 
stereochemistry of the reaction products. The two stereoisomers might be produced in 
unequal quantities and separable by LC (Bachmann and Barton, 1938, Matlin et al., 1990). 
Consistent with the report by Gilmore et al. (2006), BnONH2 was also attached to the 
decarboxylated rat renin substrate since it also possessed a reactive carbonyl group (Figure 
4.27C). In contrast, the +74 Da by-product was not modified with BnONH2, confirming that 
this by-product did not contain any reactive carbonyl groups. 
The newly imposed carbonyl group at the N-terminus of a transaminated peptide was then 
exploited for biotin tagging. As discussed above, an alkoxyamine-biotin tag was employed in 
the peptide test and was demonstrated to afford specific tagging of the transaminated N-
terminus of human ACTH. In contrast, the biotinylated rat renin substrate could not be 
identified by the Mascot search. The biotinylated peptide was suggested by the error-
tolerant search to exhibit additional mass shifts (e.g. -44 Da) due to decarboxylation or other 
unsuspected modifications. The large extent of decarboxylation may account for the failure 
to identify the expected biotinylation product of rat renin substrate. In addition, from a 
pragmatic viewpoint it is clear that transamination did not proceed with high efficiency on all 
substrates. Therefore, the yield of transamination may be another limiting factor in the 
identification of such peptides.  
The difficulties in identifying the expected biotinylated peptides may also lie in precursor ion 
fragmentation. The tandem mass spectrum of the biotinylated human ACTH showed an 
unidentified fragment ion (m/z = 270.13, z = 1) with high intensity in addition to the peptide 
backbone fragments (y3 – y8). It was proposed that this fragment ion signified the cleavage of 
the attached biotin tag itself, which contains a linker region known to easily fragment (Figure 
4.28; Tutturen et al., 2013). Cleavage of the biotin tag did not interfere with the identification 
of the biotinylated human ACTH as it solely relied on the assignment of y-series ions, which 
in theory should not contain the biotin tag. In contrast, the biotin tag cleavage would 
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significantly impact the identification of the biotinylated rat renin substrate since b-series 
ions would be predominant in this case. The fragment ion at m/z = 270.13 was exploited by 
Tutturen et al. (2014) as a marker ion to aid in confident peptide identification. Similarly, a 
recent proteomic study on protein biotinylation used a different set of marker ions derived 
from biotin tag cleavage to identify biotinylated peptides (Udeshi et al., 2017). 
 
Figure 4.28 (A) Proposed cleavage of an alkoxyamine-biotin tag (e.g. alkoxyamine-PEG4-biotin) 
attached to the N-terminus of a transaminated protein/peptide. The m/z value of the putative 
cleavage product is 270.13 (z = 1). (B) Similar fragmentation of biotin-PEG2-4-glyoxalbenzoic acid (a 
citrulline-reactive biotin tag), as proposed by Tutturen et al. (2014). The cleavage sites are indicated 
by the blue lines. ○P : a protein or peptide; m/z: mass-to-charge ratio; PEG: polyethylene glycol.  
The partial success of the peptide test was also translated to the subsequent test on two 
model proteins: lysozyme C and BSA. With the knowledge acquired from the peptide test, 
the BnONH2-modified N-terminal peptide of each protein was identified by Mascot searches 
using a pre-defined mass shift of +104.03 Da. In addition, an error-tolerant search suggested 
that the decarboxylated N-terminal peptide of BSA was also amenable to BnONH2 
modification. As explained above, the carbonyl groups introduced by transamination 
immediately require further blocking due to their susceptibility to aldol-type dimerisation. It 
is less of a problem for the transaminated peptides, which can be analysed in a timely 
fashion. However, the transaminated proteins were subjected to prolonged incubation (i.e. 
protein denaturation and proteolysis) before LC-MS/MS. Dimerisation of the transaminated 
N-termini might thus become significant. Blocking with BnONH2 helped to resolve this issue, 
despite at the risk of a greater sample loss due to a second reaction and purification step. 
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In spite of the success with BnONH2 modification of the transaminated protein N-termini, 
initial attempts to identify the protein N-termini tagged with hydrazide-biotin were proven 
largely unsuccessful. The negative result from the LC-MS/MS analysis may be partially 
rationalised by the low yields of transamination and biotin tagging. Incomplete 
transamination has been discussed above. With respect to biotin tagging, hydrazide-biotin 
was shown to have the lowest tagging efficiency among the four biotin reagents tested by 
Coffey and Gronert (2016). In comparison, the tagging efficiency of hydrazide-biotin was only 
25 % relative to that of the best performer, i.e. alkoxyamine-PEG4-SS-PEG4-biotin.  
Interestingly, dot blotting showed an opposite result of tagging the transaminated protein N-
termini with hydrazide-biotin. The discrepancy between the LC-MS/MS and dot blotting 
results may be explained in two ways. First, the biotinylated N-termini might have undergone 
unsuspected modifications that conferred additional mass shifts. For lysozyme C, an error-
tolerant search indeed assigned putative biotinylated N-terminal peptides, which had also 
undergone carbamylation, carbamidomethylation, etc. In the test with model proteins, 
lysozyme C and BSA were routinely denatured in urea solution to facilitate selective 
transamination. It is well acknowledged that urea solution can cause carbamylation of K, 
arginine (R), and protein N-termini, especially at elevated temperatures (Sun et al., 2014). 
Meanwhile, excess iodoacetamide likely caused carbamidomethylation of K, methionine (M), 
or histidine (H) residue (Boja and Fales, 2001). Therefore, such assignments may be genuine, 
and caution should be exercised when using urea or iodoacetamide in future experiments.  
Second, the hydrazone bond formed between the carbonyl group and hydrazide-biotin might 
have dissociated before LC-MS/MS analysis. Shi et al. (2015) reported that hydrazone bonds 
were labile to hydrolysis in mild acidic environments (pH < 5). After protease digestion, the 
biotinylated N-terminal peptides were indeed exposed to formic acid (0.1 – 0.5 %, v/v) 
during sample preparation and LC-MS/MS. This acidic environment might have caused 
accidental release of the biotin tag so that the biotinylated protein N-termini could not be 
identified. In comparison, oxime bonds formed by the reaction between alkoxyamines and 
carbonyl groups are more resistant to acid-catalysed hydrolysis (Kalia and Raines, 2008). 
Through direct comparisons of the hydrolytic stability between oxime and hydrazone 
linkages, the authors concluded that oxime bonds were nearly 103-fold more stable than the 
equivalent hydrazone bonds. In view of this claim and that alkoxyamines outperformed their 
hydrazide counterpart in tagging protein carbonyl groups (Coffey and Gronert, 2016), 
hydrazide-biotin was replaced by alkoxyamine-PEG4-biotin to tag the transaminated protein 
N-termini. Again, the success with biotin tagging was supported by the dot blotting results. 
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Following the confirmation of biotin tagging on intact proteins, protease digestion and LC-
MS/MS were performed once again in order to identify the biotin-tagged protein N-termini. 
Mascot searches identified the biotinylated N-terminal peptide for both lysozyme C and BSA, 
demonstrating the feasibility of the selective transamination approach for tagging protein N-
termini. However, it should be noted that Nt-biotinylation was very difficult to identify in the 
case of lysozyme C and the identification was less reliable than that for BSA. This issue may 
be related to the low quality of the corresponding tandem mass spectra as well as the 
efficiency of transamination on N-terminal K residues, the latter of which has been reported 
to be very low (Sonomura et al., 2009b). With respect to BSA, the decarboxylated protein N-
termini were also amenable to biotin tagging through oxime bond formation.  
The success with protein Nt-biotinylation led to the final test: enrichment of the biotin-
tagged N-terminal peptides by AP. This test was divided into two parts: the first part involved 
intact protein AP where the biotinylated proteins were directly purified by immobilised 
avidin resins and analysed by SDS-PAGE; the second part required protease digestion of the 
biotinylated proteins, and the resulting peptides were subjected to AP and LC-MS/MS. 
Initially, NeutrAvidin agarose was the preferred avidin resin for enriching the biotinylated 
BSA. SDS-PAGE revealed that the biotinylated BSA could be enriched by this avidin resin. 
However, it was considered to be unsuitable for the test on lysozyme C since the denaturing 
conditions to elute the bound proteins likely caused the dissociation of tetrameric 
NeutrAvidin into monomers, which could interfere with the analysis of lysozyme C by SDS-
PAGE. As a substitute for NeutrAvidin agarose, monomeric avidin agarose was demonstrated 
by SDS-PAGE to provide effective enrichment of the biotinylated lysozyme C.  
An interesting observation from the above results was the detection of a biotin 
signal/protein band in a negative control (biotinylation-only) by dot blotting and SDS-PAGE, 
respectively. Protein tagging and AP often suffer from nonspecific reactions (Dubrovska, 
2009). In addition, endogenously biotinylated proteins present a further source of 
interference with the biotin-(strept)avidin system (Tytgat et al., 2015). However, it was 
postulated that specificity was not the primary issue in this case. Neither was natural protein 
biotinylation, since lysozyme C and BSA are not endogenously biotinylated according to the 
Swiss-Prot annotations. Instead, the presence of the biotin signal/protein band may be 




Carbonylation is a major form of oxidative modification caused by both physiological (e.g. 
redox signalling) and pathological (e.g. oxidative damage) processes (Wehr and Levine, 
2012). Previous studies have shown that K, R, proline (P), threonine (T), and tryptophan (W) 
residues are the primary sites of in vivo protein carbonylation (Cabiscol et al., 2014). 
However, the chemical structures of such carbonylated residues can be highly complex as a 
result of the multiple routes for protein carbonylation: I. peptide backbone cleavage; II. side 
chain oxidation; III. attachment of carbonyl-containing lipids; IV. protein glycoxidation, i.e. 
the combination of glycation and further oxidation (Fedorova et al., 2014). For simplicity, 
only the products of side chain oxidation are shown in Figure 4.29. 
 
Figure 4.29 Chemical structures of carbonylated lysine (K), arginine (R), proline (P), threonine (T), and 
tryptophan (W) residues. The names of the carbonylation products are indicated in parentheses. 
In the present study, however, the most likely cause of spontaneous protein carbonylation is 
the long-term storage of the purified proteins in the presence of air. Background 
carbonylation was indeed detected in other commercial proteins, supporting the above 
argument (Coffey and Gronert, 2016). Nevertheless, spontaneous protein carbonylation may 
become less of an issue when proteins are prepared freshly, especially in the presence of 
reducing agents and metal ion chelators (Rogowska-Wrzesinska et al., 2014). 
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The second part of the final test was to identify the biotinylated N-terminal peptides after 
positive selection by AP. However, the success with the protein AP could not be reproduced 
at the peptide level. For BSA, only internal tryptic peptides were identified by the Mascot 
search after AP. Meanwhile, internal peptides and the native N-terminal peptide were 
identified in the lysozyme C samples after AP. The detection of internal peptides after AP 
may reflect an inadequate washing step, undesired specificity of this avidin resin, or simply 
the higher “flyability” of such peptides compared to the biotinylated N-terminal peptides. 
Nonetheless, an error-tolerant search identified the biotinylation product of the 
decarboxylated N-terminal peptide of BSA. 
In conclusion, the present study employed a systematic test at both the peptide and protein 
levels to evaluate the feasibility of selective transamination for tagging and enriching the N-
termini of proteins. One of the model peptides, human ACTH (with an N-terminal S residue), 
was readily transaminated and tagged with alkoxyamine-based biotin at the N-terminus, 
despite the presence of reaction by-products (e.g. mass shift = +74 Da). This result is in 
agreement with the previous findings that the transamination of N-terminal S residues was 
efficient (Sonomura et al., 2009b). On the other hand, it proved to be difficult to obtain the 
same result on rat renin substrate and the N-terminal peptide of BSA, both starting with a D 
residue. This is likely due to the decarboxylation of such peptides to a large extent. Using 
error-tolerant searches, the decarboxylated peptides were suggested to react with the 
alkoxyamine-based biotin tag. In addition, the N-terminal peptide of lysozyme C (with an N-
terminal K residue) was also amenable to transamination and biotin tagging, but the 
detection of this peptide in its native state even after AP suggests that the transamination of 
this peptide was incomplete. Indeed the N-terminal K residue was suggested to be one of the 
residues that were difficult to transaminate (Sonomura et al., 2009b). 
To our knowledge, this study may represent the development of the first N-terminalomic 
technique that employs carbonyl-reactive chemistry. However, the present study also 
revealed major issues in the selective transamination approach, namely the yields of 
transamination and biotin tagging. Due to time constraints, these issues were not thoroughly 
investigated in a systematic manner. Therefore, future studies should focus on improving the 
reaction yields and minimising sample loss during protein purification. Experiment 
parameters to be refined include: I. the concentration of the protein substrate, the amino 
acceptor, the metal ion catalyst, and the base; II. reaction duration and temperature; III. 
addition of a metal ion chelator after transamination; IV. use of alternative protein 
purification techniques.  
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In addition, the biotin tagging and AP need to be optimised as well. Since the pH of biotin 
tagging (6.5) was empirically determined, the refinement of this parameter should be 
emphasised. In the present study, protein and peptide AP produced mixed results: although 
effective AP of the biotinylated proteins was achieved, the same procedure on proteolytic 
peptides only showed high background binding but not the enrichment of the biotinylated 
N-terminal peptides. This procedure should benefit from the use of immobilised avidin beads 
with minimal nonspecific binding (i.e. NeutrAvidin agarose) and a biotin tag that can be 
conveniently eluted, including cleavable biotin tags (other than the thiol-cleavable ones) and 
modified biotin tags with a reduced affinity (e.g. desthiobiotin). This combination is also 
preferred by other positive selection strategies including N-CLAP, O-methylisourea, and 
Subtiligase (Xu and Jaffrey, 2010, Timmer and Salvesen, 2011, Wiita et al., 2014). 
Since selective transamination and biotin tagging produced heterogeneous products, the 
current spectral acquisition method and data analysis settings should be modified to account 
for additional mass shifts. Specifically, identification of the biotin-tagged peptides should 
benefit from targeted proteomics that screens for the potential marker ion at m/z = 270.13. 
Since the marker ion likely results from the cleavage of an attached biotin tag, any precursor 
ion that gives rise to this fragment ion (with high intensity) may correspond to a biotin-
tagged peptide. For instance, Tutturen et al. (2014) took advantage of this marker ion to 
show that the combination of a citrulline-reactive biotin tag and streptavidin beads provided 
effective enrichment of citrullinated peptides: ≥ 95 % of the resulting tandem mass spectra 
contained the marker ion at m/z = 270.13, which was only present in 1 % of the tandem mass 
spectra in the control group (i.e. without enrichment). The importance of diagnostic marker 
ions has also been highlighted by the recent study that employed biotin-specific antibodies 
to enrich and globally identify biotinylated peptides (Udeshi et al., 2017). 
In view of the difficulties to enrich for the biotinylated protein N-termini under the current 
conditions, the original scheme of the selective transamination approach was modified to 
exclude the AP step for subsequent experiments. Therefore, the modified approach only 
included four steps: transamination, biotinylation, protease digestion, and LC-MS/MS 
analysis. As described in Chapter 5, the modified approach was applied on a highly complex 
mixture of proteins (extracted from Jurkat T-lymphocytes) in order to globally identify 
protein N-termini. In addition, the feasibility of selective transamination for improving the 
proteome coverage by shotgun proteomics was also evaluated. 
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Chapter 5. Use of the transamination approach in shotgun proteomics 
5.1 Introduction 
Jurkat T-lymphocytes are a cancer cell line established from a patient with acute T-cell 
leukaemia (Schneider et al., 1977). With an exceptional ability to synthesise interleukin-2 (IL-
2), Jurkat T-cells have been used primarily as a model system to dissect the molecular 
mechanism associated with T-cell receptor (TCR) signalling pathways (reviewed in Weiss and 
Stobo, 2015). For instance, Jurkat T-cells played a pivotal role in identifying the two-stimulus 
requirement for human T-cell activation (Weiss and Stobo, 1984). A variety of mutant cell 
lines have also been derived from wild-type Jurkat T-cells to further study the signalling 
cascades upon T-cell activation (Abraham and Weiss, 2004). To date, more than 17,000 
references for “Jurkat” are documented in PubMed.  
As described in Chapter 4, a “positive selection” N-terminalomic strategy was devised on the 
basis of selective transamination. This approach was then systematically investigated using 
model peptides and proteins. As demonstrated by these tests, the transamination approach 
can be employed to specifically attach an affinity tag to the amino (N)-terminus of a peptide 
or protein. In principle, the N-terminal tag can facilitate positive selection and unambiguous 
identification of true protein N-termini through mass spectrometry (MS)-based proteomics. 
In addition to model peptides and proteins, the development of this approach requires 
further tests on a biological system that serves as a more complex model. The results of such 
tests will shed light on the feasibility of this approach for proteome-wide analysis.  
Jurkat T-cells are an ideal source of complex proteomes as they have been experimentally 
verified to express > 8,000 proteins (Geiger et al., 2012). In addition, these cells are robust 
and simple to handle in laboratory, and their expansion rate is high (population doubling 
time = 48 hours). Compared with the classical biochemical studies mentioned above, the 
proteomic analysis of this cell line is a more recent topic well into the post-genomic era 
(Kang et al., 2005). Given the importance of (de)phosphorylation events in cell signalling, 
Jurkat proteomics mainly focuses on the identification of proteins affected by this post-
translational modification (PTM) and the changes in their phosphorylation states (Nguyen et 
al., 2016). In contrast, a comprehensive analysis of the Jurkat T-cell proteome seems to have 




With respect to N-terminalomics, Jurkat T-cells have served as a robust model system of 
apoptosis to demonstrate the feasibility of several positive and negative selection 
approaches for global mapping of proteolytic processing events (described in section 1.5). 
These N-terminalomic approaches include N-terminal COFRADIC (combined fractional 
diagonal chromatography), N-CLAP (N-terminalomics by chemical labeling of the α-amine of 
proteins), and Subtiligase (reviewed in Plasman et al., 2013). In addition to proteolytic 
processing, the extent of N-terminal methionine excision (NME) in the Jurkat proteome was 
also surveyed using the N-CLAP approach (Xu et al., 2009). These studies demonstrated the 
utility of Jurkat T-cells in the development of N-terminalomic approaches.  
For the above reasons, Jurkat T-cells were also employed for testing the transamination 
approach. The present study sought to combine this approach with liquid chromatography–
tandem mass spectrometry (LC-MS/MS) in order to identify the N-termini of proteins 
expressed in Jurkat T-cells. This study was carried out with a clear emphasis on the 
identification of “free” protein N-termini, which refer to those without any PTMs. Similar to 
the previous tests with model proteins, Jurkat proteins were also transaminated under the 
“salt-free” condition (Sonomura et al., 2009a), but urea was replaced with guanidine 
hydrochloride (HCl) to avoid protein carbamylation (see sections 2.8 & 4.3). 
Additionally, it is well known that undersampling is currently a major problem in shotgun 
proteomics (Wang et al., 2010). This is partly because of the wide range of protein 
concentration in certain proteomes. In the shotgun analysis of such proteomes, peptide ions 
derived from highly abundant proteins dominate over the low-abundance ones when 
conventional data-dependent acquisition (DDA) is adopted. In certain types of protein 
samples, e.g. unfractionated blood plasma, up to 50 % of the MS machine time is spent 
analysing just 22 proteins, which account for 99 % of the blood proteome by mass (Wildes 
and Wells, 2010). A related issue is that certain peptides are not detected by LC-MS/MS, e.g. 
due to their “stickiness” which may cause them to adhere to surfaces prior to MS (Maes et 
al., 2014), or because they ionise poorly (Mirzaei and Regnier, 2006).  
Therefore, a second aim of the present study was to test the idea that transamination on a 
mixture of proteolytic peptides may help overcome the undersampling problem and thus 
increase proteome sequence coverage. Specifically, the two hypotheses are: I. with peptide 
transamination, shotgun proteomics will identify a different but overlapping set of Jurkat 
proteins relative to those identified without this treatment; and II. combining these two 
datasets will expand the surveyed Jurkat proteome. Peptide transamination also followed 




5.2.1 Experiments with complex protein mixtures from Jurkat T-cells 
Experiments using model peptides and proteins were detailed in Chapter 4. The present 
chapter will describe an investigation of selective transamination on a complex mixture of 
proteins that were extracted from Jurkat T-cells. Jurkat cell cultures were maintained in our 
lab and their morphology was routinely verified by microscopy (Figure 5.1). 
 
Initially, crude protein extracts from Jurkat T-cells were subjected to selective transamination 
immediately after the estimation of protein concentrations using a bicinchoninic acid (BCA) 
assay. After transamination, the crude protein samples were allowed to react with 2,4-
dinitrophenylhydrazine (DNPH), which is routinely used in determining protein carbonyl 
content (Wehr and Levine, 2012). The carbonyl content in the treated sample (Trans+, 
DNPH+) and three negative controls (native protein, DNPH-only, and transamination-only) 
was quantified by a spectrophotometric assay that measures the absorbance at 370 nm 
(A370). However, the result of the DNPH assay showed uniform A370 readings across all four 
samples (data not shown). 
Through a literature search, genomic DNA fragments that remained in the crude Jurkat 
protein extracts were identified as a potential source of interference in the DNPH assay. 
Previous studies have established that DNA is carbonyl-positive and thus readily reacts with 
Figure 5.1 Representative microscopic image of 
Jurkat T-cells at low density (1 x 105 cells/ml). 
Scale bar = 50 µm.  
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DNPH (Luo and Wehr, 2009). Therefore, contamination with sheared genomic DNA likely 
rendered the DNPH assay an ineffective measurement of carbonyl content in the crude 
Jurkat protein extracts. More importantly, the remaining DNA fragments also had the 
potential to interfere with downstream modifications (e.g. biotin tagging) of the carbonyl 
groups introduced by transamination.  
In view of the risks posed by these DNA fragments, the crude protein extracts were treated 
with DNase I and then subjected to gel filtration (7K MWCO) to remove genomic DNA. 
Samples of the Jurkat protein extracts with or without DNA removal were compared by 
agarose gel electrophoresis. As shown in Figure 5.2, genomic DNA was readily detected in 
the crude protein extracts as smearing bands on the gel before treatment with DNase I. After 
the treatment, such bands were nearly absent in the protein sample. Based on this result, it 
was concluded that the DNase I-treated protein samples were free from genomic DNA 
interference and could be used for further analyses. 
 
 
Figure 5.2 Gel electrophoresis of genomic DNA 
in crude Jurkat protein extracts before and after 
DNA removal with DNase I. Equal amounts of 
the protein samples (based on protein 
concentration estimation) were separated on a 
1 % (w/v) agarose gel, and then stained with 
GelRed. bp: base-pair. 
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The DNA-free protein samples were again transaminated and treated with DNPH, but the 
A370 assay for protein carbonylation quantitation was replaced by dot blotting, which used an 
antibody specific for dinitrophenol groups. As shown in Figure 5.3, the dot blotting results 
showed that the dinitrophenol signal was detected in the treated sample (Trans+, DNPH+) 
with high intensity. In contrast, three negative controls, i.e. native protein (Trans-, DNPH-), 
DNPH-only (Trans-, DNPH+), and transamination-only (Trans+, DNPH-) merely exhibited weak 
dinitrophenol signals. These results were largely consistent with those from the previous 
tests with chicken egg-white lysozyme (lysozyme C) and bovine serum albumin (BSA), which 
were also DNA-free (see Figures 4.17 & 4.19). In conclusion, selective transamination was 
also capable of introducing carbonyl groups to a complex mixture of proteins extracted from 
a cell line, and DNA removal was required for eliminating any interference with the detection 
of the introduced carbonyl groups. 
 
Figure 5.3 Dot blotting of the transaminated and DNPH-treated proteins that were extracted from 
Jurkat T-cells. In addition to the treated sample (Trans+, DNPH+), three analysed negative controls are: 
native protein (Trans-, DNPH-), DNPH-only (Trans-, DNPH+), and transamination-only (Trans+, DNPH-). 
Trans: transamination; DNPH: 2,4-dinitrophenolhydrazine; DNP: dinitrophenol groups. 
Having established that selective transamination could be employed to introduce carbonyl 
groups to Jurkat protein extracts, the DNase I-treated protein samples were transaminated 
and the resulting carbonyl groups at protein N-termini were tagged using a carbonyl-specific 
biotin reagent (Figure 5.4). The biotin-tagged proteins were then analysed by sodium 




Figure 5.4 Strategy used for selective transamination of proteins in complex mixtures. The workflow 
consists of five major steps: I. selective transamination; II. carbonyl-specific biotinylation; III. SDS-PAGE 
and Western blotting; IV. protease digestion; V. LC-MS/MS analysis. The red labels indicate new 
chemical groups introduced by selective transamination or protease digestion, whereas the hatched 
circles indicate the N-terminal biotin tags introduced through carbonyl-reactive chemistry (i.e. oxime 
bond formation). SDS-PAGE: sodium dodecyl sulfate–polyacrylamide gel electrophoresis; LC-MS/MS: 
liquid chromatography–tandem mass spectrometry. 
In each case, after transamination and tagging with alkoxyamine-PEG4-biotin, a BCA assay 
was carried out on the protein samples to estimate protein concentration prior to SDS-PAGE. 
As shown in Figure 5.5 (left), four protein samples were analysed: native protein (Trans-, 
Biotin-), biotinylation-only (Trans-, Biotin+), transamination-only (Trans+, Biotin-), and the 
treated sample (Trans+, Biotin+). Following SDS-PAGE, the same set of protein samples were 
subjected to Western blotting that employed an antibody specific for the biotin tag. The 
objective was to evaluate the efficiency and selectivity of the transamination approach on 
complex protein mixtures. Given that all the Jurkat samples were at the same protein 
concentration, the differences (if any) in the intensity of biotin signals should reflect the 




Figure 5.5 SDS-PAGE (left) and Western blotting (right) of the transaminated and biotin-tagged 
proteins from Jurkat T-cells. The carbonyl-specific biotin reagent used was alkoxyamine-PEG4-biotin. 
Equal amounts of four protein samples were separated on a 10 % NuPAGE™ Bis-Tris gel. The treated 
sample (Trans+, Biotin+) was analysed together with three negative controls: native protein (Trans-, 
Biotin-), biotinylation-only (Trans-, Biotin+), and transamination-only (Trans+, Biotin-). SDS-PAGE: 
sodium dodecyl sulfate–polyacrylamide gel electrophoresis; Trans: transamination; M: protein 
molecular weight marker. 
As expected, the biotin signal was absent in the two protein samples without biotin tagging, 
i.e. native protein (Trans-, Biotin-) and transamination-only (Trans+, Biotin-). In contrast, the 
signal was present in one of the negative controls, biotinylation-only (Trans-, Biotin+). 
However, the biotin signal was detected in the treated sample (Trans+, Biotin+) with much 
higher intensity (Figure 5.5, right). These results were consistent with those obtained via dot 
blotting of the biotin-tagged model proteins (see Figures 4.17 & 4.19). Therefore, selective 
transamination was confirmed to enable the addition of carbonyl-specific biotin tags to the 
N-termini of proteins in a complex mixture (e.g. Jurkat whole-cell extracts). 
Having tested the transamination approach on Jurkat protein extracts through SDS-PAGE and 
Western blotting analyses, this approach was then applied to study two aspects of the Jurkat 
T-cell proteome: identification of free or acetylated protein N-termini, and comprehensive 
profiling of the Jurkat proteome by shotgun proteomics. 
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5.2.2 Proteomic identification of the N-termini of Jurkat proteins using selective 
transamination 
MS-based proteomic analyses are routinely performed for various cell and tissue types in our 
group. Without prior fractionation or derivatisation, a collection of > 1,000 proteins can be 
robustly identified using the shotgun approach. MS-based proteomics is particularly well 
suited to detecting different types of protein PTMs on top of protein identification. In terms 
of T-cells, proteomic studies have mainly focused on the identification of protein 
phosphorylation, since this reversible PTM plays a key role in the TCR  signalling switched on 
by T-cell activation (Huse, 2009). 
On the other hand, PTMs at protein N-termini have not been well studied in Jurkat T-cells. 
Previous studies mainly employed N-terminalomic strategies to profile NME in the Jurkat 
proteome and to identify neo-N-termini that are indicative of proteolytic processing events 
(Van Damme et al., 2005, Xu et al., 2009). In contrast, proteins with free N-termini are 
relatively neglected since they only account for < 20 % of all human proteins (Giglione et al., 
2015). In principle, selective transamination is a promising strategy to identify free protein N-
termini when combined with carbonyl-specific biotin tagging. The irreversibly attached biotin 
tag could aid in the unambiguous identification of free protein N-termini. 
In the present study, a transamination experiment was carried out in which Jurkat proteins 
were subjected to selective transamination and then tagged with alkoxyamine-PEG4-biotin, 
alkoxyamine-PEG4-SS-PEG4-biotin, or O-benzylhydroxylamine (BnONH2) as described before. 
Subsequently, the biotin-tagged/BnONH2-modified proteins were digested with trypsin for 
LC-MS/MS analysis. The resulting LC-MS/MS data (in the Orbitrap RAW format) were 
processed and searched against a local Swiss-Prot database (taxonomy = Homo sapiens) to 
detect biotin tags at the N-termini of Jurkat proteins. N-terminal (Nt)-acetylation was also 
included in the list of variable modifications. In contrast, the transamination step was 
replaced by incubation in ddH2O in the control experiment where a database search was also 
performed to identify Nt-acetylated or free protein N-termini. In both experiments, the 
protein N-termini identified by Mascot were classified according to N-terminal PTMs, which 
will be described in detail later.  
In the control experiment, overall 20,265 tryptic peptides were reliably detected (peptide 
expectation value, E-value ≤ 0.05) from 21 biological replicates (N = 21). Figure 5.6 shows the 
cumulative addition of unique tryptic peptides by each replicate. It suggests that peptide 
detection approached saturation after the 19th replicate analysis. As described previously, it 
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was difficult to perform a pair-wise comparison of the detected peptides for all 21 replicates. 
Nevertheless, a 6-set Venn diagram was drawn to compare the detected peptides between 
every two replicates out of six, which accounted for > 75 % of the total peptide number (see 
Appendix 1). Finally, a total of 1,880 Jurkat proteins were inferred from the detected 
peptides under the “two-peptide rule” (i.e. a protein must be identified on the basis of ≥ 2 
significant peptide hits). 
 
Figure 5.6 Saturation curve of unique tryptic peptides detected by replicate analyses in the control 
experiment. The curve (blue) was fitted to the experimental data through a nonlinear regression 
analysis in R; the total peptide number is indicated by the straight line in black. 
Among the detected peptides, there were 568 N-terminal peptides assigned to 424 different 
proteins. As the local Swiss-Prot database was not featured with protein N-terminal 
annotations, the “N-terminal peptides” were defined here as the peptides starting with the 
first amino acid residue (always methionine, M) or the second one in their canonical 
sequences. Examples of the assigned N-terminal peptides are given in Table 5.1, and their 
respective protein sequences are shown in Figure 5.7. As mentioned above, these protein N-
termini were further divided into two groups according to the state of N-terminal PTMs: 
“free” or “Nt-acetyl”. There were 104 free protein N-termini (from 83 Jurkat proteins) and 





Table 5.1 Examples of N-terminal peptides assigned to Jurkat proteins by Mascot database searchesa. 
The corresponding amino acid sequences are shown in Fig. 5.7. 
Protein Name Swiss-Prot ID N-terminal Peptide (Start – End) Score 
Duplicate 
PSM No. 
Tubulin beta chain TBB5_HUMAN 
(P07437)  
MREIVHIQAGQCGNQIGAK                       
(1 – 19) 
94.23 117 
Actin, cytoplasmic 1 ACTB_HUMAN 
(P60709) 
DDDIAALVVDNGSGMCK                         
(2 – 18) + Acetyl (N-term) 
96.1 64 
a Orbitrap RAW data were processed and searched against the local decoy database (Swiss-Prot, 
taxonomy = Homo sapiens). The N-terminal peptides of tubulin beta chain (Swiss-Prot ID: 
TBB5_HUMAN/P07437) and actin, cytoplasmic 1 (ACTB_HUMAN/P60709) start with the first 
(methionine, M) and the second residues (aspartate, D), respectively. Duplicate PSM No.: number of 
duplicate peptide-spectrum matches (PSM); Acetyl (N-term): N-terminal acetylation. 
 
Notably, the sum of free (83) and Nt-acetylated (346) proteins was larger than the total 
number (424) of Jurkat proteins with assigned N-termini (Nfree + Nacetyl > Ntotal). It led to the 
speculation that the N-termini of some proteins existed in both free and Nt-acetylated 
forms. By comparing these two datasets, five overlapping protein hits were indeed 
identified. These proteins were thus excluded from the list of proteins with free N-termini. 
Since Nt-acetylation is currently regarded as an irreversible PTM (Drazic et al., 2016), this 
result suggested incomplete Nt-acetylation upon the synthesis of nascent proteins.  
Figure 5.7 Amino acid 
sequences of tubulin beta 
chain (Swiss-Prot ID: 
TBB5_HUMAN/P07437) 
and actin, cytoplasmic 1 
(ACTB_HUMAN/P60709). 
The sequences shown in 
red were matched to the 
experimental data by 
Mascot database searches. 
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The remaining 78 proteins in the list were further cross-referenced with their corresponding 
entries in the online Swiss-Prot database, which is featured with N-terminal annotations. The 
N-termini of nine proteins identified in this study were shown to contradict with existing 
database annotations (Table 5.2). As a result, it was concluded that 69 out of the 78 Jurkat 
proteins possessed free N-termini. Two particular Jurkat proteins, cytoplasmic serine-tRNA 
ligase (Swiss-Prot ID: SYSC_HUMAN/P49591) and peptidyl-prolyl cis-trans isomerase FKBP5 
(FKBP5_HUMAN/Q13451), were shown to have undergone NME. These novel discoveries 
were not documented in the Swiss-Prot database.  
Table 5.2 List of the experimentally identified free protein N-termini that conflict with existing N-
terminal annotations in the online Swiss-Prot databasea.  
Protein Swiss-Prot ID                        N-terminal Peptide (Start – End)                       N-terminal PTM 
GSTP1_HUMAN (P09211) MPPYTVVYFPVR (1 – 12) NME 
SRP14_HUMAN (P37108) MVLLESEQFLTELTR (1 – 15) NME 
RNH2C_HUMAN (Q8TDP1) MESGDEAAIERHR (1 – 13)                                 
+ Oxidation 
Nt-acetyl 
LSM4_HUMAN (Q9Y4Z0) MLPLSLLK (1 – 8) Nt-acetyl 
H2B1O_HUMAN (P23527) PDPAKSAPAPK (2 – 12) NME & Nt-acetyl 
FKBP4_HUMAN (Q02790) TAEEMKATESGAQSAPLPMEGVDISPK    
(2 – 28) 
NME & Nt-acetyl 
SAE1_HUMAN (Q9UBE0) VEKEEAGGGISEEEAAQYDR (2 – 21) NME & Nt-acetyl 
DOPD_HUMAN (P30046) PFLELDTNLPANRVPAGLEK (2 – 21) NME & Nt-acetyl 
EIF2A_HUMAN (Q9BY44) APSTPLLTVR (2 – 11) NME & Nt-acetyl 
a Orbitrap RAW data were processed and searched against the local decoy database (Swiss-Prot, 
taxonomy = Homo sapiens). After cross-referencing with the online N-terminal annotations, these 
protein N-termini were removed from the free dataset. PTM: post-translational modification; NME: 
N-terminal methionine excision; Nt-acetyl: N-terminal acetylation. 
In summary, the control group consisted of 415 (69 + 346) instead of 424 Jurkat proteins with 
assigned N-termini (Figure 5.8). They constituted > 20 % of the overall identified proteins. In 
detail, Nt-acetylated proteins (346) and free proteins (69) accounted for 18 % and < 4 % of all 
the identified proteins, respectively. These figures were in stark contrast to those reported 
elsewhere (Giglione et al., 2015). However, this discrepancy drastically diminished when only 
focusing on the 415 proteins with assigned N-termini: 20 % of them were free of N-terminal 




Figure 5.8 Number of Jurkat proteins with assigned N-termini in the control or transamination groups. 
The assigned protein N-termini are divided into “free” and “Nt-acetyl” groups based on their N-
terminal post-translational modifications (PTMs). Nt-acetyl: N-terminal acetylation. 
Proteomic analysis of the transaminated samples (N = 21) initially detected a total of 21,922 
tryptic peptides with high confidence (E-value ≤ 0.05). Similar to the control group, peptide 
detection approached saturation by the 19th round of analysis of the transaminated samples 
(Figure 5.9). Furthermore, a Venn diagram was also drawn to compare the tryptic peptides 
detected by six replicates, which covered > 80 % of the total peptide number (see Appendix 
1). The 21,922 peptides in turn led to the identification of 2,022 Jurkat proteins. Within this 
cohort, 489 N-terminal peptides were identified and assigned to 382 Jurkat proteins. These 
proteins were further divided into four categories according to the state of N-terminal PTMs: 
“free”, “Nt-trans”, “Nt-biotin”, or “Nt-acetyl”. “Nt-trans” referred to the proteins with 
transaminated N-termini or those further modified with BnONH2, whereas the “Nt-biotin” 
group contained the proteins of which the N-termini were biotin tagged following 
transamination. Initially, there were 83 Jurkat proteins identified with free N-termini, 18 Nt-
trans proteins, and 299 Nt-acetylated proteins. In terms of biotin tagging, only 4 out of 22 
Nt-biotin proteins met the stringent criteria (E-value ≤ 0.05; the cognate proteins were 




Figure 5.9 Saturation curve of unique tryptic peptides detected by replicate analyses in the 
transamination experiment. The curve (blue) was fitted to the experimental data through a nonlinear 
regression analysis in R; the total peptide number is indicated by the straight line in black. 
Similar to the control group, the sum of proteins from all four categories was not equal to 
the total number of proteins with assigned N-termini. A hierarchical strategy was thus 
employed to generate a non-duplicate dataset of protein N-termini (Figure 5.10). First, the 
free, Nt-biotin, and Nt-trans proteins were merged to generate a combined free dataset. 
Overlapping protein hits were removed since in principle they were all derived from proteins 
with free N-termini. The combined free dataset was then compared with the Nt-acetyl 
dataset to remove protein hits that existed in both free and Nt-acetylated forms. Finally, 
cross-referencing with the online Swiss-Prot database was performed to remove protein hits 
that contradicted with existing N-terminal annotations. 
Initially, the combined free dataset consisted of 88 Jurkat proteins. Five protein hits were 
then removed from this dataset as they existed in both free and Nt-acetylated forms. Cross-
referencing with the online Swiss-Prot database resulted in further removal of three protein 
hits from the non-duplicate free dataset. These were ribonuclease H2 subunit C 
(RNH2C_HUMAN/ Q8TDP1), SUMO-activating enzyme subunit 1 (SAE1_HUMAN/ Q9UBE0), 
and D-dopachrome decarboxylase (DOPD_HUMAN/P30046). Consequently, there were 80 
Jurkat proteins with free N-termini and 299 Nt-acetylated proteins in the transamination 
group (Figure 5.8). A novel finding was the Nt-acetylation of macrophage migration 




Figure 5.10 Hierarchical strategy used to remove duplicate or conflicting hits in the case of protein N-
termini. Nt: N-terminal; trans: transamination; acetyl: acetylation. 
form. Overall, there were 379 Jurkat proteins with assigned N-termini (80 free + 299 Nt-
acetylated), which was 19 % of the total protein number (2,022) in the transamination group. 
Free and Nt-acetylated proteins accounted for 21 and 79 % of the proteins with assigned N-
termini (or 4 and 15 % of the total proteins), respectively. 
In particular, the transamination approach helped to assign the N-termini of 19 Jurkat 
proteins: 17 in the Nt-trans group and three in the Nt-biotin group (with one overlapping 
protein hit, see below). A further comparison with the free group showed that only three 
protein N-termini were uniquely assigned through the transamination approach (i.e. they 
were absent in the free group). Among them, the N-terminus of tubulin beta-1 chain 
(TBB1_HUMAN/Q9H4B7) was solely detected in the Nt-trans form, whereas the N-terminus 
of 60S ribosomal protein L6 (RL6_HUMAN/Q02878) was only detected after transamination 
and biotin tagging (i.e. exclusive to the Nt-biotin group). The third protein, 60S ribosomal 
protein L32 (RL32_HUMAN/P62910), was present in both the Nt-trans and Nt-biotin groups 
as mentioned above. This result suggested that the N-terminus of this protein could be 
transaminated but the subsequent biotin tagging did not proceed to completion.  
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Finally, the control and transamination data were merged to compile a complete list of Jurkat 
protein N-termini identified in the present study. Overall, 2,275 Jurkat proteins were 
identified and 22 % of them (i.e. 493) were assigned with N-termini (103 free + 390 Nt-
acetylated). Among these 493 proteins, 61 % were identified in both the control and 
transamination groups. In contrast, 23 % of the proteins were unique to the control group 
and the remaining 16 % were exclusive to the transamination group (Figure 5.11 left). 
Regarding the state of N-terminal PTMs, 79 % of these proteins were in the Nt-acetyl group 
and the remaining 21 % possessed free N-termini (Figure 5.11 right). The complete list of the 
assigned protein N-termini is shown in Appendix 3. 
 
Figure 5.11 (Left) Contribution of the transamination approach to the assignment of overall 493 
protein N-termini. (Right) Classification of the 493 assigned protein N-termini according to their N-
terminal post-translational modifications (PTMs): “free” or “Nt-acetyl”. Trans: transamination; Nt-








The complete dataset of the assigned protein N-termini was then compared with publicly 
available datasets from other N-terminalomic studies. Subtiligase is a positive selection 
strategy that has been applied to identify caspase substrates in apoptotic Jurkat T-cells 
(Mahrus et al., 2008). The resulting data contained not only neo-N-termini resulting from 
caspase cleavage but also free protein N-termini as background. Therefore, it allowed for the 
comparison of free protein N-termini between the present and Subtiligase studies. With 
respect to the Subtiligase study, protein N-termini (i.e. peptides starting with the first/second 
residue in the canonical protein sequences) identified in either control or apoptotic cells 
were merged to generate a complete dataset of Jurkat proteins with free N-termini. 
The complete Subtiligase dataset contained 106 proteins with free N-termini, whereas the 
present study identified 103 such proteins (see above). Interestingly, these two datasets 
showed strikingly little overlap: 95 proteins with free N-termini were exclusive to the 
present study; 98 such proteins were only identified in the Subtiligase study; only eight 
proteins with free N-termini were shared by both (Figure 5.12). Therefore, the present study 
and the Subtiligase study identified two distinct sets of free protein N-termini, which might 
be attributed to undersampling. 
 
Figure 5.12 Comparison of the identified Jurkat proteins with free N-termini between the selective 
transamination and Subtiligase datasets. Protein N-termini were extracted from the original 
Subtiligase data with the following filter: peptide start residue = 1 or 2. The resulting data were then 
processed to combine the proteins identified in either control or apoptotic Jurkat T-cells. 
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As mentioned previously, N-terminal COFRADIC is a negative selection strategy that can be 
employed to identify proteins with either free or blocked N-termini. This strategy has been 
applied to comprehensively analyse protein N-termini in Jurkat T-cells, and the resulting 
data are publicly available (Staes et al., 2011). Data from the present study and the N-
terminal COFRADIC study were also comparable since both studies could identify free and 
Nt-acetylated protein N-termini. 
As one of the well-developed N-terminalomic strategies, N-terminal COFRADIC assigned 856 
protein N-termini in Jurkat T-cells, including 147 proteins with free N-termini and 709 Nt-
acetylated proteins. This dataset was compared with the 493 protein N-termini (103 free + 
390 Nt-acetylated) assigned in the present study. The comparative analysis showed that 60 % 
of the protein N-termini (297/493) assigned in this study were absent in the N-terminal 
COFRADIC dataset (Figure 5.13). A similar trend was also observed when only focusing on 
free N-termini or the Nt-acetylated ones (Figure 5.14). In conclusion, the present study 
identified a distinct set of protein N-termini in Jurkat T-cells by comparison with the N-
terminal COFRADIC dataset. 
 
Figure 5.13 Comparison of the identified protein N-termini in Jurkat T-cells between the selective 
transamination and N-terminal COFRADIC datasets. Protein N-termini were extracted from the 
original N-terminal COFRADIC data with the following filter: peptide start residue = 1 or 2. COFRADIC: 




Figure 5.14 Comparison of free, Nt-acetylated, and total protein N-termini assigned in Jurkat T-cells 
between the selective transamination and N-terminal COFRADIC datasets. “Trans Only”: protein N-
termini exclusive to the selective transamination dataset; “Common”: protein N-termini shared by 
both the selective transamination and N-terminal COFRADIC datasets; “COFRADIC Only”: protein N-
termini exclusive to the N-terminal COFRADIC dataset. Protein N-termini were extracted from the 
original N-terminal COFRADIC data with the following filter: peptide start residue = 1 or 2. COFRADIC: 
combined fractional diagonal chromatography. 
As demonstrated by the above comparisons, none of these N-terminalomic strategies 
achieved complete coverage of the N-terminal proteome in a single cell line. On the contrary, 
drastically different sets of protein N-termini were identified using different strategies. This 
observation seems to support the use of selective transamination, when combined with 
biotin tagging and affinity purification (AP), to complement other positive selection 
strategies (e.g. Subtiligase). But even the negative selection strategies (e.g. N-terminal 




5.2.3 Proteomic analysis of Jurkat T-cells using selective transamination 
As indicated previously, using the instrumentation available to us, it is routine to identify > 
1,000 proteins from unfractionated Jurkat T-cell samples. Without prior fractionation or the 
use of multiple proteases, the size of this collection is not comparable with those reported 
by other groups (e.g. Bekker-Jensen et al., 2017). Nevertheless, larger datasets are obtained 
typically at the cost of longer instrument time. Previously, a large-scale study required three 
days of instrument time alone to survey the proteome of a cell line (Geiger et al., 2012). 
In principle, selective transamination provides a promising opportunity to improve protein 
identification in Jurkat and other cells without significantly sacrificing the speed of analysis. 
As described previously, the transamination reaction selectively replaces the N-terminal α-
amino group of a protein/peptide with a carbonyl group. Consequently, a modified peptide 
not only exhibits a -1.03 Da mass shift but also a loss of one positive charge. In addition, 
transamination alters the behaviour of the modified peptides during reversed-phase high-
performance liquid chromatography (RP-HPLC), which likely indicates a change in peptide 
hydrophobicity. Potentially, such changes in peptide charge states and hydrophobicity could 
be exploited to achieve orthogonal separation that in turn improves peptide detection and 
hence protein identification.  
A similar concept is adopted by the COFRADIC strategy, which separates the peptides of 
interest (e.g. N-terminal peptides) from others through shifts in peptide hydrophobicity 
(Figure 5.15; Gevaert et al., 2003). Although the COFRADIC strategy is elegant and potentially 
powerful, it is rather labour-intensive, which has hampered its widespread use. In contrast, 
transamination is a simple reaction but may exert a similar effect on peptide separation. 
 
Figure 5.15 Simplified illustration of N-terminal peptide sorting by the COFRADIC strategy (modified 
from http://penyfan.ugent.be/labo/joelv/Cofradic.html). The reaction with TNBS increases the 
hydrophobicity of internal peptides, which can be exploited to achieve the negative selection of N-
terminal peptides. COFRADIC: combined fractional diagonal chromatography; TNBS: 2,4,6-
trinitrobenzenesulphonic acid; RP-HPLC: reversed-phase high-performance liquid chromatography. 
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Since selective transamination potentially alters peptide charge states and hydrophobicity, it 
was postulated that transamination at the peptide level would enable the identification of 
peptides that were otherwise undetectable. Therefore, in the present study transamination 
was carried out on all tryptic peptides from Jurkat proteins after the protease digestion. The 
transaminated peptides were directly analysed by LC-MS/MS without further modifications 
(e.g. biotin tagging). Both the transamination and the corresponding control (i.e. without 
transamination) groups involved three biological replicates, each with two repeats of spectral 
acquisition (N = 6). Peptides identified in either group were then pooled for group 
comparisons. The hypotheses of this study were: I. different sets of tryptic peptides should 
be identified in the control and transamination groups; and II. combining the two datasets 
should improve the sequence coverage and hence increase the robustness of protein 
identification, and possibly also increase the total number of identified proteins. 
In either the control or transamination groups, each of the six replicates detected a set of 
tryptic peptides with high confidence (E-value ≤ 0.05). For either group, the tryptic peptides 
detected by the six replicates were compared by drawing a 6-set Venn diagram (Figure 5.16). 
The cumulative addition of tryptic peptides by the six control replicates gave rise to a total of 
10,388 significant peptides, whereas the total number of significant peptides was only 5,164 
in the transamination group (Figure 5.17).  
 
Figure 5.16 Venn diagram comparing the detected peptides between every two out of six replicate 





Figure 5.17 Saturation curves of unique tryptic peptides detected by replicate analyses in the control 
(blue) or transamination (red) experiments. For each group, the curve was fitted through a nonlinear 
regression analysis in R; in each case, the total peptide number is indicated by a straight line in black. 
After combining the data from both the control and transamination groups, a total of 12,834 
non-duplicate peptides were reliably detected (Figure 5.18). Among them, 2,718 peptides 
were shared by both groups. In contrast, there were 7,670 peptides only detected in the 
control group and 2,446 peptides exclusive to the transamination group. Therefore, selective 
transamination contributed to a 25 % increase in the number of detected peptides relative to 
the control data. Moreover, a similar degree of improvement in peptide detection was 
observed in each pair of the replicate analyses (data not shown). The complete data can be 
retrieved from the ProteomeXchange Consortium depository (dataset ID: PXD009427). 
The effect of selective transamination on peptide separation and detection was further 
investigated by plotting the distribution of detected peptides over the retention time (RT) in 
RP-HPLC. Compared to the control group (10,388 tryptic peptides), peptides detected in the 
transamination group (5,164) were more evenly distributed in spite of a lower total number. 
As a result, a higher proportion of such peptides were detected after ~ 200 minutes (min) in 
RP-HPLC (Figure 5.19). Furthermore, the shapes of peptide distributions resembled their 
respective RP-HPLC elution profiles, as revealed by the total ion current chromatograms (TIC) 
before and after transamination (Figure 5.20). This observation suggested that selective 
transamination indeed altered peptide behaviour during RP-HPLC, which in turn led to the 




Figure 5.18 Venn diagram summarising the increase in the number of peptides detected by LC-MS/MS 
due to selective transamination. The control experiment (N = 6) detected 10,388 tryptic peptides from 
Jurkat proteins, and the transamination experiment contributed to the detection of 2,446 additional 
peptides. There are 2,718 peptides shared by both groups. LC-MS/MS: liquid chromatography–tandem 
mass spectrometry; N: number of replicate analyses. 
 
Figure 5.19 Distribution of tryptic peptides detected in the control or transamination experiments. 
Data are presented as a plot of kernel density estimation. The x-axis represents the retention time (RT) 
in RP-HPLC, whereas the y-axis (density) is an estimate of the peptide counts at a given RT. RP-HPLC: 
reversed-phase high-performance liquid chromatography. 
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Figure 5.20 Total ion current chromatogram (TIC) of tryptic peptides from Jurkat proteins in the 
control (black) or transamination (red) groups. RT: retention time; NL: normalised intensity level. 
eluted more evenly during RP-HPLC might also be advantageous when conventional DDA is 
used in LC-MS/MS analysis. This is because the average number of co-eluting peptide ions 
per unit time is likely to be lower following transamination. 
Next, the observed effect of selective transamination was also statistically validated using a 
hierarchical cluster analysis. This statistical analysis computed the degree of dissimilarities 
(distance) between every two normalised measurements for all six replicates. For both the 
control and transamination groups, peptides detected by each replicate were indeed 
clustered within the group and distant from the other group (Figure 5.21). It was therefore 
concluded that the observed improvement in peptide detection was indeed attributed to the 
treatment (i.e. transamination), which altered the behaviour of tryptic peptides during RP-






Figure 5.21 Hierarchical cluster analysis of the tryptic peptides identified in the control and 
transamination groups. For both groups, all six replicates are shown to cluster within the group. A/B 
denotes two separate technical replicates in each independent biological replication.  
The behaviour of peptides during RP-HPLC and electrospray ionisation (ESI) is tightly 
associated with two physico-chemical properties, isoelectric point (pI) and hydrophobicity 
(Mirzaei and Regnier, 2006). For instance, the pI value reflects the basicity of a peptide, 
which has been suggested as a key predictor of peptide charge states in ESI-MS (Liu et al., 
2011). Meanwhile, peptide hydrophobicity is correlated with not only the RT in RP-HPLC but 
also the ionisation yield in ESI-MS since this property seems to affect peptide desorption 
(Mirzaei and Regnier, 2006, Osaka and Takayama, 2014). In view of these arguments, the 
present study set out to investigate the pI and hydrophobicity of the detected peptides. The 
hypothesis was that the detection of different peptides between the control and 
transamination groups could be explained by the changes (if any) in these two properties. 
To test this hypothesis, three datasets were extracted from the peptide detection data: 
control-only (peptides exclusive to the control group), trans-only (peptides solely detected in 
the transamination group), and common (peptides shared by both groups). For all three 
datasets, both the theoretical pI and hydrophobicity index of the detected peptides were 
computed solely on the basis of their amino acid composition. Data analysis was performed 
using the Peptides R package (Osorio et al., 2015).  
The results showed a marked difference in peptide pI among the three datasets (control-
only, common, and trans-only). As shown in Figure 5.22, the relationship of median pI (pI� ) 




Figure 5.22 Theoretical isoelectric point (pI) of the peptides detected in both the control and 
transamination groups (common) or in either group (control-only or trans-only). Theoretical pI of each 
peptide was computed solely on the basis of its amino acid composition. Data are presented as a box 
plot.  
 
Figure 5.23 Distribution of the theoretical isoelectric point (pI) of the peptides in the common, 
control-only, and trans-only groups. Data are presented as a plot of kernel density estimation. The x-
axis represents the pI range, whereas the y-axis (density) is an estimate of the peptide counts at a 
given pI value. 
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Between the control-only and trans-only groups, the aggregate difference in median pI was 
2.27. This corresponded to a > 186-fold difference in peptide basicity. In addition, the 
distribution of peptide pI was also plotted for all three groups (Figure 5.23). Compared to the 
control-only and common groups, the distribution in the trans-only group clearly shifted 
towards higher pI. In conclusion, selective transamination allowed the detection of more 
basic peptides (i.e. with higher pI). 
The same datasets were also employed to compute the hydrophobicity index of peptides. 
Figure 5.24 shows the median hydrophobicity index (Hphob� ) for the control-only, trans-only, 
and common groups: Hphob� control-only (-0.1143) < Hphob� trans-only (-0.0031) < Hphob� common 
(0.0862). Therefore, peptides solely detected in the control or transamination groups were 
indistinguishable with respect to the hydrophobicity index. Furthermore, the distribution 
plot of hydrophobicity index also revealed nearly identical patterns across all three groups 
(Figure 5.25). These results seemed to support the notion that peptide hydrophobicity was 










Figure 5.24 Theoretical hydrophobicity index of the peptides detected in both the control and 
transamination groups (common) or in either group (control-only or trans-only). The hydrophobicity 
index was calculated using the “Kyte & Doolittle” scale (Kyte and Doolittle, 1982). Data are presented 
as a box plot. 
 
Figure 5.25 Distribution of the theoretical hydrophobicity index of the peptides in the common, 
control-only, and trans-only groups. Data are presented as a plot of kernel density estimation. The x-
axis represents the range of hydrophobicity index, whereas the y-axis (density) is an estimate of the 
peptide counts at a given hydrophobicity index value. 
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In addition to the analyses at the peptide level, it was also of interest to investigate the effect 
of selective transamination on protein identification. Initially, overall 2,963 Jurkat proteins 
were identified by combining the control (2,533 proteins) and transamination (1,955 
proteins) datasets. Since 430 Jurkat proteins were solely identified in the transamination 
group, this treatment contributed to a 17 % increase in the number of identified proteins 
relative to the control group (see Appendix 1). However, the total number of identified 
proteins decreased to 1,594 when the two-peptide rule was applied: 827 proteins were 
shared by both the control and transamination groups, 664 proteins were exclusive to the 
control group, and 103 proteins were solely identified in the transamination group (Figure 
5.26). As a result, transamination improved the protein identification by 7 % when compared 
to the 1,491 proteins in the control group. This number is considerably lower than the 25 % 
improvement in peptide detection, and a plausible explanation is that some of the newly 
detected peptides were likely mapped to proteins that had already been identified in the 
control group. 
 
Figure 5.26 Venn diagram summarising the increase in the number of Jurkat proteins identified by LC-
MS/MS due to selective transamination. Overall, 1,491 and 930 Jurkat proteins were identified in the 
control and transamination groups, respectively. In both cases, a protein was identified on the basis of 
≥ 2 significant peptide hits (E-value ≤ 0.05). The false discovery rate (FDR) was 2.23 %. LC-MS/MS: 
liquid chromatography–tandem mass spectrometry; E-value: peptide expectation value.  
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The identified Jurkat proteins were analysed for Gene Ontology (GO) term enrichment using 
the DAVID Bioinformatics Resources v6.8 (Huang et al., 2008). First, the 1,594 proteins 
identified in the present study were enriched in disease terms including AIDS, infection, and 
blood cancers when compared to all human proteins in the Swiss-Prot database (Figure 
5.27). With respect to protein-protein interactions (PPIs), a diverse range of proteins involved 
in T-cell activation and general immune response were enriched in this dataset. These 
proteins include interleukin enhancer-binding factor 2 (Swiss-Prot ID: ILF2_HUMAN/Q12905) 
and vascular cell adhesion protein 1 (VCAM1_HUMAN/P19320). In addition, two subunits of 
the T-cell surface glycoprotein CD3 (CD3D_HUMAN/P04234 and CD3E_HUMAN/P07766) 
were also identified in the present study. These results provided definitive evidence that the 
identified proteins were indeed extracted from cancer cells and exhibited a T-cell phenotype. 
The complete list of PPI enrichment is shown in Appendix 4. 
 
Figure 5.27 Disease term enrichment of all the identified Jurkat proteins relative to total human 
proteins in the Swiss-Prot database. The x-axis lists the enriched disease terms, whereas the y-axis (P-
value) represents the expected probability by chance. The enrichment analysis was performed using 





Proteins only identified in either the control or transamination group were then compared 
with the total identified proteins (1,594) for the enrichment analysis. With respect to GO 
terms, the 664 proteins in the control-only group were enriched primarily in basic cellular 
constituents, e.g. integral components of cell membrane and the Golgi apparatus (Figure 
5.28A). As expected, protein tyrosine phosphatases were also enriched in resting Jurkat T-
cells since they negatively regulate the initiation and propagation of TCR signalling to 
maintain the resting state (Mustelin and Tasken, 2003). On the other hand, the GO terms 
enriched in the trans-only group (103) were transport, NADH dehydrogenase (ubiquinone) 
activity, and kinetochore (Figure 5.28B). Therefore, selective transamination helped to 
identify a different set of nuclear and mitochondrial proteins in comparison with the control 
group. However, it was difficult to draw any definitive conclusion from this result due to the 
lower protein number in the trans-only group. 
 
Figure 5.28 Gene Ontology (GO) term enrichment of the proteins only identified in the control (A) or 
transamination (B) group. The overall identified proteins (1,594) were set as background. The x-axis 
lists the enriched GO terms, whereas the y-axis (P-value) represents the expected probability by 
chance. The enrichment analyses were performed using the DAVID Bioinformatics Resources v6.8 







In terms of pathway enrichment, the control-only proteins were enriched in mitogen-
activated protein kinase (MAPK) signalling, oxidative phosphorylation, and the underlying 
pathways of the Huntington’s disease (HD; Figure 5.29). Interestingly, proteins exclusive to 
the transamination group were only enriched in the pathways that underlie the Alzheimer’s 
disease (AD). HD and AD are two types of neurodegenerative disorder characterised by the 
aggregation of misfolded proteins in the brain, and they have several conserved molecular 
mechanisms (Ross and Poirier, 2004, Flavin et al., 2017). Recently, a transcriptomic study 
reported the upregulation of many immune-related pathways in both HD and AD (Moss et 
al., 2017). However, the enrichment of AD or HD in the present study was more likely due to 
the identification of non-overlapping components of the mitochondrial respiratory chain in 
either group. For instance, the control-only group contained the subunits of mitochondrial 
Complex I, III, IV, and V, whereas four additional subunits of Complex I (NADH 
dehydrogenases) were identified in the trans-only group. These results again supported the 
hypothesis that different sets of proteins, in this case different subunits of the same protein 
complex, should be identified in the control and transaminated samples. 
 
Figure 5.29 Pathway enrichment of the proteins only identified in the control (left) or transamination 
(right) group. The overall identified proteins (1,594) were set as background. The x-axis lists the 
enriched pathways, whereas the y-axis (P-value) represents the expected probability by chance. The 






The N-terminal proteome represents an intriguing target for studying the location, function, 
and interaction of proteins. However, profiling it proves to be challenging with existing 
technologies. Even with the state-of-the-art instruments in MS, identification of protein N-
termini is often hampered by infrequent detection of N-terminal peptides. It is further 
complicated by various types of PTMs at protein N-termini in eukaryotic cells. These include 
NME, Nt-acetylation, and Nt-myristoylation (reviewed in Giglione et al., 2015). Furthermore, 
proteolytic processing (e.g. signal peptide removal) and alternative translation initiation 
generate neo-N-termini that are previously unknown and hence unannotated in protein 
databases (Van Damme et al., 2014, Lange and Overall, 2013). 
As described previously, several proteomic strategies have been developed to overcome 
limitations in conventional shotgun approaches and thus improve the identification of 
protein N-termini/neo-N-termini. These include negative selection strategies such as N-TAILS 
(N-terminal amine isotopic labeling of substrates) and N-terminal COFRADIC, as well as 
positive selection strategies including N-CLAP and Subtiligase (reviewed in Eckhard et al., 
2016). Based on the results described in Chapter 4, the transamination reaction exhibits 
selectivity for N-terminal α-amino groups over lysine (K) ε-amino groups, and it thus has the 
potential to be developed as a positive selection strategy for identification of protein N-
termini in complex proteomes. 
Advancing from the experiments with model peptides and proteins, it was necessary to 
choose a suitable system with greater complexities for testing the transamination approach 
regarding its feasibility and efficiency. Jurkat T-lymphocytes were considered as an ideal 
candidate because they are well characterised and can be conveniently cultured on a large 
scale in laboratory. Consequently, it is possible to obtain large quantities of complex protein 
mixtures from this cell line within a relatively short period of time. A three-step study was 
then carried out to test the transamination approach on this complex proteome: I. 
biochemical evaluation of transamination and biotin tagging on intact Jurkat proteins; II. 
global identification of Jurkat protein N-termini (free or Nt-acetylated) through protein-level 
transamination and biotin tagging; III. shotgun analysis of the Jurkat proteome with the aid 
of peptide-level transamination. 
In the first step, SDS-PAGE and Western blotting analyses demonstrated that Jurkat proteins 
(DNA-free) were amenable to selective transamination and the subsequent biotin tagging. 
The Western blotting analysis detected an intense signal of biotin in the treated sample 
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where Jurkat proteins were subject to both transamination and biotin tagging, but not in the 
two negative controls without biotin tagging (Figure 5.5). Biotin is naturally bound to five 
human carboxylases (where it acts as a cofactor in the transfer of CO2; Wood and Barden, 
1977) and perhaps also to histones (Kuroishi et al., 2011). However, the absence of biotin 
signals in these two negative controls suggests that endogenous protein biotinylation is 
negligible as compared with the carbonyl-specific biotin tagging after transamination. 
Nevertheless, a low level of biotin signal was still detected in a third negative control where 
Jurkat proteins were directly treated with the biotin tagging reagent without prior 
transamination. As discussed in Chapter 4, the presence of a biotin signal in this sample likely 
reflects spontaneous protein carbonylation (a hallmark of oxidative stress; Dalle-Donne et 
al., 2003). A prompt analysis of protein samples is paramount in avoiding artificial protein 
carbonylation, as with the cautious use of thiols and metal ion chelators (Luo and Wehr, 
2009, Rogowska-Wrzesinska et al., 2014). In addition, hydralazine (a reactive carbonyl 
scavenger) has been reported to effectively prevent protein carbonylation, but none of the 
other tested scavengers showed the same effect (Zheng and Bizzozero, 2010). Therefore, 
addition of this compound during protein extraction may also help to reduce the 
spontaneous carbonylation. Alternatively, protein carbonyl groups can be blocked with 
hydrazide or alkoxyamine compounds (e.g. BnONH2) prior to selective transamination. 
Another source of biotin signals may be glycoproteins in the extracts of Jurkat T-cells. 
Conventionally, the primary usage of carbonyl-reactive chemistry is to label glycoproteins 
after mild periodate oxidation of protein glycans (Weber et al., 1975, Zeng et al., 2009). 
Therefore, the possibility that glycoproteins were spontaneously oxidised and hence 
susceptible to carbonyl-specific biotinylation should not be excluded arbitrarily. However, 
identification of biotinylated glycoproteins is beyond the scope of this study due to the 
structural complexity of protein glycosylation. In the future, this problem can be largely 
overcome by either enzymatic or chemical removal of glycans from glycoproteins. For 
instance, treatment with peptide-N-glycosidase F (PNGase F) provides effective removal of 
N-linked glycans (Maley et al., 1989), whereas the reaction with trifluoromethanesulfonic 
acid (TFMS) has been employed to remove all types of glycans without destroying the 
protein component (reviewed in Edge, 2003). 
Notably, there are several gaps between the results of SDS-PAGE and Western blotting, which 
lead to the conclusion that some Jurkat protein N-termini are not amenable to selective 
transamination. The limited scope of transamination can be envisioned on the basis of 
protein chemistry. For instance, proteins with an N-terminal proline (P) residue have no 
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reactive α-amino group and thus do not serve as transamination substrates. The limited 
reaction scope has also been experimentally determined, and will be discussed later in this 
section. Nevertheless, many Jurkat proteins can still be transaminated and biotin tagged 
according to the Western blotting results. Therefore, the transamination approach could be 
employed in a positional proteomic study to globally identify Jurkat protein N-termini. 
Positional proteomics is inherently associated with the issue of “one-hit wonders” (Veenstra 
et al., 2004). In the case of N-terminalomic analysis, protein identification necessarily relies 
on the assignment of a single peptide (i.e. the N-terminal peptide), which is by definition a 
one-hit wonder (McDonald et al., 2005). However, Davidson et al. (2011) argued that N-
terminalomic strategies limit the search space for peptide assignment by providing the 
positional information, thus greatly increasing the confidence of protein identification. Other 
researchers have recommended the use of intelligent post-processing tools (Impens et al., 
2010) or multiple proteases in parallel experiments (Mommen et al., 2012) to screen the 
identified one-hit wonders. 
However, the issue with one-hit wonders was circumvented in the present study: Jurkat 
proteins could be identified with ≥ 2 different peptides due to the exclusion of an AP step 
(i.e. positive selection). Therefore, any protein N-termini assigned were accompanied by 
other internal peptides and thus did not conform to the definition of one-hit wonders. Such 
assignments of protein N-termini were also highly reliable given the mass accuracy and 
resolution of the MS instrument used. Nonetheless, confident assignments were obtained at 
the cost of undersampling, as some protein N-termini might not be detected by MS due to 
the overwhelming internal peptides. 
Based on the results described in section 5.2.2, this study detected the N-terminal peptides 
in 493 out of 2,275 Jurkat proteins. It highlights the challenges in profiling the N-terminal 
proteome as mentioned above: only one fifth of these proteins contained assigned N-
termini. Further scrutiny of these protein N-termini has uncovered novel findings: the N-
terminal M residue was excised from two proteins, serine--tRNA ligase (Swiss-Prot ID: 
SYSC_HUMAN) and peptidyl-prolyl cis-trans isomerase (FKBP5_HUMAN); a rare case of Nt-
acetylation on a terminal P residue was detected in macrophage migration inhibitory factor 
(MIF_HUMAN). Such N-terminal PTMs (i.e. NME and Nt-acetylation) have not been reported 
for these proteins based on existing annotations in the Swiss-Prot database and may be 
attributed to cell-type specificity in this case. These results highlight the fact that the 
annotation of N-terminal PTMs is still an ongoing project and will certainly benefit from 
further generation of proteomic data. 
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Among the 493 proteins with assigned N-termini, the free-to-acetylation ratio was about 1:4. 
This ratio is in agreement with the current consensus that the vast majority (> 80 %) of 
cytosolic proteins in humans are susceptible to Nt-acetylation (Giglione et al., 2015). 
However, this ratio should be treated with caution as it may vary considerably when the N-
termini of the rest 1,782 proteins are also identified. In addition, we have determined that 
the N-termini of several proteins existed in both free and Nt-acetylated forms. These 
overlapping protein hits were then removed from the dataset of free N-termini on the 
ground of incomplete Nt-acetylation, since this PTM is irreversible in nature (Arnesen, 2011). 
In the human proteome, 9 % of protein N-termini are reported to exist in both free and Nt-
acetylated forms (Arnesen et al., 2009). Therefore, these two forms are not mutually 
exclusive. 
Protein transamination and the subsequent biotin tagging proved to be relatively inefficient 
for assigning protein N-termini. Only 3 out of 103 free protein N-termini were exclusively 
identified through this approach. Among them, only one N-terminal peptide was assigned 
solely due to the N-terminal biotin tag. All three N-terminal peptides are derived from highly 
abundant proteins (e.g. subunits of ribosome or cytoskeleton complex). The scarcity of the 
biotin-tagged N-termini is probably due to several factors: I. transamination of protein N-
termini did not proceed efficiently; II. a single proteoform was transaminated to yield 
multiple products with different mass shifts, but only the expected product could be 
assigned by Mascot; III. the abundance of biotin-tagged protein N-termini was further 
reduced by incomplete biotinylation; IV. without an AP step, MS detection of the 
transaminated or biotin-tagged protein N-termini was suppressed by internal peptides with 
higher “flyability”. 
A major limitation of the present study is the narrow definition of protein N-termini. Without 
a local protein database featured with N-terminal annotations, the N-terminus of a protein is 
automatically defined by the Mascot search engine as the first/second amino acid residue in 
the canonical sequence of that protein. By this definition, N-terminal biotin tagging and 
other modifications will only be assigned to the N-terminal M residue or the next one if the 
position of such modifications is set as “protein N-term”. Consequently, information on two 
types of N-terminal peptides will be lost. First, true N-termini of mature proteins will not be 
recognised by Mascot or only treated as internal peptides, since protein maturation often 
requires proteolytic processing in the N-terminal region. Second, previously unannotated 




To partially compensate for the loss of this information, the position of two variable 
modifications (Nt-trans and Nt-biotin) was further specified to be at the N-termini of semi-
tryptic peptides. In this case, these two modifications can be assigned to the N-terminal 
residue of any peptide from a protein, instead of only the first/second residue in the 
canonical sequence. A semi-tryptic peptide itself must have a K or arginine (R) residue at its 
carboxyl (C)-terminus (not further followed by a P residue), but its N-terminus can be any 
residue. The hypothesis was that this approach should lead to the identification of previously 
unannotated free N-termini (or neo-N-termini), albeit at the expense of a higher false 
discovery rate (FDR = 3.13 %).  
Indeed, a canonical protein N-terminus and 1,214 neo-peptides were further identified 
through this approach (see Appendix 5). Cross-referencing with the Swiss-Prot database 
validated the canonical N-terminal peptide and three neo-peptides as free N-termini of 
Jurkat proteins (Table 5.3). In the latter cases, the cognate proteins of these neo-N-termini 
have undergone the removal of mitochondrial transit peptides or signal peptides (Hughes et 
al., 1993, Vaca Jacome et al., 2015). With respect to the effect of biotin tagging, 45 neo-
peptides were solely identified due to the Nt-biotin modification. Potentially, the 1,214 neo-
peptides may be derived from processed, stable proteoforms that are physiologically 
relevant. However, discrimination of these neo-peptides from protein degradation 
intermediates is beyond the scope of this study and requires further analysis. 
Table 5.3 List of validated canonical and neo-N-termini of Jurkat proteinsa. 
Protein Swiss-Prot ID                        N-terminal Peptide (Start – End)                       N-terminal PTM 
Canonical protein N-terminus 
RL40_HUMAN (P62987) MQIFVKTLTGK (1 – 11) Nt-trans 
neo-N-termini 
COX5B_HUMAN (P10606) ASGGGVPTDEEQATGLER (32 – 49) Nt-biotin 
GLRX5_HUMAN (Q86SX6) AGSGAGGGGSAEQLDALVKK (32 – 51)                                  Nt-biotin
SDF2L_HUMAN (Q9Y4Z0) AKTGAELVTCGSVLK (29 – 43) Nt-biotin 
a Two variable modifications (Nt-trans and Nt-biotin) were permitted to be at the N-terminus of any 
semi-tryptic peptide when searching with Mascot. The N-terminus of a semi-tryptic peptide can be 
any residue but the C-terminus must be either a lysine (K) or arginine (R) residue (not followed by 
proline, P). False discovery rate (FDR) was 3.13 %. The listed canonical protein N-terminus and neo-N-
termini were validated by cross-referencing with the online Swiss-Prot database. PTM: post-
translational modification; Nt-trans: N-terminal transamination; Nt-biotin: N-terminal tagging with 
alkoxyamine-PEG4-biotin or alkoxyamine-PEG4-SS-PEG4-biotin. 
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Two comparative analyses further revealed surprisingly little overlap among the protein N-
termini identified by the present and two prior N-terminalomic studies, all of which used the 
Jurkat cell line. For instance, the present study identified a total of 201 free protein N-termini 
when combined with a Subtiligase dataset (Mahrus et al., 2008), but only 4 % of them were 
shared by both datasets. This number only increased to a limited extent (17 %) when 
comparing the current result with that from a COFRADIC study (Staes et al., 2011). A similar 
result was shown by the comparison between the Subtiligase and COFRADIC datasets, as 
only 6 % of the total free N-termini were present in both. Thus, a complete survey of the N-
terminal proteome may require collective efforts that each employs a different approach. It 
should be noted that the strength of Subtiligase lies primarily in the identification of 
protease substrates, and free protein N-termini were only identified as background in that 
study. On the other hand, the COFRADIC approach resulted in a much larger collection of 
protein N-termini (both free and Nt-acetylated), demonstrating the efficacy of negative 
selection. Finally, such comparative analyses should benefit from integrating the data from 
other N-terminalomic studies that used the same cell line, e.g. N-CLAP (Xu and Jaffrey, 2010). 
However, their data are published in a format that prevents reprocessing. 
From the results of model peptide/protein experiments, selective transamination is capable 
of altering peptide RT during RP-HPLC even without further derivatisation. The COFRADIC 
technique employs a similar approach to retain and detect the peptides of interest (e.g. N-
terminal peptides; Gevaert et al., 2002, Staes et al., 2011). Accordingly, it was hypothesised 
that: I. peptide-level transamination would help to detect additional proteolytic peptides by 
shotgun proteomics; and II. combining the control and transamination datasets should 
increase the number of identified peptides and proteins. In principle, this treatment is 
analogous to the use of multiple proteases for improving proteome coverage.  
By combining the control and transamination datasets, a total of 12,834 tryptic peptides 
were detected from six replicate analyses. Among them, 60 % of the peptides were unique to 
the control group and 20 % were shared by both groups. Peptide transamination contributed 
to the final 20 % of the peptides (2,446), which would have otherwise been undetected. 
These figures support the first hypothesis that a different set of tryptic peptides would be 
detected due to transamination. 
Similar to the LC elution profiles extracted from Orbitrap RAW data, the RT distributions of 
the detected peptides varied markedly between the control and transamination groups. For 
the control group, the detected peptides were more clustered within the 100 – 200 min 
interval. In contrast, a higher proportion of the peptides were detected after 200 min in the 
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transamination group. This change in the chromatographic behaviour of peptides (i.e. the 
shifts in peptide RT) is a plausible reason why transamination could help to detect many 
previously missing peptides. This argument is further supported by the result of a statistical 
analysis, which showed that the detection of additional peptides was not because of deeper 
sampling but instead was due to the treatment (i.e. transamination). 
In the next step, the present study attempted to determine the possible correlation between 
transamination and the change in peptide behaviour. Two different physico-chemical 
properties, peptide pI and hydrophobicity, were investigated. Although a significant 
difference in peptide hydrophobicity was not identified, there was a substantial change in 
the pI of the detected peptides following transamination. The result of a computational 
analysis showed that the peptides in all three groups (control-only, common, and trans-only) 
had a median pI below 7. However, the transaminated peptides were 17-fold more basic 
relative to the peptides in the common group, and 186-fold more basic relative to the 
control-only peptides. The experimental data shown here seem to suggest that: I. LC-MS/MS 
(positive ESI, DDA mode) more readily detects peptides with lower pI; II. transamination 
modifies the behaviour of tryptic peptides primarily by lowering their pI, which in turn 
enables the detection of more basic peptides.  
The effect of transamination on peptide pI is possibly attributed to the removal of the N-
terminal α-amino group (pKa ≈ 9.0; Grimsley et al., 2009, Oregioni et al., 2017). However, 
interpreting such findings can be difficult: in positive ESI, charges on an ionised peptide are 
mainly retained by K, R, and histidine (H) residues as well as the N-terminus (i.e. highly basic 
groups; Krusemark et al., 2009); removing the N-terminal α-amino group may thus be 
adverse to peptide ionisation/detection. Nevertheless, transamination led to the observed 
shifts in peptide RT during RP-HPLC, which may benefit peptide detection by mitigating the 
problem of ion suppression, also termed the “matrix effects” (Taylor, 2005). It describes the 
suppression of (low-abundance) peptide ionisation by co-eluting peptides that are of higher 
“flyability” (Qian et al., 2006). Since the transaminated peptides no longer co-elute with the 
suppressive peptides, they are more easily ionised and detected in DDA-mode LC-MS/MS.  
The 2,718 peptides shared by both the control and transamination groups were further 
analysed to unveil any interesting features. We first determined that the enrichment of these 
peptides was not correlated with their positions in the cognate protein sequences (data not 
shown). Subsequently, the extent of transamination was assessed using the peptide-
spectrum matches (PSMs) retrieved from the transamination dataset. The 2,718 peptides of 
interest were detected in their native form in the control group but existed in either native or 
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transaminated forms (or both) in the transamination group. It was calculated that 25 % of 
the peptides (660) in the transamination group were only detected in the native form. These 
peptides may thus represent unfavourable substrates for this reaction. In contrast, 17 % of 
the peptides (450) existed in both native and transaminated forms. Therefore, such peptides 
were amenable to transamination but the reaction was incomplete. The remaining 59 % 
(1,608) were exclusively detected in the transaminated form, probably indicating the highly 
efficient transamination of these peptides. 
A comparative analysis was then performed between the 660 peptides that were seemingly 
refractory to transamination and the 3,977 transaminated peptides. This analysis revealed 
overrepresentation of the N-terminal threonine (T), valine (V), and H residues in the 660 
peptides, as well as moderate enrichment of the P residue at the second position (Figure 
5.30). These residues may thus be refractory to transamination or may undergo further 
reactions. Conversely, leucine (L) is the most underrepresented N-terminal residue, followed 
by alanine (A) and isoleucine (I). These three residues may represent the optimal substrates 
for transamination. Taken together, the result of this comparative analysis implies that 
different N-terminal residues indeed affect the efficiency of transamination. 
The above statement is generally in agreement with the limited scope of transamination as 
experimentally determined using libraries of synthetic peptides: 17 out of the 20 standard 
amino acid residues can serve as substrates for transamination, but N-terminal H, P, and 
tryptophan (W) residues do not undergo transamination; the yield of transamination is low 
when peptide substrates start with a cysteine (C), K, T, or asparagine (N) residue (Papanikos 
et al., 2001, Gilmore et al., 2006, Sonomura et al., 2009b). Nevertheless, the comparative 
analysis suggested that the N-terminal V residue was difficult to transaminate, which was not 
mentioned in the previous reports. Indeed, a further examination showed that 287 out of 
the 3,977 transaminated peptides start with a V residue but transamination was incomplete 
for 200 of them. The discrepancy between these results may simply be a result of the higher 
sample complexity: the present study relied on the use of human protein extracts, which are 
intrinsically more heterogeneous than the synthetic peptide libraries with respect to the 
absolute abundance and the distribution of N-terminal residues. An alternative explanation 
for the discrepancy may be that transamination reduced the “flyability” of peptides with an 





Figure 5.30 Sequence logo depiction of the five amino acid residues (P1’ – P5’) from the N-terminal 
end of the 660 peptides that are seemingly refractory to transamination. The y-axis denotes the 
percentage difference in appearance frequency, relative to the 3,977 peptides that are amenable to 
transamination (P-value = 0.05). The sequence logo was created using iceLogo (Colaert et al., 2009).  
At the protein level, there are overall 2,963 proteins identified from the combined dataset, 
but the removal of one-hit wonders reduced this number to 1,594. Among them, 103 
proteins were solely identified from the 2,446 peptides exclusive to the transamination 
group. Proportionally, there is a substantial difference in the improvements between peptide 
detection and protein identification: a 25 % increase in peptide detection versus a 7 % 
increase in protein identification. A plausible explanation is that different peptides detected 
in the control or transamination groups may contribute to the identification of the same 
proteins. To test this hypothesis, sequence coverage information of the 827 proteins shared 
by both groups were retrieved for a comparative analysis. Mean sequence coverage was 
calculated to be 35.34 and 42.30 % for the control and combined datasets, respectively. 
Therefore, the 2,446 trans-only peptides contribute to a 7 % increase in the sequence 
coverage of the 827 shared proteins as well as the identification of 103 additional proteins. It 
is anticipated that protein identification will be further improved when data-independent 
acquisition (DIA) is adopted in future studies. 
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The difference in the improvements between peptide detection and protein identification 
also owes in large part to the removal of one-hit wonders. As described previously, one-hit 
wonders refer to proteins that are only identified by a single peptide match, and their validity 
has been a major concern to the proteomics community (Veenstra et al., 2004). At present, 
protein identification follows the Paris guidelines for reporting proteomic data (Bradshaw et 
al., 2006), which enforces the two-peptide rule and rejects one-hit wonders. Consequently, 
nearly 1,400 proteins identified in the present study were regarded as one-hit wonders and 
excluded from the final results. This number is roughly equal to that of the proteins 
identified with high confidence (≥ 2 significant peptides, E-value ≤ 0.05). Therefore, highly 
informative data are potentially lost during this process. This argument is supported by 
Gupta and Pevzner (2009), who showed that excluding one-hit wonders actually resulted in a 
lower sensitivity of proteomic studies, and that a large proportion of one-hit wonders were 
indeed expressed. 
Even though the confidence in peptide assignments can be provided by the high resolving 
power/mass accuracy of state-of-the-art MS instruments and strict FDR control, one-hit 
wonders still present a major problem at the data analysis step. This “protein inference 
problem” (Huang et al., 2012) refers to the ambiguity in mapping the identified peptides to 
their parent proteins due to the existence of one-hit wonders and degenerate peptides (i.e. 
peptides that are shared by multiple proteins). Several algorithms have been developed to 
tackle this problem at multiple stages (reviewed in Huang et al., 2012). Recently, an artificial 
intelligence (AI) method was also introduced to address the challenges in protein inference. 
This deep-learning technique is termed DeepPep, which employs an artificial neural network 
to afford robust protein inference by integrating the probability of peptide detection with 
positional information (Kim et al., 2017). In the future, advances in MS instrumentation and 
bioinformatics analysis will likely provide an ultimate solution to the problems with one-hit 
wonders and protein inference. 
In conclusion, the present proteomic study employed selective transamination to modify 
Jurkat protein N-termini for biotin tagging, and to modify the N-termini of tryptic peptides 
for improved peptide/protein identification. The former experiments identified 490 protein 
N-termini, with some novel discoveries (e.g. two proteins undergo NME and a third has 
acetylation at its N-terminus). However, transamination and the subsequent biotin tagging 
only contributed to the identification of three protein N-termini. The low efficiency reflects 
incomplete transamination/biotinylation, and highlights the importance of AP. The latter 
experiments combined the control and peptide transamination data to identify nearly 13,000 
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peptides or 1,594 Jurkat proteins with high confidence (E-value ≤ 0.05). In comparison with 
the control data, peptide transamination led to a 25 % increase in the number of detected 
peptides, or a 7 % increase in the number of identified proteins. These improvements were 
larger than expected and significantly improved proteome sequence coverage. In view of the 
simplicity of this technique, which we term STONE (Selective Transamination Of N-Ends), it 
could be implemented widely. Due to its intrinsic limitations, the present study requires 
further analyses that include: I. amending database and search parameters to discover and 
validate neo-N-termini; II. adopting different data acquisition methods to identify low-
abundance proteins; III. employing AI methods to deal with the protein inference problem 







Chapter 6. Conclusions 
The extreme amino (N)-terminus of a protein is generated during protein synthesis, at which 
point the nascent polypeptide chains start with an N-terminal (formyl-)methionine residue. 
The N-terminus is highly informative regarding a protein’s stability, function, and regulation. 
The importance of protein N-termini is reflected by the “N-end rule”: the degradation signal 
of a protein has already been planted at its N-terminus from the moment of its birth, linking 
an N-terminus to its cognate protein’s in vivo half-life (Varshavsky, 1997). A newly 
synthesised protein often endures a plethora of co- and post-translational modifications 
(PTMs) at its N-terminus in order to become fully mature. These PTMs further influence 
protein stability and activity, as illustrated by another branch of the N-end rule in eukaryotes, 
“Ac/N-end rule pathway”. This pathway describes the regulation of protein half-lives by 
specific PTMs: N-terminal methionine excision (NME) and N-terminal (Nt)-acetylation 
(Varshavsky, 2011). Recently, a third branch of the N-end rule was discovered in yeasts, 
termed the “Pro/N-end rule pathway” (Chen et al., 2017). This pathway refers to the 
recognition and selective degradation of gluconeogenic enzymes that possess a proline (P) 
residue at the N-terminus or the second position. 
Proteolytic processing represents another major form of PTM. Many newly synthesised 
proteins require proteolytic processing (e.g. NME) for maturation, thus producing new 
proteoforms with different N- or carboxyl (C)-termini (i.e. neo-termini). In addition, 
expression of the same gene often gives rise to multiple proteoforms with different N-
termini, owing to genetic mutations, alternative splicing, alternative translation initiation, 
and so on (Lange et al., 2014b). All these events contribute to a greater complexity of the 
proteome: the apparent N-terminus of a protein does not always conform to that predicted 
by bioinformatics analysis of the genome. Currently, an emerging subfield of proteomics, 
termed “N-terminalomics”, attempts to resolve this issue. The primary objectives of N-
terminalomics are to determine the exact N-termini of all proteoforms in a biological system 
and the biological relevance of such N-termini. In addition, N-terminalomic strategies are 
widely adopted in efforts to identify proteolytic processing events and protease substrates. 
N-terminalomic strategies are divided into two main categories: positive and negative 
selection. The former involves direct enrichment of protein N-termini through chemical 
reactions that differentiate between the α-amino group at protein N-terminus and ε-amino 
groups on the side chain of lysine (K) residues. In contrast, the latter requires the removal of 
peptides other than protein N-termini (i.e. internal peptides) and does not require 
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discrimination between α- and ε-amino groups (Agard and Wells, 2009). This thesis describes 
the efforts to critically evaluate and improve an existing negative selection strategy, which 
relies on the use of N-hydroxysuccinimide (NHS)-activated Sepharose to remove internal 
peptides (McDonald et al., 2005). It is referred to as the “NHS-Sepharose” approach.  
This work has also focused on a positive selection strategy called “Selective Transamination 
Of N-Ends (STONE)”. This approach is based on a chemical reaction largely developed by 
Dixon (1964). Two major advantages of STONE are the simplicity to implement this approach 
and the introduction of a reactive carbonyl group, which greatly facilitates further 
manipulation. The following conclusions can be drawn from this study: 
• The NHS-Sepharose approach efficiently blocked both protein N-termini and the side 
chain of K residues; however, the efficiency of internal peptide scavenging was not 
satisfactory due to the presence of specific internal peptides after the negative selection. 
• Systematic refinement of this approach resulted in complete removal of internal 
peptides from the N-terminal peptide of chicken egg-white lysozyme (lysozyme C) or 
bovine serum albumin (BSA); in principle, these refinements should be applicable to 
many proteins, thus allowing the implementation of this approach to study complex 
proteomes. 
• The STONE approach efficiently converted the N-terminus of various peptides and 
proteins to a reactive carbonyl group, which allowed further attachment of a carbonyl-
reactive biotin tag to the N-terminal residue of these peptides/proteins. 
• It was also possible to purify such biotin-tagged model proteins (lysozyme C and BSA) 
through avidin-biotin interaction. 
• Shotgun proteomics of Jurkat T-cells identified several novel N-terminal proteoforms. 
• STONE helped to further identify > 1,000 putative neo-N-termini in the Jurkat proteome, 
with 45 of such neo-peptides solely identified by the carbonyl-specific biotin tag. 
• STONE complemented standard shotgun proteomics with a 25 % increase in the number 
of detected peptides, which in turn contributed to a 7 % increase in Jurkat protein 
identification and 7 % higher sequence coverage of the proteins identified in both the 
standard shotgun and STONE experiments. 
In addition, the present work led to a better understanding of these N-terminalomic 
approaches. With respect to NHS-Sepharose, we have determined that the reactivity of the 
amine scavenger (i.e. NHS-activated Sepharose) was a major bottleneck in this approach. 
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Indeed, we learned that this limitation was a driving force behind the development of some 
recent N-terminalomic approaches (personal communication). Prolonged treatment with an 
increased amount of NHS-activated Sepharose achieved complete removal of internal 
peptides of model proteins, but at the expense of a more complex protocol, greater reagent 
consumption, and potential sample loss. Meanwhile, blocking of primary amines with N-
succinimidyl S-acetylthioacetate (SATA) requires further optimisation since its efficiency was 
not comparable to amine acetylation with NHS-acetate. The current protocol of shotgun 
proteomics is not compatible with citraconic anhydride (CA) modification because the 
modified peptides will be exposed to a low-pH environment that readily dissociates the 
amide linkage.  
Regarding the STONE approach, the reaction products exhibited a ~ 6-minute increase in the 
retention time (RT) during reversed-phase high-performance liquid chromatography (RP-
HPLC). Furthermore, shotgun proteomics of Jurkat T-cells revealed that STONE-modified 
tryptic peptides eluted more evenly during RP-HPLC. This is possibly attributed to a loss of 
charges that altered peptide isoelectric points (pI). The reaction scope was also briefly 
examined through the shotgun analyses: tryptic peptides with an N-terminal threonine (T), 
valine (V), or histidine (H) residue were less susceptible to transamination. In contrast, 
peptides starting with a leucine (L), isoleucine (I), or alanine (A) residue were transaminated 
with very high efficiency. This finding is largely in agreement with that reported by 
Sonomura et al. (2009b), but the impact of the N-terminal V residue requires further analysis. 
Also in keeping with the previous study, formation of the correct transamination product 
was accompanied by some minor side reactions, including decarboxylation and glyoxylate 
addition. It remains to be seen if these can be further reduced or abolished by optimisation 
of the STONE approach. Finally, it was determined that the carbonyl-specific biotinylation 
did not efficiently tag all the STONE-modified proteins/peptides, hindering the affinity 
purification (AP) of biotinylated N-terminal peptides. 
The present study also reveals that N-terminal annotations in human protein databases are 
currently incomplete. For example, the STONE experiments identified three endogenously 
modified protein N-termini that were previously unregistered. This study also identified > 
1,000 putative neo-N-termini that might represent stable proteolytic products. These results 
imply that database annotations of protein N-termini may be incomplete for any organism, 
due to complications in gene expression and subsequent PTMs. Complete N-terminal 
annotations thus require unremitting endeavours to generate new proteomic data, with a 
significant contribution from N-terminalomic strategies. Since these methods have their 
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respective strengths and weaknesses (Table 6.1), it would be wise to choose an appropriate 
method that serves a specific purpose (e.g. profiling protein N-termini or identifying 
protease substrates). Alternatively, parallel experiments using different strategies can be 
performed to increase the number of N-terminal assignments. Also, such assignments are 
obviously more reliable if the same peptide is independently identified by two or more 
orthogonal methods. 
As discussed in previous chapters, the STONE approach provides a new option for N-
terminalomic studies. As a positive selection approach, STONE possesses unique advantages 
that well complement other approaches in the same category. Compared to N-CLAP (N-
terminalomics by chemical labeling of the α-amine of proteins) and O-methylisourea, STONE 
does not involve modification of ε-amino groups on K side chains. The Subtiligase approach 
requires a proprietary enzyme and a large amount of samples to start with, whereas STONE 
employs simple and inexpensive reagents to achieve N-terminal tagging. Conversely, N-CLAP 
surpasses the STONE approach (in its current state) with a better-defined chemistry. The 
Subtiligase approach is superior over STONE owing to its single-step biotinylation of protein 
N-termini. Consequently, STONE may be performed to validate protein N-termini that are 
assigned by other positive selection approaches. Traditionally, protein N-termini identified 
through positive selection are questionable due to the problem of “one-hit wonders”, i.e. 
the protein assignments necessarily rely on the identification of a single peptide.  
In formal terms, there are two problems associated with protein identifications based on 
single peptides. The first is that peptide might be erroneously identified, i.e. the tandem 
mass spectra may be incorrectly matched to a peptide sequence. In principle, such errors 
should diminish as MS technology improves in terms of mass accuracy and precision. In the 
short term, this problem can be overcome if the protein N-termini are independently 
identified by two or more orthogonal methods. The second problem, known as the protein 
inference problem, is more difficult. In such cases, the peptide is correctly identified but it is 
impossible to assign it to a single protein because it is degenerate, i.e. the same peptide can 
be produced by multiple proteins (Huang et al., 2012). Although solving this problem is 
outside the scope of the present work, it is worth noting that bioinformatics approaches, e.g. 
using artificial intelligence (AI) strategies, may eventually resolve the issue (Kim et al., 2017). 
Alternatively, top-down MS strategies may be helpful since they directly acquire sequence 
and structural information from intact proteins. But much remains to be done before these 
can be routinely implemented. 
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Table 6.1 Strengths and weakness of major N-terminalomic approachesa.  
N-terminalomics Strength Weakness 
COFRADIC 
ChaFRADIC 
Widely available and inexpensive 
reagents, 
retains modified protein N-termini 
Instrument intensive, 
require highly skilled personnel, 
potential sample loss 
N-TAILS 
Versatile and easy to use, 
lower demand for MS time, 
retains modified protein N-termini 
Relies on specific amine-scavenging 
polymers (limited availability), 
potential sample loss during solid-
phase extraction 
Subtiligase 
Absolute specificity towards the N-
terminal α-amine, 
direct enrichment leads to less false-
positives, 
ideal for identifying neo-N-termini 
due to proteolytic processing 
Relies on a proprietary enzyme with 
limited availability, 
requires a large amount of protein 
samples, 
limited reaction scope leads to false-
negatives, 
unable to identify modified protein 
N-termini 
N-CLAP 
Widely available and inexpensive 
reagents, 
direct enrichment leads to less false-
positives, 
ideal for identifying neo-N-termini 
due to proteolytic processing 
Complicated chemical modifications 
lead to potential sample loss, 
difficult to identify modified protein 
N-termini 
STONE 
Desired specificity towards the N-
terminal α-amine, 
widely available and inexpensive 
reagents, 
well-suited to peptide detection by 
shotgun proteomics 
Potential sample loss during sample 
handling, 
produces false-negatives due to 
limited reaction scope and side 
reactions, 
difficult to identify modified protein 
N-termini 
a COFRADIC: combined fractional diagonal chromatography; ChaFRADIC: charge-based fractional 
diagonal chromatography; N-TAILS: N-terminal amine isotopic labeling of substrates; N-CLAP: N-
terminalomics by chemical labeling of the α-amine of proteins; STONE: selective transamination of N-
ends; MS: mass spectrometry. 
A major limitation of all negative selection approaches is the blocking of both α- and ε-amino 
groups, which potentially destroys protease recognition sites. It may also lead to large-scale 
protein precipitation and elongated peptides, which adversely impact peptide yields and 
identification. Since STONE does not modify ε-amino groups, in theory it is ideal for 
identifying in vitro protease substrates and minimising the peptide loss. Furthermore, this 
approach is less instrument-intensive in comparison with N-terminal COFRADIC and 
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ChaFRADIC. Finally, STONE is highly versatile in terms of potential applications. In addition to 
the proposed usage as a positive selection approach, STONE can also be implemented in the 
negative mode to enrich and identify blocked protein N-termini (Sonomura et al., 2009a). In 
principle, it can be combined with N-terminal COFRADIC or ChaFRADIC as well. Similar to 
these approaches, STONE prolongs the RT of internal peptides during RP-HPLC and removes 
a positive charge from each internal peptide, whereas blocked protein N-termini are 
unaffected. Apart from complementing other N-terminalomic approaches, STONE in its 
simplest form also increases proteome coverage when combined with shotgun proteomics.  
With respect to the NHS-Sepharose approach, future research should focus on improving 
the efficiency of free amine scavenging that ultimately leads to improved enrichment of 
protein N-termini. Recently, Yeom et al. (2017) described a negative selection protocol built 
upon the NHS-Sepharose approach (referred to as “N-terminal peptides enrichment on the 
filter” or “Nrich”). It combined the removal of internal peptides by NHS-activated Sepharose 
with alternative primary amine blocking (see below) and filtered aided sample preparation 
(FASP). Iterative interrogations of the acquired MS/MS data using either Swiss-Prot or a 
customised N-terminal database reported a 50 – 80 % enrichment of protein N-termini. This 
result implies that compartmentalisation of different chemical reactions reduces the 
interference from internal peptides. 
The Nrich approach employed two parallel reactions, propionation or isotopic acetylation, to 
block all primary amines. Both reactions enabled discrimination between endogenously 
modified and free protein N-termini. Each reaction was then followed by either tryptic or 
Glu-C digestion. As a result, nearly 5,000 protein N-termini were identified with high 
confidence since they were present in at least two (out of a total of four) independent 
experiments. In view of this report, we argue that the use of orthogonal methods will greatly 
increase the confidence of peptide assignments. Such orthogonal methods include not only 
the implementation of multiple N-terminalomic strategies, but also isotopic/isobaric 
labelling and parallel protease digestions. Among them, the use of multiple proteases has 
already been shown to improve the identification of low-abundance proteins in a complex 
proteome and to increase the protein sequence coverage by ~ 200 % (Swaney et al., 2010). 
The simplicity and versatility of STONE should permit its use as an orthogonal method to 
complement both positive and negative selection approaches to identify protein N-termini 
or protease substrates. However, a premise of such potential applications is the optimal 
performance of this approach. In its current state, STONE exhibits varied reaction 
efficiencies depending on different N-terminal residues. Even efficiently transaminated 
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proteins or peptides may further yield multiple side products, which could potentially exist 
in higher abundances than the anticipated transamination product. Consequently, future 
studies should focus on systematic refinement of the experimental conditions. For instance, 
addition of ethylenediaminetetraacetic acid (EDTA) has been suggested to stop the reaction 
and suppress the formation of  side products (Sarkar et al., 1978).  
Once optimised, STONE can be combined with relative (e.g. stable isotope labeling with 
amino acids in cell culture, SILAC) and absolute quantitative techniques such as selected 
reaction monitoring (SRM) or sequential window acquisition of all theoretical fragment-ion 
spectra (SWATH) to measure the abundance of identified protein N-termini. In the future, it 
is also desirable to invent one-step (or one-pot) tagging reactions based upon the STONE 
method. This type of strategy is exemplified by the N-terminal modification with 2-
pyridinecarboxaldehyde (2PCA; MacDonald et al., 2015) and metal-free click chemistry (Ning 
et al., 2010). Such reactions will undoubtedly improve tagging efficiency, reduce sample loss, 
and eliminate the chance of nonspecific tagging. In conclusion, the simplicity and versatility 
of STONE and its potential derivatives may drastically advance research in positional 
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